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Pippa Anderson,3 Chris Tweed,1 Charlotte Grey,1 Shiyu Jiang,1
Rhodri Johnson,2 Alan Watkins2 and Thomas G Winfield3
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Background: Cold homes and fuel poverty contribute to health inequalities in ways that could be
addressed through energy efficiency interventions.
Objectives: To determine the health and psychosocial impacts of energy performance investments in
low-income areas, particularly hospital admissions for cardiorespiratory conditions, prevalence of respiratory
symptoms and mental health status, hydrothermal conditions and household energy use, psychosocial
outcomes, cost consequences to the health system and the cost utility of these investments.
Design: A mixed-methods study comprising data linkage (25,908 individuals living in 4968 intervention
homes), a field study with a controlled pre-/post-test design (intervention, n = 418; control, n = 418),
a controlled multilevel interrupted time series analysis of internal hydrothermal conditions (intervention,
n = 48; control, n = 40) and a health economic assessment.
Setting: Low-income areas across Wales.
Participants: Residents who received energy efficiency measures through the intervention programme
and matched control groups.
Main outcome measures: Primary outcomes – emergency hospital admissions for cardiorespiratory
conditions, self-reported respiratory symptoms, mental health status, indoor air temperature and indoor
relative humidity. Secondary outcomes – emergency hospital admissions for chronic obstructive pulmonary
disease-related cardiorespiratory conditions, excess winter admissions, health-related quality of life,
subjective well-being, self-reported fuel poverty, financial stress and difficulties, food security, social
interaction, thermal satisfaction and self-reported housing conditions.
Methods: Anonymously linked individual health records for emergency hospital admissions were analysed
using mixed multilevel linear models. A quasi-experimental controlled field study used a multilevel repeated
measures approach. Controlled multilevel interrupted time series analyses were conducted to estimate
changes in internal hydrothermal conditions following the intervention. The economic evaluation
comprised cost–consequence and cost–utility analyses.
Data sources: The Patient Episode Database for Wales 2005–14, intervention records from 28 local
authorities and housing associations, and scheme managers who delivered the programme.
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Results: The study found no evidence of changes in physical health. However, there were improvements
in subjective well-being and a number of psychosocial outcomes. The household monitoring study found
that the intervention raised indoor temperature and helped reduce energy use. No evidence was found of
substantial increases in indoor humidity levels. The health economic assessment found no explicit cost
reductions to the health service as a result of non-significant changes in emergency admissions for
cardiorespiratory conditions.
Limitations: This was a non-randomised intervention study with household monitoring and field studies
that relied on self-response. Data linkage focused on emergency admissions only.
Conclusion: Although there was no evidence that energy performance investments provide physical health
benefits or reduce health service usage, there was evidence that they improve social and economic
conditions that are conducive to better health and improved subjective well-being. The intervention has
been successful in reducing energy use and improving the living conditions of households in low-income
areas. The lack of association of emergency hospital admissions with energy performance investments
means that we were unable to evidence cost saving to health-service providers.
Future work: Our research suggests the importance of incorporating evaluations with follow-up into
intervention research from the start.
Funding: The National Institute for Health Research Public Health Research programme.
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Plain English summary
What was the question?
Living in cold homes can be harmful to people’s mental and physical health. In this study, we wanted to
see whether or not improving the energy efficiency of homes, through measures such as wall insulation
and new heating systems, could improve the health of people living in them.
What did we do?
We analysed the health records of people who received energy efficiency measures to assess changes in
emergency admissions to hospital over time. We also interviewed residents before and after they received
energy efficiency measures, and monitored the homes of a smaller number of households.
What did we find?
We found that energy efficiency measures contributed to people’s general well-being by making homes
warmer, and easier and cheaper to heat to a comfortable level. Warmer homes also made people feel less
socially isolated. However, we found no evidence that energy efficiency measures improved people’s
mental and physical health.
What does this mean?
Improving the energy efficiency of homes provides social and economic benefits to people living in them.
However, area-based programmes may not improve chronic health conditions, reduce the number of
hospital visits or reduce costs for the health service.
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxi

Scientific summary
Background
Research suggests that living in fuel poverty and cold homes contributes to poor physical and mental health,
and that interventions targeted at those living in poor-quality housing may lead to health improvements.
Most studies thus far have focused on a limited number of health outcomes and have excluded psychosocial
outcomes that may be part of pathways to health. Furthermore, anonymous data linkage of routinely
collected health-service utilisation data has not been used before to examine the impact of energy efficiency
improvements. The overall aim of the study was to determine the health and psychosocial impact of energy
performance investments in low-income areas through a mixed-methods programme of work. The research
focused on a major investment programme that took place in Wales in two separate phases between 2010
and 2015.
Objectives
The project aimed to determine the impact of an energy performance investment programme on
(1) hospital admissions for cardiorespiratory conditions, (2) the prevalence of respiratory symptoms and
mental health status of residents, (3) internal hydrothermal conditions and household energy use and
(4) psychosocial outcomes that may be part of pathways to health. It also aimed to (5) estimate the costs
and consequences of the energy performance investments to the health system and (6) undertake a
cost–utility analysis (CUA) of these investments.
Methods
The project used multiple methods to evaluate the health impact of energy performance investments
in low-income neighbourhoods, including data linkage, a community-based field study, a household
monitoring study and an economic evaluation. The project included a number of qualitative focus groups
as part of the resident engagement.
Data linkage study
Data linkage was used to undertake a longitudinal analysis of residents living within homes who received
energy efficiency improvements in 2010 and 2011. Routinely collected data were anonymously linked to
intervention records provided by local authorities (LAs) and social housing providers who delivered the
schemes. Counts of emergency hospital admissions from 2005 to 2014 were extracted from the Patient
Episode Database for Wales. Primary health outcomes were obtained for baseline and follow-up periods
for 25,908 people residing within the intervention homes (n = 4968) as well as for two comparator
populations: 48,261 people living in 12,350 social homes and 524,596 people living in 118,982 homes
in the top 10% of deprived areas according to the Welsh Index of Multiple Deprivation. Mixed multilevel
linear regression models were constructed to assess associations of change in cardiorespiratory emergency
admissions before and after the intervention, adjusting for potential confounders.
Community-based study
The community-based study had a quasi-experimental, controlled before-and-after design (intervention,
n = 364; control, n = 418) to investigate the short-term health and psychosocial impacts of the
intervention. The community-based study specifically focused on schemes that were delivered in 2014
and 2015. Matched control areas were identified with the assistance of LAs. Data were collected through
self-completion questionnaires in the winters before and after installation of energy efficiency measures,
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii
and at the same time in the matched control areas. The primary health outcomes were changes in mental
health status and self-reported respiratory and asthma symptoms. Secondary health outcomes were
changes in self-reported health-related quality of life (and subjective well-being). Secondary psychosocial
outcomes included changes in fuel poverty status, financial difficulties and stress, food security, social
interaction, thermal satisfaction and reported housing conditions. Data were analysed using a multilevel
modelling, repeated measures approach, with measurement occasions nested within the intervention or
control individuals.
Household monitoring study
The household monitoring study used a quasi-experimental, controlled before-and-after design consisting
of high-resolution long-term monitoring of indoor air temperatures and relative humidity (RH) levels in two
consecutive heating seasons, before and after energy efficiency improvements, and controlled for external
hydrothermal conditions. The final data set consisted of 99 households (intervention, n = 50; control,
n = 49) at baseline and 88 households (intervention, n = 48; control, n = 40) at follow-up that were
observed for a minimum of 4 weeks in the two periods. The main outcomes of the household monitoring
study were average indoor air temperature and RH at different times of the day and in different rooms
within the home, and the average daily duration and cumulative substandard internal hydrothermal
conditions (i.e. the duration and time intensity integral of indoor temperatures of < 18 °C or < 16 °C and
RH levels of > 60%). The final data consisting of 15,771 data points were analysed by constructing a series
of controlled multilevel interrupted time series regression models.
Economic evaluation
The main health economic evaluation involved a cost–consequence analysis (CCA) and a CUA utilising the
health outcomes from the data linkage study and utility values from the literature. The CCA considered
resource use and cost impacts of the intervention associated with secondary care. The health consequences
for the CCA were changes in emergency hospital admissions for cardiovascular and respiratory conditions.
The CUA was undertaken using utility values for the relevant chronic obstructive pulmonary disease (COPD)
health states for people who experienced an emergency hospital admission for an exacerbation. Each
adverse health event resulting in an emergency hospital admission had a survival curve mapped from these
utility values across the study period. This approach incorporated an initial impact of the event on utility
and a time-variable component, using the area under the curve approach to generate an incremental
cost-effectiveness ratio (ICER). Negative binomial regression models were constructed for both the CCA
and CUA.
Resident engagement
A reconvened focus group study was conducted as part of the wider resident engagement of the project.
Three focus groups were held with residents before (n = 28) and then again after (n = 22) they received
energy efficiency improvements under the intervention programme. The focus groups were conducted to
obtain a better understanding of the views and experiences of residents living in energy-inefficient houses,
and to explore the ways in which the intervention may have improved those experiences. The recorded and
transcribed discussions were analysed according to the themes of health and well-being, thermal comfort,
staying warm and the use of living space, fuel poverty and experiences with the intervention programme.
Results
Data linkage study
The data linkage study assessed the impact of the intervention on health service use. No significant effect
was found on our primary outcome of cardiorespiratory emergency hospital admissions [adjusted results:
Δ 0.0011, 95% confidence interval (CI) –0.0103 to 0.0125]. No association was found with admissions for
respiratory-related conditions (Δ 0.0042, 95% CI –0.0046 to 0.131), COPD (Δ 0.0002, 95% CI –0.0025 to
0.0022) or cardiovascular conditions (Δ 0.0014, 95% CI –0.0083 to 0.0055). We subsequently analysed the
same outcomes for people aged ≥ 60 years. No evidence was found that the intervention had a significant
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effect on outcomes, with the exception of cardiovascular-related emergency hospital admissions.
A significant increase was found in cardiovascular-related emergency hospital admissions after adjusting
for potential confounders (Δ 0.0273, 95% CI 0.0068 to 0.0479).
Community-based study
The community-based study found no evidence that investments in energy efficiency improve respiratory
or mental health in the short term. It was found that, after controlling for sex, age, housing benefits,
household income and smoking status, investments were not associated with improvements in Mental
Health Composite Scale scores [unstandardised regression coefficient (B) 0.00, 95% CI –1.60 to 1.60],
self-reported respiratory symptoms (B –0.14, 95% CI –0.54 to 0.26) or self-reported asthma symptoms
(B –0.14, 95% CI –0.54 to 0.25). Furthermore, no evidence was found that they provide physical health
benefits in the short-term, as indicated by Short Form questionnaire-12 items Physical Health Composite
Scale scores (B 0.38, 95% CI –0.34 to 2.29). The study found that, compared with participants in control
households, participants who received the intervention reported improved subjective well-being (B 0.38,
95% CI 0.12 to 0.65; p = 0.004) as well as fewer financial difficulties (B –0.15, 95% CI –0.25 to –0.05;
p = 0.003), higher thermal satisfaction [odds ratio (OR) 3.83, 95% CI 2.40 to 5.90] and higher satisfaction
with the improvement of their homes (OR 3.87, 95% CI 2.51 to 5.96). Participants in the intervention
group were also less reluctant to invite friends or family to their homes after they received the energy
efficiency measures (OR 0.32, 95% CI 0.13 to 0.77; p = 0.012). The results were similar before and after
controlling for socioeconomic covariates selected a priori.
Household monitoring study
The study found that the intervention raised indoor air temperature by an average of 0.84 °C (95% CI 0.64
to 1.04 °C), whereas daily gas usage dropped by an average of 37%. Similar increases were observed across
different heating demand conditions. The largest changes were observed in the evening (1.17 °C, 95% CI
0.94 to 1.39 °C) and at night (1.01 °C, 95% CI 0.79 to 1.24 °C), and in the living room (1.01 °C, 95% CI
0.78 to 1.23 °C) and bedroom (1.28 °C, 95% CI 1.04 to 1.52 °C), suggesting that the biggest increases were
for spaces that were in use. The intervention measures were not equally effective: external wall insulation
(1.12 °C, 95% CI 0.69 to 1.55 °C) and connection to the gas mains network (0.69 °C, 95% CI 0.29 to
1.09 °C) significantly increased indoor air temperatures; windows and doors (–0.02 °C, 95% CI –0.39 to
0.35 °C) or a new heating system (–0.19 °C, 95% CI –0.69 to 1.09 °C) did not.
Overall, the intervention did not increase indoor RH levels (0.04% RH, 95% CI –0.74% to 0.83% RH),
although some individual measures did. Both a gas network connection (3.86% RH, 95% CI 2.31% to
5.41% RH) and the installation of new windows and doors (5.15% RH, 95% CI 3.73% to 6.57% RH)
increased indoor RH levels. External wall insulation (–0.60% RH, 95% CI –2.26% to 1.06% RH) and
installation of boilers or heating systems (–1.59% RH, 95% CI –3.52% to 0.34% RH) did not change
indoor RH levels.
The intervention reduced the cumulative amount of indoor air temperature of < 18°C (3.62 °C·hour,
95% CI –6.95 to –0.30 °C·hour) and < 16 °C (4.20 °C·hour, 95% CI –6.64 to –1.76 °C·hour) and
the average daily duration (1.14 hours, 95% CI –2.00 to –0.28 hours) and cumulative amount
(19.32% RH·hour, 95% CI –29.68% to –8.96% RH·hour) of indoor RH levels of > 60%.
Economic evaluation
In the CCA, the disaggregated outcomes derived from the intervention were balanced against the costs.
The intervention resulted in no meaningful change in emergency admissions from the pre-intervention
period. When undertaking the CUA, exploring the impact on quality-adjusted life-years (QALYs) of the
change in rate of emergency admissions for people with COPD, the small non-significant change in
emergency admissions for COPD is overpowered by the cost of the intervention, and the ICER of > £10M
per QALY gained is not cost-effective using commonly accepted norms, even with discounted costs and
benefits to present-day values in line with best practice.
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Resident engagement
The reconvened focus group study found that living in a cold home was generally viewed as depressing,
stressful and detrimental to both mental and physical health. According to residents, the energy efficiency
work made great improvements to their comfort and indoor temperatures, opened up spaces within the
home and substantially reduced their heating bills. This not only helped to relieve financial stress and fuel
poverty but made them less reluctant to invite others to their homes. Residents felt that physical health
improvements following the work were secondary to improvements in thermal comfort and their ability
to invite friends and family into their homes. Although the improvements were, for the most part,
positively received by residents, and clearly fulfilled the goal of the programme to make homes warmer
and cheaper to heat, the focus group study identified the need to consider community engagement and
communication to involve residents more closely in the decision-making and delivery of affordable
warmth programmes.
Discussion
The research found no evidence of demonstrable effects of the intervention on health or health service
utilisation in the short and medium term. As a result, the health economic analysis concluded that the
intervention may not be considered cost-effective in a traditional sense. These findings are in line with a
recent systematic review that concluded that area-based programmes are less likely to produce measurable
health improvements than those that specifically target at-risk populations. It is nevertheless surprising
that no apparent effects were found, given that the intervention programme targeted low-income
neighbourhoods with poor-quality housing where residents were consequently at a higher risk of living in
fuel poverty.
That does not, however, mean that the intervention is without substantial merit. The main purpose of the
intervention was to deliver affordable warmth, alleviate fuel poverty and reduce CO2 (carbon dioxide)
emissions. The research found clear evidence that this was achieved. The research showed that the
intervention provided a wide range of benefits to residents. Public health decision-makers and budget
holders may feel that these improvements alone are worth the investments. The lack of association with
emergency hospital admissions may indicate that benefits do not show up in hospital statistics; future
evaluations should perhaps focus on less-severe conditions that may be treated in primary care settings.
Strengths of our study include the use of multiple methods to explore the health impacts of a government-
led energy efficiency programme. Together, the methods provide a more comprehensive evaluation of
the intervention than could have been delivered by a single method alone. For example, although the
community-based field study was subject to a number of biases, it was able to cover a wider range
of subjective psychosocial outcomes and, although routine data may lack detail regarding subjective
health experiences, it minimises selection and attrition biases with near-complete follow-up. Household
monitoring showed objective changes in internal hydrothermal conditions, and focus groups provided
an in-depth exploration of how residents experienced the intervention. Limitations included a lack of
randomisation and, as with all observational studies, the potential for unmeasured confounding remains.
Data quality was also an issue. The effort required to validate and clean intervention records received from
data providers was considerable, and there was missing data for many intervention homes.
Future housing improvement programmes should build in health and economic evaluation components
from conception with longer follow-ups; strategies may then be developed to increase response and
retention rates. A stepped wedge randomisation in the delivery of a programme, together with improved
reporting standards regarding the timing, delivery and costs, would provide more-robust evidence
regarding health and psychosocial benefits. This research has shown that the use of multiple methods is
preferable over single-method evaluations, and that there is a need to directly compare area-based with
more-targeted affordable warmth programmes. Finally, process evaluation should become an essential part
of testing complex housing-based interventions.
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Chapter 1 Background and aims
Introduction
It has long been recognised that poor housing conditions can have a detrimental impact on health.1 Early
evidence, dating back to the late nineteenth century, suggested a link between cold and damp housing
and poor physical health.2 At around that same time, cold and damp living conditions were also linked to
poor mental health.3 However, it has only been within the past 10–20 years that empirical studies have
drawn strong links between housing quality and health.4
The recent literature on housing and health has shown that low indoor air temperatures are associated
with increased risk of stroke, heart attack and respiratory illness in temperate climates, as well as with
common mental disorders.5 Countries with the lowest thermal efficiency standards have the highest levels
of excess winter mortality and people living in the least energy-efficient housing are at higher risk of death
than those living in more energy-efficient homes.6–8 Excess winter deaths are almost three times as high in
cold homes as in warm homes.6,8 The World Health Organization (WHO) estimates that 40% of excess
winter deaths are caused by living in a cold home.9
Excess winter mortality is thought to be linked predominantly to circulatory and respiratory conditions.6,10–12
Prolonged exposure to low temperatures can have an impact on blood pressure and blood chemistry13–15
as well as blood viscosity and vasoconstriction.16,17 Low temperatures can also suppress the function of
the immune system,18 raising the risk of respiratory infection among vulnerable groups.10 Living in low
temperatures has been linked to a higher prevalence of respiratory infections and hospital admissions
among the elderly,19–21 as well as to increased severity and frequency of asthmatic symptoms in children.4
Low indoor temperatures can also encourage the development of damp and mould in the home,22 which
are known risk factors for respiratory disease in adults23–26 and children.22,27
In addition to links with cardiorespiratory conditions and excess winter mortality, living in cold and damp
homes has been associated with negative impacts on mental health.6,28,29 Living in cold and damp homes
may be stressful for a number of reasons, including stigmatisation, financial worries, a lack of control
over the living environment and prolonged thermal discomfort.6,30–33 Harris et al.29 found that people with
common mental disorders are also more likely to experience different aspects of fuel-related poverty; living
in a cold home, the presence of mould and using less fuel than needed because of worries about costs
were all found to be associated with common mental disorders, even after adjusting for financial and
socioeconomic factors. Living in a cold home may also have an impact on social interactions:31 it may
make people reluctant to invite others into their homes and it may prevent them from going out as a
result of financial concerns and fears of returning to a cold home.4,6,34 Social isolation can increase the
risk of depression and coronary heart disease, thereby having the potential to exacerbate the negative
effects of living in a cold home.35
Those affected by fuel poverty often adopt various strategies to deal with their financial circumstances.36
Households may reduce fuel usage through rationing, or self-disconnect where pre-payment meters are
present.37–41 Studies have found that fuel-poor households reduce lighting usage or limit their consumption
of hot water.42–44 Others may trade warmth for other essentials, such as food.34,45,46 This phenomenon has
become known as the ‘heat-or-eat’ dilemma.45,46 When heating is prioritised, disposable income and food
choices become restricted, affecting both the quantity and quality of foods purchased and consumed.34,36
Households may also choose not to adopt coping strategies and instead continue their normal spending
patterns, which can lead to arrears in fuel payments and the accumulation of debt.47
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Health impacts of energy efficiency improvements
It is clear that housing quality is associated with a range of health and psychosocial outcomes. However,
most evidence is derived from cross-sectional research. This is problematic, as those living in poor housing
are most likely to be socioeconomically deprived and have long-standing illness. The causal pathways
between poor housing and poor health can therefore be determined only by intervention studies. In a
systematic review of the literature, Thomson et al.48 identified 39 housing intervention studies that
reported quantitative or qualitative data on health and associated socioeconomic outcomes. Of these,
19 evaluated affordable warmth and energy efficiency improvements relevant to modern-day housing
conditions (i.e. post 1985), including five randomised controlled trials, five controlled before-and-after
studies and five uncontrolled or retrospective studies. Thomson et al.48 concluded that affordable warmth
and energy efficiency measures may produce improvements in general health, respiratory health and
mental health, but that interventions targeting at-risk populations (i.e. those with inadequate warmth and
pre-existing conditions) are more likely to be successful than general, area-based, programmes.
Two randomised controlled studies conducted in New Zealand by Howden-Chapman et al.49,50 found that
improving energy efficiency through insulation improved respiratory health in both children and adults, and
that improved non-polluting heating systems reduced symptoms of pre-existing asthma in children. In the
case of asthmatic children, benefits could be linked to the rise in temperature in both the living room and
the child’s bedroom as well as lower levels of nitrogen dioxide.50 In a randomised trial, Barton et al.51
found substantial reductions in non-asthma-related chest problems and the number of reported asthma
symptoms among the intervention group for both adults and children.
Energy efficiency measures also appear to be beneficial for mental health, although studies have shown
mixed results.48 Howden-Chapman et al.49 found significant improvements in three subscales of the Short
Form questionnaire-36 items (SF-36), namely in the ‘happiness’, ‘vitality’ and ‘role emotional’ scales.
However, the authors did not report the overall results for the Mental Health Composite Scale (MCS).
Barton et al.51 found no significant differences between the intervention and control groups regarding
the mental health subscales of either the SF-36 or the General Health Questionnaire-12 items. Braubach
et al.52 similarly found non-significant differences in self-reported depression between the intervention and
control groups. The authors noted that the follow-up questionnaire was distributed within a few months
of the intervention, and that detailed analysis of the data had not been undertaken in order to better
understand the impacts of both time and socioeconomic variables such as age. Shortt and Rugkåsa53
reported that stress and mental illness increased significantly in the control group but showed a
non-significant decrease in the intervention group.
Psychosocial impacts of energy efficiency improvements
Studies examining the impacts of energy efficiency improvement programmes have thus far focused
primarily on a limited number of health outcomes. Few large-scale controlled studies have been
undertaken to understand the wider psychosocial impacts of such programmes.48 The predominantly
qualitative literature suggests two inter-related pathways that may link energy efficiency investments to
better mental and physical health.54–56 The first pathway is the process in which energy efficiency
improvements to homes lead to better thermal living conditions, through improved indoor air temperature
and decreased humidity, both of which contribute to reduced damp-related housing problems.57 Warmer,
drier homes can contribute to improved respiratory health, and also better mental health through
improved thermal satisfaction,58 expanded living space and reduced social interactions.59 The second
pathway is the process in which energy efficiency measures lead to improved well-being by making
heating more affordable.6 Reduced spending on heating bills alleviates financial stress and fuel poverty
among low-income households,60,61 and helps to free financial resources for better food security45,46 and
reduced social isolation.31 Social isolation may reduce further because people may become less reluctant to
invite people into their homes with improved internal conditions.62
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Energy efficiency improvements and internal conditions
The evidence of the impact of energy efficiency improvements on indoor conditions is limited. Overall,
based on available studies that have been conducted so far, energy efficiency measures produce modest
increases in mean indoor air temperatures and small increases in mean humidity levels.48 The Warm Front
study group reported mean living room temperature increases of 0.58 °C for insulation and 1.36 °C for
heating measures, and mean bedroom temperature changes of 1.14 °C for insulation and 1.98 °C for
heating measures, with greater changes for dwellings that received both heating and insulation measures
(1.52 °C and 2.31 °C for living room and bedroom, respectively).63 Howden-Chapman et al.49 reported an
average increase in bedroom temperature of 0.50 °C and an average decrease in humidity level of 2.3%
relative humidity (RH). The Glasgow Warm Homes Study60 reported increases in mean temperatures of
> 2 °C in the living room and almost 3 °C in the bedroom, but no significant changes in RH levels.
More recently, there have been suggestions that increasing the energy efficiency of a home could have
detrimental effects on people’s health.64 Reduced ventilation through insulation and draughtproofing may
increase RH levels65 and, as a result, promote mould growth.66,67 Indeed, low ventilation rates and homes
with greater energy efficiency are associated with asthma and allergic symptoms in children.68–70
The evidence on energy efficiency investments and indoor conditions, however, is scant. Most research in
the area has been cross-sectional71 and has not included control households,72 spot measurements8 or
short-term monitoring.60 As previously observed by Oreszczyn et al.,68 most studies did not correct for
external conditions during the monitoring periods. Evidence for increases in RH levels has been anecdotal
or inferred from cross-sectional studies only. Raising indoor air temperatures through better insulation
should reduce RH levels unless there is inadequate ventilation.64 Overall, based on the available studies that
have been conducted to date, it appears that energy efficiency investments produce modest increases in
mean indoor air temperatures and small increases in mean humidity levels.48
Conclusion
The literature review presented here shows that housing improvements that increase the energy efficiency
of homes have the potential to improve the health of residents, in particular if they are targeting at-risk
populations with inadequate warmth and pre-existing conditions.48 However, most research involves
observational studies using self-completion questionnaires. Field studies that rely on survey methodologies
are vulnerable to biases from low response rates, attrition and self-reporting. Anonymous data linkage of
routinely collected health data, which is less vulnerable to such biases, has not, to our knowledge, been
used before to examine the impact of energy efficiency improvements (see Chapter 2).73 In addition, less is
known about the wider psychosocial impact of energy efficiency improvements. There is a distinct lack of
good-quality quantitative evidence regarding the pathways and processes that may contribute to better
health in the longer term (see Chapter 3).54 Moreover, only a limited number of household monitoring
studies have been conducted to examine the impacts of energy efficiency improvements on indoor
hydrothermal conditions. Research in this area has been marred by a number of methodological and
analytical issues and has relied on studies with relatively small sample sizes (see Chapter 4). Finally,
economic evaluations have rarely been carried out alongside housing improvement programmes to assess
their health-related quality of life and economic impacts.74 Health economic evaluations are essential to
inform policy-makers about the value for money of energy efficiency investments (see Chapter 5).
Aims of the project
In this study, we make use of a major energy performance investment programme (referred to hereafter as
‘the intervention’) that took place in Wales in two separate phases between 2010 and 2015. Arbed is,
along with Nest, part of the Welsh Government Warm Homes programme. It was established to bring
environmental, social and economic benefits to Wales through co-ordinated investments in the energy
performance of homes located in low-income areas (see The intervention). Our project aimed to examine
whether or not the investments provided additional benefits in terms of improved health of residents.
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More specifically, the project aimed to determine the impact of the intervention on (1) hospital admissions
for cardiorespiratory conditions, (2) the prevalence of self-reported respiratory symptoms and mental health
status of residents, (3) internal hydrothermal conditions and household energy use and (4) psychosocial
outcomes that may be part of the pathways to health. It also aimed to (5) estimate the costs and
consequences of the energy performance investments to the health system and (6) undertake a cost–utility
analysis (CUA) of these investments.
The intervention
The Welsh Government tries to address fuel poverty through demand-led and area-based elements.75 The
Welsh Government Warm Homes programme provides funding for energy efficiency improvements to low
income households on demand (Nest) and to those living in deprived communities across Wales (Arbed).
The research reported here focuses on the area-based Arbed (meaning ‘save’ in Welsh) programme.
The Arbed energy performance investment programme was set up in 2009 by the Welsh Government
to bring environmental, social and economic benefits to Wales. The programme was designed to improve
the energy efficiency of existing homes in low-income areas and aimed to (1) reduce the number of
households living in fuel poverty, (2) create jobs and regeneration in Wales and (3) combat climate change
by reducing greenhouse gas emissions. The programme consisted of two phases. The first phase (Arbed 1)
took place in 2010 and 2011. The second phase (Arbed 2) took place between 2012 and 2015.
Both phases of the intervention programme were Wales-wide, with work prioritised within the Welsh
Government’s seven Strategic Regeneration Areas of the Heads of the Valleys, Môn a Menai, North Wales
Coast, Western Valleys, Swansea, Aberystwyth and Barry. Many of these schemes were in old slate- and
coal-mining areas and in a number of deprived urban areas.
The first phase of the intervention programme focused specifically on energy efficiency improvements to
homes in low-income areas as identified by social housing providers. A total of £36.6M was invested by
the Welsh Government, with an additional £32M leveraged by energy suppliers, housing associations and
local councils.76 This phase consisted of 28 schemes across 18 local authorities (LAs) in Wales, and helped
to improve the energy performance of around 7500 homes. It mainly improved social housing (79%),
but also a number of privately rented and owner-occupied houses (21%). The programme funded retrofit
measures such as solid wall insulation (> 4000 homes), solar panels (> 1800 homes), solar hot water
(> 1080 homes) and heat pumps (> 100 homes). Leveraged funds from energy providers and social
housing providers were used to enable homes to receive additional measures, such as boiler upgrades
and replacements, window upgrades, roof extensions, structural work and energy saving advice.77
The second phase of the intervention programme was co-funded by the Welsh Government and the
European Regional Development Fund (ERDF), and had an overall budget of £45M. This comprised
£33M of ERDF funding and a further £12M from the Welsh Government. The second phase consisted
of 32 schemes and helped to improve the energy performance of > 4800 homes. In contrast to the first
phase, which primarily focused on social housing, the second phase of the intervention programme
specifically targeted mixed-tenure, low-income neighbourhoods that had a high number of hard-to-heat,
hard-to-treat homes, and when, as a result, people were at a higher risk of living in fuel poverty.
‘Hard-to-heat, hard-to-treat’ is a term used for low-energy-performance dwellings that, for whatever
reason, cannot accommodate staple or cost-effective fabric energy efficiency measures.78 Typical energy
efficiency measures included external wall insulation, heating system upgrades (including gas combination
boilers, heating controls and central heating systems), voltage optimisers and connecting communities to
the gas mains network.
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Both phases of the intervention programme aimed to boost local economies by using local businesses to
manufacture, supply and install as many of the measures as possible and provide training and employment
opportunities for local workers through a tendering process to recruit contractors and subcontractors.77
There were, however, a number of differences in the delivery of the programme between the two phases.
The first phase of the programme was managed by LAs and social housing providers themselves, and
delivered through contractors and subcontractors. The LAs and social housing providers submitted
proposed schemes to the Welsh Government, which decided which were to be funded. The second phase
of the programme was managed by two scheme managers: Melin Homes, a housing association, managed
schemes in South Wales; and Wilmott Dixon, a private construction company, managed schemes in North
and Mid Wales.
Local authorities were invited by the Welsh Government to propose schemes based on scoring criteria
using proxies to identify areas at fuel poverty risk, and once a scheme was approved this was passed
on to the two scheme managers for work to commence. The selected areas were visited by surveyors to
determine the most appropriate and cost-effective measures for the schemes. Contractors were used
to deliver the improvement work, overseen by the two scheme managers. The areas were subsequently
visited by representatives and community events were set up to encourage households to sign up for the
improvement programme.
For both phases, depending on the measures chosen for each home, residents would have been in contact
with representatives of the scheme managers who recruited householders to the scheme, chose suitable
measures for the property and allocated selected contractors and businesses to undertake the work. Each
household would have been in contact with a variety of stakeholders from start to finish, including, but
not exclusively, scheme managers, community engagement teams, project managers and contractors
including building surveyors, scaffolders, insulation installers and central heating engineers. The process
from initial contact with householders through community engagement to finishing the whole scheme
could take up to a year or, in a few cases in which the work was delayed, longer.
A TIDieR (Template for Intervention Description and Replication) checklist is provided in Appendix 6.
The project
The project provided a multimethod investigation of the health impacts of energy performance investments
in low-income neighbourhoods through four interlinked studies. The project comprised the use of the
Secure Anonymised Information Linkage (SAIL) databank, a community-based field study, a household
monitoring study and an economic evaluation. In addition, the project included a number of resident
engagement activities.
The SAIL databank was used to retrospectively evaluate the first phase of the intervention programme.
SAIL is an ethically approved tool, developed and hosted by Swansea University, that ensures that
individuals remain anonymous and retain the ability to make links between different data sets.79
Intervention records of the first phase of the programme were anonymously linked to individual health
records to determine the impacts of the intervention on hospital admissions for cardiorespiratory
conditions. Data generated in this work package were used in the economic evaluation to calculate the
cost savings of the investments to the health system. Findings of the data linkage study are reported in
Chapter 2.
A community-based study was set up to evaluate the second phase of the intervention programme. The
field study aimed to determine the impact of the intervention on the prevalence of respiratory conditions
and mental health status of residents as well as on psychosocial outcomes that may be part of pathways to
health. The findings of the community-based study are reported in Chapter 3.
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Chapter 4 presents the results from the household monitoring study. The household monitoring study was
conducted to determine the impact of the intervention on internal hydrothermal conditions. It further
provided evidence on whether or not the intervention resulted in lower household energy use and an
expansion of living space.61 Gas and electricity meter readings were taken during the installation and
collection visits to determine the impacts of the programme on household energy use.
The fourth study, reported in Chapter 5, presents the results of an economic evaluation of the energy
performance investments. Data from both the data linkage and community-based studies were used to
determine whether or not the investments improved public health over and above the other intended
benefits of the programme. A cost–consequences analysis (CCA) compared the costs of delivering the
intervention to the cost savings as a result of reduced health service use. A CUA estimated the benefits of
the programme as a result of improving the quality of life of residents of low-income neighbourhoods.
Resident engagement
A reconvened focus group study was conducted as part of the wider resident engagement of the research
project. Three focus groups were held with residents before and after they received energy efficiency
improvements in the second phase of the intervention programme. The aims of the focus groups were
to obtain a better understanding of the views and experiences of residents living in energy-inefficient
(hard-to-heat, hard-to-treat) houses, and the ways in which the programme may have changed those
experiences. The protocol of the focus group discussions can be found in Appendix 1. The results of the
reconvened focus groups are summarised in Appendix 2, with the consolidated criteria for reporting
qualitative research (COREQ) checklist provided in Appendix 3. A number of focus group participants were
subsequently invited to form a resident panel, which met on three occasions throughout the project and
contributed to the biannual study steering committee (SSC) meetings. The resident panel provided advice
on how to disseminate the findings at the end of the project. Findings of the community-based and
household monitoring studies were disseminated through an easy-to-understand key findings brochure
(see Appendix 4) and three community dissemination meetings. Appendix 5 shows the pull-up banner that
was used in meetings.
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Chapter 2 The data linkage study
Introduction
This chapter follows the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)
reporting guidelines for observational study designs.81
Background
This chapter describes the retrospective evaluation of the first phase of the intervention programme
that ran in 2010 and 2011. The evaluation used anonymised, routinely collected health records held
within the SAIL databank.82,83 Intervention records of the first phase of the intervention programme were
anonymously linked to individual health records to determine the impact of the intervention on hospital
admissions for cardiorespiratory conditions and a number of secondary outcomes. The study used data on
emergency hospital admissions for cardiovascular and respiratory conditions held in the Patient Episode
Database for Wales (PEDW), which contains all hospital records for people treated at hospitals in Wales.
Governance approval (reference SAIL0273) for this research was received from the independent
Information Governance Review Panel (IGRP) in March 2014. Membership of the IGRP consists of senior
representatives from the British Medical Association, National Research Ethics Service, Public Health Wales,
NHS Wales Informatics Service (NWIS) and the SAIL Consumer Panel.
Objectives
The overall aim of this study was to examine the long-term impact on health-care utilisation of energy
efficiency investments. In particular, the study aimed to establish the change in the primary outcome of
emergency hospital admissions for cardiovascular and respiratory conditions combined for people of all
ages following the intervention.
The study had four secondary outcomes:
1. Change in emergency hospital admissions for cardiovascular conditions for people aged ≥ 60 years,
and for people of all ages, following the intervention.
2. Change in emergency hospital admissions for respiratory conditions for people aged ≥ 60 years, and for
people of all ages, following the intervention.
3. Change in emergency hospital admissions for chronic obstructive pulmonary disease (COPD) conditions
for people aged ≥ 60 years, and for people of all ages, following the intervention.
4. Change in excess hospital admissions during the winter months for people aged ≥ 60 years, and for
people of all ages, following the intervention.
Methods
Study design
The data linkage study consisted of a quasi-experimental analysis of residents living within homes having
undergone energy efficiency improvements. The research utilised individual-level health data held within
the SAIL databank anonymously linked with property-level intervention data provided by the housing
scheme operators. Intervention and comparator groups were created through retrospective analysis of SAIL
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data from interventions carried out in 2010 and 2011. Health outcomes were obtained for the entire
period that residents were present within the homes.
Setting
In the first phase of the intervention programme, a total of £68M was invested, including leveraged
funding. The programme had the joint aims of delivering affordable warmth, alleviating fuel poverty,
reducing CO2 (carbon dioxide) emissions and boosting economic development and regeneration in Wales.
LAs and registered social landlords (RSLs) submitted project plans to improve the thermal efficiency of
homes in Wales. The majority of homes were social homes. Work for 28 schemes was carried out in 2010
and 2011; it covered a wide geographical area across Wales and is referred to as the intervention study
group (Figure 1).
Participants
Intervention home addresses and measures were collated and imported into the SAIL databank through a
split file method designed to maintain the anonymity of people living in the properties.83 The first part of
the split file containing addresses and unique property reference numbers was sent to a trusted third party,
the NWISs, and replaced with a Residential Anonymous Linking Field (RALF).79,84 The RALFs were securely
transferred to the SAIL databank with a further level of encryption added by the SAIL technical team prior
to being made available to researchers under controlled data access agreements. The second part of the
split file contained intervention data with no identifiable data. This file was issued directly to SAIL and the
two files were re-linked in the SAIL databank after removing the address data.
A similar split file method was followed to create anonymous (individual) linking fields (ALFs) for each
person in the SAIL databank.82 The first part of the split file containing identifiable data (including names
and dates of birth) was issued to NWIS and replaced with the ALF prior to a further level of encryption
(a) (b)
FIGURE 1 Locations (in blue) of (a) the top 10% of deprived areas; and (b) the intervention areas.
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added prior to researcher data access. Data relating to health-care utilisation and other administrative data,
as supplied to SAIL in the second half of the split file process, was relinked in the SAIL databank, ensuring
that anonymity was maintained.
The encrypted property-level (RALF) data is linked to individual-level (ALF) data in the Welsh Demographic
Service (WDS) data set, which contains details of every person registered with a general practitioner (GP)
in Wales along with their address histories and are based on addresses registered with a GP. We extracted
people living within intervention properties according to our study inclusion criteria: a person needed to be
resident in the property for ≥ 60 days during the study period (2005–14). People were retained in the
study if they were living in the property during the intervention, moved out pre intervention or moved in
post intervention. We used multilevel modelling methods that take into account unbalanced data; people
did not need to be in the study for both the before and after phases.
Obtaining individual ALFs registered as occupants of the houses in our study allowed us to link to
individual-level health data and mortality records without ever seeing personal, identifiable information or
low-level geographical information.
The same method was applied for two groups of comparator homes. Social housing addresses from a
Welsh LA were provided for the first comparator group. The second comparator group comprised all
homes located in the top 10% of deprived lower super output areas (LSOAs) in Wales, based on the 2011
Welsh Index of Multiple Deprivation (WIMD) income domain.
Data sources
Address and intervention data were collected through contacting and requesting standard information
from 28 LAs and RSLs. The supplied information was collated into a master data set by researchers at
Cardiff University who had no access to SAIL data. This was important to maintain data privacy so the SAIL
data analyst did not have access to both the identifiable address data and the anonymised version. The
data were subsequently imported into SAIL through a split file method by our trusted third-party supplier,
as described previously. The procedure ensured that the anonymity of homes and, thus, residents was
maintained. Intervention dates were received in SAIL in a non-standard, non-codified manner. Data
cleansing was carried out within the SAIL databank to reformat intervention dates and descriptions with a
number of rules applied, described in Participants.
A Welsh LA provided all addresses of their social housing stock, which were transferred into SAIL to form
the first comparator group. A second comparator group was created by selecting LSOAs forming the top
10% of deprived areas in Wales from the WIMD 2011 income domain, then linked to homes within the
WDS containing addresses based on GP address registrations.
Homes from the three groups were linked to individual residence records across the study period within
WDS, providing start and end dates of residence.
The WIMD 2011 was used to obtain income-related deprivation data at the LSOA level. The urban/rural
classification was obtained using the Office for National Statistics (ONS) classification. Person-level
demographic data, including age and sex, were obtained from the WDS data set. When relevant, the date
of death was obtained by linking the ONS death registration data to the WDS data set. When a conflict
existed, the ONS deaths data set was used as the primary data source.
Data sets were set up in a panel design containing one record for each person within a home for each
monthly period in which they were present in the study. Study entry dates were defined as the earliest
date selected for either the date of moving into the property or the start of the study period (January
2005). Study exit dates were defined as the latest date selected for the month of death, date of moving
out of the home or the end of the study period (December 2014). Variables such as comorbidity, outcomes
and age were updated to be reflective of the specific period within the study.
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Variables
Records of emergency hospital admissions for relevant conditions from 2005 to 2014 were extracted from
the PEDW data set, which contains records of all inpatient and day case episodes of care undertaken in
NHS Wales plus data on Welsh residents treated in other UK nations (primarily England). NWIS provides
SAIL with a de-identified version of PEDW via monthly electronic feeds.
We selected the first episode from each case of emergency admissions, representing continuous periods
of inpatient care for a single patient, for diseases indicated by the selection of specific International
Classification of Diseases, Tenth Edition (ICD-10)85 codes. Total admissions were counted for each month a
person was included in the study. Our primary outcome was defined as any admission for cardiovascular
(codes I00–I99) or respiratory (codes J00–J99) reasons. Episodes representing symptoms and signs involving
circulatory and respiratory systems (R00–R09) in the first diagnostic position with no subsequent secondary
diagnosis codes were also included in the primary outcome.
The secondary cardiovascular outcome consisted of records with ICD-10 codes I00 to I99, with the
respiratory outcome identified by ICD-10 codes J00 to J99. Admissions that were attributable to COPD
were selected using a combination of age and ICD-10 codes: any age for admissions with codes J40–J44,
or R06 primary diagnostic position combined with J40–J49 any position, and codes J45–J46 for those aged
≥ 40 years (see Appendix 7).
Comorbidity was calculated using Bottle and Aylin’s86 algorithm, which was created using English National
Health Service Hospital Episode Statistics data. We amended the algorithm, opting not to include ICD-10
code C44 (Non-Melanoma Skin Cancer) within the comorbidity algorithm to avoid potential bias as a result
of differential treatment practices, which can be carried out in primary or secondary settings depending on
geographical location in Wales.
Bias
We were supplied with address details for 5801 homes, from which we were able to geocode 4968
(86%). The 14% loss of property data was a result of a number of reasons, including incomplete or
poor-quality address data, properties not present within WDS or properties with no residents registered
within the study period. This loss of properties represents potential selection bias; however, as a result of
the anonymised nature of SAIL and information governance, we were unable to explore this in more
detail. The largest risk of selection bias arises from the exclusion of 509 properties that we were unable
to link in the WDS. An analysis of non-matched properties showed that 70% were multiple-occupancy
residences (blocks and flats), with the remaining 30% predominantly in terraced housing. From our
experience, these linkage rates are typical of secondary address-level administration data.87 This indicates
a potential issue with source data and classification of properties at the National Land and Property
Gazetteer.
Loss to follow-up bias is avoided because of the use of routinely collected data in SAIL. We were able to
follow participants over a long period retrospectively, allocating health-care utilisation to individuals for the
full period they were resident within an intervention home. Potential bias arising from background trends
in emergency hospital admissions was explored by comparing changes in rates of emergency hospital
admissions between study groups over a long period, taking into account pre-, mid- and post-intervention
health-care utilisation. The trends were comparable and required no specific adjustment.
Study size
The process described in Participants generated our study data set, comprising 25,908 people living within
the 4968 intervention homes over the 10-year study period, allowing for people moving in and out of
homes. We had comparable data on two comparator groups. The first, a social housing comparator group,
contained 48,261 people living within 12,350 homes; the second, drawn from the top 10% of deprived
LSOAs in Wales, contained 524,596 people living in 118,982 homes.
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Quantitative variables
Two date fields were received in relation to the intervention: start and end date. The quality and extent of
these data were varied; some properties had both start and end dates recorded, whereas other properties
had either start or end dates or no dates at all. We reviewed the data and imputed intervention dates
based on the logic described in this section. We assumed that the month of the intervention end date
represented the start of the ‘after’ period, all data prior to this month being allocated to the ‘before’ data
collection period. Although we completed a validation exercise to ensure that we were using the correct
addresses of intervention properties, there was no available method to validate dates or intervention
measure data. We applied rules to allocate property dates by following these steps:
1. reversed dates when end date was prior to start date (n = 22)
2. calculated median days between start and end date for all homes with valid start and end dates
(median = 92)
3. for homes with a valid end date only, subtracted the median days to impute a start date
4. for homes with a valid start date only, added the median days to impute an end date
5. calculated median start and end dates for all homes after applying steps 1–4
6. applied the static start and end dates from step 5 across all remaining homes.
Statistical methods
The methodological approach, adopted for the primary and secondary outcomes and the subgroup analyses,
is based on initial investigations to assess the nature of any trends present in the observed data over the
study period. This observed data is available on a monthly basis and, for both primary and secondary
outcomes, comprises counts of events in that month. In the absence of any obvious trend over time, data on
each individual’s residence is conflated into two values, comprising the number of events occurring before
and after the intervention. To take account of the different time durations in the pre- and post-intervention
phases, these aggregated counts were transformed into annualised rates. These annualised rates were
summarised and compared using mixed multilevel linear models featuring an indicator variable for phase,
adjusting for explanatory factors and covariates, and incorporating random effects to account for clustering.
This approach takes the basic unit for clustering purposes to be a person’s unbroken period of residence
in a property, so data on an individual arising from a second residence is regarded as independent of data
collected during that individual’s first residence. This applies even if the two residences are the same, that
is, when there is a break in a person’s residence at a property. The pre- and post-intervention phases are
defined using the assumption that the intervention is effective from its end date. We set the phase
indicator to be 0 for pre intervention and 1 for post intervention, so that the coefficient for this variable
corresponds to the effect of the intervention.
We included several individual-level covariates and factors in our analyses. Specifically, we considered
covariates summarising participant age for each phase, calculated using the mid-point of residence in an
intervention study home; a seasonality score for each phase; a single comorbidity score, ranging from
0 to 1, summarising comorbidities recorded across all months; and an indicator of sex (male, female).
We also considered area-based variables recording income deprivation (summarised by five ordered
categories ranging from 1 = least deprived to 5 =most deprived) and a measure of rurality (1 = village and
hamlet, 2 = town and fringe, 3 = urban), both obtained at LSOA level.88
We defined sine-based factors for each month, taking negative values for October to March inclusive and
positive values for April to September inclusive, resulting in an aggregate factor of zero for each complete
year. Our seasonality covariate was based on seasonality scores for each phase, defined as the sum of
monthly factors across each phase.
To assess excess winter admissions, we created a binary indicator for winter or non-winter, set to 1 for
December, January, February and March, and to 0 for all other months.89
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Our modelling approach, aimed at obtaining the precise estimate of the intervention effect on each
variable in turn, used appropriate univariate linear mixed models (implicitly assuming normality) and
progressed by eliminating, in turn and starting with the least significant, all covariates and factors with
a coefficient with a p-value of > 0.05, concluding when all remaining explanatory variables were
statistically significant.
Results
Participants
Address records and intervention details for 5801 intervention homes were collated and supplied to SAIL
for the intervention. There were 172 records with insufficient address data to allow data linkage. A further
99 records were excluded as a result of multiple source records matching to individual homes held within
SAIL. A further 509 records were removed because there was no record of the home within the WDS
data set. Finally, 53 records were removed when there were no residents recorded by the WDS as living in
the home over the study period. This left 4968 properties for analyses, as shown in Figure 2. The supplied
intervention addresses were validated against a separately sourced list of addresses from the Welsh
Government, with 88% of addresses common to both sources. This is a conservative estimate because a
number of addresses from both sources had insufficient address details to generate a linkable address.
The number of individuals linked to these properties in the study period was 25,908.
Descriptive data
Our final study size was 25,908 people living within 4968 intervention homes over the study period.
We arrived at the study size through the process described in Methods, Participants and Results, Participants.
Properties
Just over 70% of intervention homes received one energy efficiency measure, around 20% received two
measures and the remainder received three or more. The most common type of intervention measure
carried out on the intervention homes was the installation of external wall insulation. Over 50% of homes
received external wall insulation, 30% received photovoltaics, 20% received solar hot water, 15% switched
fuels and 5% received an air source heat pump.
Individuals
We summarised the data by property and participant, because the interventions apply to properties
but outcomes relate to residents. Each property can house multiple residents, who can be present
simultaneously or consecutively, and each study participant can reside in multiple properties continuously
or with breaks over the study period. We have demographic data for individuals living within 136,300
distinct study homes, of which 4968 are intervention homes, 12,350 are social housing comparator homes
and 118,982 are comparator homes in areas designated in the top 10% of deprived areas by WIMD 2011.
There were 4968 properties that received the intervention (Table 1): for 2021 properties (40.7%), both the start
and end dates for the intervention were known and for a further 1739 properties (35.0%), either the start
or end date was known and the other was imputed. For the remaining 1208 properties (24.3%), both the
start and end dates were imputed. Many people moved home during the intervention period. The extent of
residential mobility is indicated by the association of several residents with multiple homes (Table 2).
Main results
Monthly emergency admission rates per person across the study period offer a visual confirmation of little
or no trend in this rate (Figure 3). There were approximately three or four admissions per month per
1000 people throughout the study. Corresponding time plots for the comparator groups showed only
weak correlation with the intervention cohort for the primary outcome, and considerable noise (see
Appendix 8). Therefore, we did not use the comparator groups to control the analyses.
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Data and model summaries for our primary outcome and several secondary outcomes are presented, firstly
for all ages (Table 3 and Figure 4) and then for older residents who are aged ≥ 60 years (Table 4 and
Figure 5). All outcomes possess both more skewness and kurtosis than is consistent with the assumption
of normality.
The intervention did not have a statistically significant effect on our primary outcome, neither did it
have a significant effect on any of our all-age secondary outcomes. Table 3 and Figure 4 show that
the intervention was not significantly associated with a change in cardiorespiratory, COPD-related,
cardiovascular or respiratory emergency admissions for people of all ages. The results include summaries of
the raw, unadjusted data for the pre- and post-intervention phases, and the paired differences for those
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FIGURE 2 The flow diagram for the intervention group.
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TABLE 1 Intervention start and end months for 2021 properties with both start and end dates known
End date
Start date
2010 2011
July August September October November December January February March May
2010
August 1
September 19
October 1 68
November 20 75
December 10 126 2
2011
January 65 79 68 2
February 83 100 86 4 9
March 76 257 50 318 116 92 74
April 45 40
May 1
June
July 8
August
September 3
October
November 80
December 2
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TABLE 1 Intervention start and end months for 2021 properties with both start and end dates known (continued )
End date
Start date
2010 2011
July August September October November December January February March May
2012
January 35
February
March 2
April
May
June
July
August
September 4
Total 19 21 323 793 138 390 167 92 74 4
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TABLE 2 Numbers of residents by property, subdivided by property groups
Intervention
only
Social housing
only
Top 10% deprived areas
only
Intervention and
social housing
Intervention
and top 10%
deprived areas
Social housing
and top 10%
deprived areas
Intervention, social
housing and top 10%
deprived areas Total
Sexa
Male 8972 19,188 255,021 331 2995 4058 131 290,696
Female 9545 19,874 254,667 367 3410 4155 157 292,175
Residents associated with
1 home 17,097 29,644 398,788 0 0 0 0 445,529
2 homes 1265 7101 79,633 454 3736 4271 0 96,460
3 homes 127 1723 21,439 183 1675 2335 112 27,594
4 homes 25 444 6472 37 583 966 99 8626
5 homes 2 110 2248 18 254 381 43 3056
6 homes 1 29 756 5 98 170 19 1078
7 homes 0 6 235 1 36 54 6 337
8 homes 0 5 69 0 14 22 5 116
9 homes 0 0 35 0 3 6 3 47
10 homes 0 0 10 0 4 5 0 19
11 homes 0 0 5 0 2 2 1 10
12 homes 0 0 0 0 0 1 0 1
Total 18,517 39,062 509,690 698 6405 8213 288 582,873
a Sex was not recorded for two residents.
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FIGURE 3 Monthly emergency admission rates per person (study month 1 is January 2005) for residents within
intervention homes.
TABLE 3 Summary of analyses for primary and secondary outcomes for the full intervention group for people of all
ages. Significant covariates are detailed in the footnotes
Outcome
Raw data, M (SD) [n]
Adjusted
comparison 95% CI
Post
intervention
Pre
intervention
Paired
differences
Primary
Annualised rate of
cardiorespiratory
emergency admissions
per persona
0.0577 (0.7079)
[18,527]
0.0543 (0.4788)
[22,209]
0.0152 (0.9144)
[12,433]
Δ= 0.0011
(p = 0.852)
–0.0103 to 0.0125
Secondary
Annualised rate of
COPD-related
emergency admissions
per personb
0.0069 (0.1150)
[18,527]
0.0062 (0.1468)
[22,209]
0.0054 (0.1526)
[12,433]
Δ= –0.0002
(p = 0.895)
–0.0025 to 0.0022
Annualised rate of
cardiovascular-related
emergency admissions
per personc
0.0171 (0.4377)
[18,527]
0.0179 (0.2709)
[22,209]
0.0108 (0.5264)
[12,433]
Δ= –0.0014
(p = 0.694)
–0.0083 to 0.0055
Annualised rate of
respiratory-related
emergency admissions
per persond
0.0371 (0.5430)
[18,527]
0.0324 (0.3720)
[22,209]
0.0045 (0.7374)
[12,433]
Δ= 0.0042
(p = 0.348)
–0.0046 to 0.0131
CI, confidence interval; M, mean; SD, standard deviation.
Significant factors and covariates (p < 0.001 unless otherwise stated):
a Age (p= 0.003), comorbidity score and sex.
b Age, comorbidity score and seasonality.
c Age, comorbidity score and seasonality.
d Age (p= 0.005), comorbidity score and sex.
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FIGURE 4 Graphical representation of the intervention effects in Table 3 (with 95% CI) by emergency admission
category for people of all ages.
TABLE 4 Summary of analyses for secondary outcomes for the intervention subgroup comprising people aged
≥ 60 years. Significant covariates are detailed in the footnotes
Outcome
Raw data, M (SD) [n]
Adjusted
comparison 95% CI
Post
intervention
Pre
intervention
Paired
differences
Primary
Annualised rate of
cardiorespiratory
emergency admissions
per persona
0.1805 (1.4538)
[2226]
0.1714 (0.8747)
[2804]
0.1152 (1.5524)
[1991]
Δ = 0.0490
(p= 0.136)
–0.0153 to 0.1132
Secondary
Annualised rate of
COPD-related
emergency admissions
per personb
0.0391 (0.2656)
[2226]
0.0386 (0.3945)
[2804]
0.0229 (0.3595)
[1991]
Δ = 0.0133
(p= 0.109)
–0.0030 to 0.0295
Annualised rate of
cardiovascular-related
emergency admissions
per personc
0.0704 (0.3725)
[2226]
0.0974 (0.7176)
[2804]
0.0313 (0.3880)
[1991]
Δ = 0.0273
(p= 0.009)
0.0068 to 0.0479
Annualised rate of
respiratory-related
emergency admissions
per persond
0.1074 (1.3990)
[2226]
0.0712 (0.4727)
[2804]
0.0835 (1.4960)
[1991]
Δ = 0.0412
(p= 0.144)
–0.0141 to 0.0964
CI, confidence interval; M, mean; SD, standard deviation.
Significant factors and covariates (p< 0.001 unless otherwise stated):
a Age, comorbidity score and seasonality.
b Comorbidity score.
c Age, comorbidity score, income category 3 and seasonality.
d Age (p= 0.003), comorbidity score and sex (p= 0.050).
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people who were in the study for both phases (irrespective of the lengths of residency periods). We
subsequently included covariates and factors in univariate linear models for each outcome, and the
adjusted comparisons are taken from models that retain all significant covariates and factors (listed at the
end of Tables 3 and 4). Age was a significant covariate in all ‘all ages’ models.
Estimates of overall intervention effects are small – for instance, the estimated Δ = 0.0011 for the primary
outcome equates to 1.1 further cardiorespiratory emergency admissions per year per 1000 people – and
generally consistent with the differences in pre- and post-intervention rates. However, widths of the
95% confidence intervals (CIs) for the intervention effect vary quite considerably across outcomes,
reflecting both prevalence and variability of that outcome in study data. There is only moderate agreement
between the (adjusted) intervention effects and the (unadjusted) paired differences in rates for those in the
study for both phases. More detailed consideration of the characteristics of that subgroup may further
reconcile these summaries.
Figure 5 shows the associations of the intervention with changes in cardiorespiratory, COPD-related,
cardiovascular or respiratory emergency admissions for people aged ≥ 60 years. This is a relatively small
subgroup, so interpretation of these results should take account of the reduced sample size. The intervention
was not linked to significant changes in emergency admissions for cardiorespiratory, COPD-related and
respiratory conditions. However, it had a significant effect on cardiovascular-related emergency admissions.
In contrast to expectations, there was an increase in admissions in the post-intervention period.
In order to determine the excess winter hospital admissions for the primary outcome of the study (the
annualised rate of combined cardiovascular or respiratory emergency admissions per person), we classified
months as winter (December to March) or non-winter (April to November). Table 5 summarises the
observed rates by phase (pre or post intervention) and season (winter or not winter).
Table 5 shows that, as per intuition, rates are higher in the winter months than in the non-winter months
in both the pre- and post-intervention phases. In this analysis, we are also interested in the interaction
between intervention phase and season. This is because the statistical interaction summarises the extent to
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FIGURE 5 Graphical representation of the intervention effects in Table 4 (with 95% CI) by emergency admission
category for people aged ≥ 60 years.
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which differences in admissions occur between seasons for each of the pre- and post-intervention phases
separately. Table 5 therefore presents details from the interaction analysis for this term (ΔPS), adjusted for
comorbidity score and sex (both with p < 0.001). The interaction between season and intervention phase
was not significant.
Discussion
Key results
The study found no intervention effect of reduced admissions for either the primary outcome (combined
cardiovascular and respiratory emergency admissions) or any of the secondary outcomes for people of all
ages living in an intervention home. It also did not find an intervention effect of reduced cardiorespiratory
emergency admissions when we focused analyses on residents who were aged ≥ 60 years. However, we did
see a statistically significant intervention effect of increased cardiovascular-related emergency admissions for
residents aged ≥ 60 years. Cardiorespiratory emergency admission rates were found to be higher in winter
than in non-winter months, in both the pre- and the post-intervention phases. The interaction between
season and phase was not statistically significant, so there was no evidence that the intervention had an effect
on the difference between winter and non-winter rates.
Limitations
Routine data allowed us to evaluate this intervention using retrospective links from individuals living in
intervention homes for the relevant times. We were able to retrospectively analyse health-care utilisation
data for a large number of people across a 10-year period and minimise the bias experienced in
more-traditional research caused by factors such as recruitment and subsequent loss to follow-up.
Problems of recall bias are avoided with routinely collected health data that are based on observed health
events and not subjectively reported conditions.
However, we were unable to randomise participants into intervention and control groups and, as with all
observational studies, the potential for unmeasured confounding remains. For example, it is challenging to
control for the multiple associations between poverty, poor housing and poor health.90
The study was only able to determine the impact of the intervention on events recorded as hospital
admissions. The lack of association with emergency hospital admissions indicated that benefits do not
appear in the hospital statistics within the follow-up period and that future evaluations should focus on
less-severe conditions that may be treated in primary care settings, although recent research suggests that
housing interventions may not necessarily change established patterns in primary health-care utilisation in
populations with a long-term lack of well-being.91
Furthermore, we acknowledge the data limitations, including the lack of depth of the routine data. For
instance, using routine data means that we cannot understand how people’s lives have changed in their
home; this needed the additional studies that were completed as part of this research (see Chapter 3).
TABLE 5 Summaries for the primary outcome, categorised by phase and season
Season
Raw data
Adjusted
comparison 95% CI
Post-intervention phase,
M (SD) [n]
Pre-intervention phase,
M (SD) [n]
Winter months 0.0582 (0.6771) [18,147] 0.0566 (0.5889) [21,750] ΔPS = 0.0097
(p= 0.074)
–0.0009 to 0.0204
Non-winter months 0.0520 (0.6195) [18,226] 0.0461 (0.3319) [21,618]
M, mean; SD, standard deviation.
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Data quality was also an issue. Intervention home addresses and intervention dates required considerable
time and effort to collect, and subsequently convert to a structured format that could be used within the
databank. There were missing dates for several hundred intervention homes.
We relied on a routinely collected demographic data set (WDS) to link people into homes for the correct
time periods. Research by the ONS suggested that some segments of the younger male population are
more likely to be missing from this data set. Further work is needed to quantify potential bias in this
routine anonymised data set.
Finally, we acknowledge that assumptions implicit in linear models are unlikely to be entirely satisfied by
the study data, and that it would be useful to investigate further models that seek to account more
explicitly for features observed in this data.
Interpretation
There was no evidence that energy efficiency investments, as implemented in the intervention programme,
provided a reduction in health-care utilisation in the short to medium term. Residents were not involved in
the intervention implementation and so may have felt a lack of control; this may have contributed to the
lack of a significant reduction in health-care events.92 Longer-term studies, of a decade or longer, may be
needed to realise an intervention effect on health-care utilisation recorded using routine data, including
hospital as well as primary care outcomes.
Generalisability
The research is generalisable to residents of homes located in temperate regions, with similar
socioeconomic characteristics, living in homes in need of thermal efficiency measures. The intervention
homes were predominantly social housing, maintained by LAs and RSLs and located within low-income
areas. The results may also be generalisable to some extent to residents of private rented homes or
homeowners in low-income areas.
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
21

Chapter 3 The community-based study
This chapter contains material from Grey et al.80 This article is distributed under the terms of the CreativeCommons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit
to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. The text
below includes minor additions and formatting changes to the original text.
Introduction
This chapter follows the STROBE reporting guidelines for observational study designs.81
Background
Chapter 2 reported on the impacts of energy efficiency investments on hospital admissions for
cardiovascular and respiratory conditions using the SAIL databank. The first phase of the intervention
programme, which took place between 2010 and 2012, was evaluated by anonymously linking address
and intervention records to the PEDW, containing all hospital admissions and day case activity in Welsh
hospitals and Welsh residents being treated in hospitals in England. The strength of this approach is that it
can retrospectively evaluate the intervention without the results being biased as a result of low response
rates and losses to follow-up. However, although national health records can be used to link the
intervention to actual health service use, it does not detect mental health conditions that do not involve
the use of health services, as well as more-subjective psychosocial aspects that may be part of pathways to
health. The community-based study reported in this chapter specifically focused on mental health and
well-being, self-reported respiratory conditions and wider psychosocial impacts of the intervention.
As discussed in Chapter 1, the literature suggests two interrelated pathways between energy efficiency
investments and better mental and physical health.54,56 Energy efficiency investments may improve living
conditions through increased indoor air temperatures and fewer damp-related housing problems.
Improving living conditions may not only contribute to better respiratory health but can also contribute to
better mental health through improved thermal satisfaction.58 Furthermore, an expansion of living space
and improved social interactions (and therefore reduced social isolation) may be beneficial for residents’
mental well-being.59 Energy efficiency investments also contribute to improved well-being by making
heating more affordable.6 Reduced spending on heating bills alleviates financial stress and fuel poverty
among low-income households60,61 and helps to free financial resources for better food security45,46 and
social interactions.31
Objectives
This chapter describes the methodology and findings of the community-based evaluation of the second
phase of the intervention programme. The overall aim of the study was to better understand the
short-term health and psychosocial impacts of energy efficiency investments in low-income areas.
More specifically, the study aimed to determine the impacts of (1) the intervention on the primary health
outcomes of self-reported respiratory symptoms and mental health, (2) the intervention on the secondary
health outcomes of overall physical quality of life and subjective well-being and (3) energy efficiency
investments on secondary psychosocial outcomes that may be part of pathways to health, including
self-reported fuel poverty, food security and financial difficulties and stress, as well as self-reported thermal
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satisfaction, housing conditions, the number of heated rooms and social interactions. An additional aim
was the health economic evaluation of the extent to which the intervention changes the health-related
quality of life of inhabitants, through the calculation of quality-adjusted life-years (QALYs).
The research described in this chapter received ethics approval from the School Research Ethics Committee
(SREC) of the Welsh School of Architecture, Cardiff University (EC1308.160).
Methods
Study design
The community-based study used a quasi-experimental controlled pre-/post-test design and collected data
through self-completion questionnaires. Questionnaires were distributed in low-income areas where energy
efficiency improvements were scheduled but had not yet started, as well as in matched control areas
where no energy efficiency improvements were scheduled. The intervention programme ran for 3 years
between 2012 and 2015. The community-based study focused on schemes that were delivered in 2014
and 2015, respectively.
Setting
The energy efficiency investment programme targeted low-income mixed-tenure neighbourhoods. The
schemes were selected on the basis of the number of low-income households, the number of households
owning or privately renting their house and the number of hard-to-heat, hard-to-treat homes in the area.
The schemes mostly took place in Strategic Regeneration Areas with high numbers of hard-to-heat,
hard-to-treat homes. Matched control areas were selected using the WIMD and with the assistance of
the LAs where the schemes were taking place. In total, 24 intervention and 23 control areas were included
in the study. Anglesey was the only scheme that did not have a direct matched control area. Figure 6
shows the locations of the intervention areas that were included in the study.
Baseline (pre-intervention) data for year 2 schemes were collected during the 2013/14 heating season,
before energy improvement work had started on homes scheduled to receive the intervention. Follow-up
(post-intervention) data for year 2 schemes were collected during the 2014/15 heating season, after the
work was completed. Baseline and follow-up data for year 3 schemes were collected during the 2014/15
and 2015/16 heating seasons, respectively. Data for the intervention and control areas were collected
during the same time periods. Data for one year 2 scheme (Gwynedd) could not be collected in two
subsequent heating seasons as a result of delays in the delivery of the improvements. In this case, the
follow-up data for both the intervention and matched control area were collected during the 2015/16
heating season, at the same time as the follow-up data for year 3 schemes.
Participants
We used a purposive sampling strategy to recruit residents living in the eligible intervention and control
areas. The survey was administered using the drop-off-and-collect method of data collection.93 Initial
contact was made by postal letter, introducing the study and informing residents that they were going to
be visited by researchers from the university. Researchers then visited all selected areas to deliver the
questionnaires by hand and, when possible, personally invite residents to take part in the study. When at
the time of delivery no residents were at home, a pack containing a cover letter, questionnaire and Freepost
envelope was left in their letter box. Researchers then returned at a later date, usually within a week, to
collect the questionnaires. Similarly, a reminder to return the questionnaire was left if occupants were away
at the time of the return visit. The questionnaire could then be returned by Freepost. Participants were
asked to provide their contact details and consent to be recontacted for the follow-up phase of the study.
Any adult resident currently living in the selected intervention and control areas was eligible for inclusion.
The initial invitation letter and the questionnaire were both translated into Welsh. The Welsh version of the
questionnaire was available on request.
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All participants who had returned a completed questionnaire in the baseline period and had consented to
be recontacted were invited to fill out a second questionnaire for the follow-up. Participants were sent a
postal questionnaire that was addressed to them personally. They were subsequently visited by researchers
to collect the questionnaire in person when possible. A reminder was left if the participants were not at
home during the follow-up visit.
Incentives were used to increase the baseline and follow-up response rates. Participants were entered into
a prize draw for one of 25 £50 shopping vouchers (year 2 baseline) or for one of three iPads (Apple Inc.,
Cupertino, CA, USA) (year 3 baseline and all follow-up stages).
Not every eligible household within the scheme areas elected to have energy efficiency work done to their
house. Records from the two scheme managers were used to confirm which properties were upgraded
and which improvements were made. Respondents from intervention areas who did not have energy
efficiency work done to their home became part of the control group. A small number of properties
located within the matched control area of a delayed year 2 scheme (Gwynedd) became part of a year 3
scheme. Respondents from these properties became part of the intervention group.
Variables
Data were collected via a self-completion questionnaire covering the topics of health and well-being, fuel
poverty, financial difficulties and stress, food security, social interactions, thermal satisfaction, housing
conditions and number of heated rooms. The sociodemographic section of the questionnaire contained
questions about sex, age, household composition, marital status, employment status, household income,
smoking and housing benefits (see Appendix 9).
FIGURE 6 Locations of the intervention areas.
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The primary health outcomes were changes in mental health status [MCS from the Short Form
questionnaire-12 items (SF-12)] and self-reported respiratory and asthma symptoms. Secondary health
outcomes were changes in self-reported health-related quality of life [Physical Health Composite Scale (PCS)
from the SF-12] and subjective well-being. Other secondary psychosocial outcomes included changes in fuel
poverty status, financial difficulties and stress, food security, social interactions, thermal satisfaction and
reported housing conditions.
The Short Form questionnaire-12 items
The SF-12 is a validated and widely used measure to assess overall health-related quality of life.94 The
12-item survey includes questions on physical and mental health, covering the eight subdomains of general
health, physical functioning, physical role functioning, bodily pain, vitality, emotional role functioning,
mental health and social functioning. The questions consist of 10 five-point items and two three-point
items as measured on a Likert scale. The items were combined using a standardised scoring algorithm to
form the separate PCS and MCS, which range from 0–100 with a standardised mean score of 50 and a
standard deviation (SD) of 10. Higher scores represent better well-being.
Respiratory symptoms
Self-reported respiratory symptoms were measured using items adapted from Fisk et al.26 and WHO.95
Respondents were asked if they had experienced any of the following symptoms over the past month:
coughing, bringing up phlegm, shortness of breath, wheezing attack, chest tightness, runny nose, blocked
nose, sinus swelling, sneezing, sore throat and cold or flu. The respiratory symptoms were summed
creating a scale ranging from 0 to 11.
Asthma symptoms
The short version of the European Community Respiratory Health Survey was included in the questionnaire,
which contains nine questions about the presence of respiratory symptoms during the previous 12 months
(wheezing and whistling, breathlessness, chest tightness, shortness of breath, nocturnal coughing), attacks
of asthma during the previous 12 months, current use of asthma medication and nasal allergies including
hay fever. The survey was designed to estimate prevalence of asthma, asthma-like symptoms and airway
responsiveness.96 The asthma symptoms were summed creating a scale ranging from 0 to 9.
Subjective well-being
Subjective well-being was measured using four questions developed by the ONS.97 The questions measure
three different aspects of subjective well-being, including respondents’ life satisfaction (an evaluation or
global assessment measure), happiness and anxiousness (both hedonic well-being measures, reflecting
feelings over short periods of time) and worthwhileness (a eudemonic measure). Each of the four questions
could be answered using an 11-point Likert scale. The four responses were combined into a single scale
after reversing the anxiousness item (Cronbach’s α = 0.90). The final scale ranged from 0 (low subjective
well-being) to 10 (high subjective well-being).
Fuel poverty
One self-reported indicator of subjective fuel poverty was used. Respondents were asked whether or not,
within the past 12 months, they had put up with feeling cold to save heating costs. Respondents could answer
yes or no. This question has previously been used in the New Zealand Housing, Heating and Health Study.98
Financial difficulties and stress
The study used a financial stress scale from the Renton-I study99 that was used to measure how often
respondents had difficulties meeting the cost of different house-related expenses, such as rent or mortgage,
repairs or maintenance of home, fuel bills or credit payments. Each question could be answered using a
four-point Likert scale ranging from 1 (never) to 4 (very often). The responses to the four items were
averaged to create a single scale (Cronbach’s α = 0.79). Respondents were further asked about their
general level of financial stress using a question derived from the INTERHEART study.100 The question used a
five-point Likert scale ranging from none (1) to high (5).
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Food security
The questionnaire included three questions from the US Adult Food Security Survey (2012) to determine
households’ economic access to food in terms of quantity, quality and variety.101 Food security is defined
as access at all times to enough food for an active, healthy life, including readily available nutritionally
adequate and safe foods that can be acquired in socially acceptable ways.102 The following three questions
were asked: (1) ‘In the last 12 months, the food I bought just didn’t last, and I didn’t have money to get
more’; (2) ‘In the last 12 months, I couldn’t afford to eat balanced meals’; and (3) ‘In the last 12 months,
did you ever cut the size of your meals or skip meals because there wasn’t enough money for food?’.
Each question could be answered using a four-point Likert scale ranging from 1 (very often) to 4 (never).
The responses were averaged to create a single scale (Cronbach’s α = 0.92).
Thermal satisfaction
Thermal satisfaction was measured by asking respondents how satisfied they are with the temperature
in their home on a typical winter day. The five-point response scale ranged from 1 (very dissatisfied) to
5 (very satisfied). This question was previously used in the Carmarthenshire Homes Standard Health Impact
Assessment Study.103
Housing conditions
Housing conditions were assessed in two ways. First, respondents were asked about their satisfaction with
the current state of repair of their home. Respondents could answer the question on a five-point Likert
scale ranging from 1 (very dissatisfied) to 5 (very satisfied). Second, respondents were asked whether or
not they were currently experiencing six housing-related problems. These were condensation, leaking
roofs, damp walls and/or floors, rot in windows and door frames, draught and mould. The housing
problems were summed, creating a scale ranging from 0 to 6.
Number of heated rooms
Respondents were asked about their heating behaviours, in particular which rooms were heated on a
typical winter day and evening. The items were combined to provide a sum of the number of rooms that
are typically heated during the day and in the evening, focusing on four key rooms within the home: the
kitchen, main living room, main bedroom and bathroom. The sum of the number of heated rooms was
used in the analyses.
Social interactions
Social interactions were measured by asking respondents whether or not, in the last year, they had ever felt
reluctant to invite friends or family to their home because of difficulties with keeping it warm. The question
originated from the Adult Psychiatric Morbidity in England study.104 Respondents could answer yes or no.
The Short Form questionnaire-6 Dimensions
The Short Form questionnaire-6 Dimensions (SF-6D) utility score was calculated from the SF-12 into the
SF-6D using the ‘Sheffield algorithm’.105 The weighting algorithm was calculated using the preference-based
standard gamble approach. The resulting SF-6D index value incorporates all health domains from the SF-12,
with higher numbers associated with better health utility. Full health is represented by a value of 1 and death
corresponds to a score of 0. The SF-6D utility score allows for the calculation of QALYs. One QALY is equal to
living 1 year in full health; the duration in years is multiplied by the utility score.
Bias
The community-based study reported in this chapter used a quasi-experimental, controlled pre-/post-test
design to control for time-variable factors such as external hydrothermal conditions and other temporal
trends. The assignments of participants to the intervention and control groups was not randomised.
Selection bias occurs when selection to the intervention and control groups results in differences in unit
characteristics between conditions that may be related to outcome differences.106 In order to maximise initial
comparability, the matched control areas were selected using the same criteria as the intervention schemes.
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The drop-off-and-collect method of survey administration and incentives were used to reduce selection
bias as a result of non-response as much as possible.93 The overall response rate was 16.5%, with 1508 of
the 9127 distributed questionnaires being completed and returned. Of the 1508 baseline respondents,
1288 consented to be recontacted (85.4%). The attrition rate between baseline and follow-up was 48.1%
owing to a lack of consent and loss to follow-up (n = 726), resulting in a final total sample of 782
respondents who filled out both the baseline and follow-up questionnaires (Figure 7).
The overall response for the baseline data collection rates were similar for the intervention and control
groups (15.0% vs. 17.9%), although there were some differences in attrition (44.5% vs. 50.9%) between
the baseline and follow-up phases [χ2(1) = 6.132; p = 0.013]. Differences were also seen in the rate of
consent between the intervention and control areas (89.0% vs. 82.6%) [χ2(1) = 12.165; p = 0.000]. The
resulting intervention and control populations were comparable in terms of sociodemographics, with
chi-squared tests showing non-significant differences between the two groups for all variables listed.
A loss to follow-up analysis showed that there were a number of socioeconomic differences between
the respondents included in the final study sample and those who dropped out between baseline
and follow-up (Table 6). Respondents lost to follow-up were more likely to be female [χ2(1) = 9.661;
p = 0.002], younger in age [χ2(7) = 73.053; p = 0.000] and have children living in the household
[χ2(1) = 28.738; p = 0.000]. Respondents lost to follow-up were also more likely to have a lower household
income [χ2(8) = 15.950; p = 0.043] and to receive housing benefits [χ2(1) = 8.763; p = 0.003]. In terms
of health outcomes, the respondents lost to follow-up were more likely to be at risk of common mental
disorders, as measured by the MCS of the SF-12 [χ2(1) = 8.594; p = 0.003]. However, there were no
differences with regard to physical health, as measured by the PCS of the SF-12, subjective well-being
and self-reported respiratory and asthma symptoms.
Recall bias may be another possible source of bias, which was minimised by asking respondents to answer
questions regarding the current heating season. Missing data bias is possible when respondents may have
chosen not to answer specific questions in either questionnaire. Overall, there were few missing values,
except for self-reported asthma symptoms. A missing-values analysis found that data were missing
completely at random.
Study size
We aimed to achieve a total sample size of 1000 participants (intervention, n = 500; control group,
n = 500) to have 80% statistical power to detect an effect size (d) of 0.16 at the 5% significance level.
The final achieved samples of n = 364 for the intervention group and n = 418 for the control group
provide 80% statistical power to detect effect sizes of d = n = 0.18 at the 5% significance level, which is in
line with effect sizes observed in comparable field studies examining the short-term health effects of
housing improvements.48,51,107
Statistical methods
Statistical analyses were conducted with IBM SPSS Statistics version 20.0 (IBM Corporation, Armonk, NY,
USA) and MLwiN version 2.36 (MLwiN, Centre for Multilevel Modelling, Bristol, UK) software packages.108–110
The effects of the intervention on the primary and secondary health and psychosocial outcomes were initially
assessed using mixed design analyses of variance (ANOVAs) as proposed, and subsequently using a multilevel
modelling, repeated measures approach. The two types of analyses produced similar results. Here we only
present the results of the multilevel modelling analyses for the purpose of clarity.
A longitudinal data set was created with the two measurement occasions (level 1) nested within individuals
(level 2), allowing the analyses to take into account non-independence between measurement occasions.
The basic model included the intervention group (intervention vs. control) as an individual-level factor and
measurement occasion (follow-up vs. baseline) as a within-person factor. Differential changes between
the intervention and control groups were assessed with a cross-level interaction between measurement
occasion and intervention group. Only the interaction effects indicating the differential changes between
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Communities enrolled
(n = 47)
Intervention Control
Follow-up data received
(n = 364)
Confirmed intervention
(n = 656)
Non-response
[n = 3721 (85.0%)]
Confirmed control
(n = 852)
Follow-up data received
(n = 418)
Non-response
[n = 3908 (82.1%)]
• No consent to be
   recontacted, n = 72
• Lost to follow-up, n = 220
• No consent to be
   recontacted, n = 148
• Lost to follow-up, n = 286
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FIGURE 7 The flow diagram for the community-based study.
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TABLE 6 Sociodemographic and health characteristics of study respondents and those lost to follow-up
Characteristics
Respondents, % (n/N)
Study Lost to follow-up
Sociodemographic
Sex
Male 40.7 (311/764) 32.9 (230/700)
Female 59.3 (453/764) 67.1 (470/700)
Age (years)
≤ 25 1.6 (14/776) 5.7 (41/712)
26–35 6.4 (50/776) 13.9 (99/712)
36–45 10.1 (78/776) 15.4 (110/712)
46–54 12.6 (98/776) 15.3 (109/712)
55–64 27.3 (213/776) 17.3 (123/712)
≥ 65 41.6 (323/776) 32.3 (230/712)
Household composition
Households with no children 81.2 (623/767) 69.8 (484/693)
Households with children 18.8 (144/767) 30.7 (209/693)
Marital status
Single 12.5 (97/778) 16.6 (119/716)
Married/cohabiting 53.3 (414/778) 51.5 (369/716)
Separated/divorced 19.1 (148/778) 17.1 (123/716)
Widowed 15.0 (117/778) 13.8 (99/716)
Household income
£0–4999 3.6 (26/731) 7.6 (49/641)
£5000–9999 24.8 (182/731) 24.1 (155/641)
£10,000–19,999 35.0 (256/731) 37.2 (238/641)
£20,000–29,999 16.6 (121/731) 15.0 (96/641)
≥ £30,000 20.0 (146/731) 16.1 (103/641)
Housing benefits
Yes 24.7 (187/756) 31.7 (222/700)
No 75.3 (569/756) 68.3 (478/700)
Fuel poverty (putting up with feeling cold to save heating costs)
Yes 59.4 (464/774) 64.4 (457/710)
No 40.6 (310/774) 35.6 (253/710)
Health
MCS
At risk of CMD 57.1 (444/777) 64.6 (461/714)
Not at risk of CMD 42.9 (333/777) 35.4 (253/714)
PCS
At risk of physical complaints 58.8 (456/776) 59.9 (427/714)
Not at risk of physical complaints 41.2 (320/776) 40.1 (287/714)
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the intervention and control groups are reported. All analyses were conducted with and without adjusting
for the covariates selected a priori: sex, age, housing benefit, household income and smoking status.
Cohen’s d was calculated to determine the size of interaction effects. Cohen’s d is a standardised measure
of the magnitude of an effect, with the values of 0.2, 0.5 and 0.8 generally taken to reflect ‘small’,
‘medium’ and ‘large’ effect sizes, respectively.111,112
Different types of models were constructed depending on the type of outcome variable. Linear regression
models were constructed for the primary health outcomes of respiratory symptoms, asthma symptoms,
MCS, the secondary health outcomes of PCS and subjective well-being, as well as for the secondary
psychosocial outcomes of financial difficulties and food security. Ordered multinomial response models
were constructed for the ordinal psychosocial outcome variables of financial stress, thermal satisfaction,
satisfaction with the current state of repair of their home, number of reported housing problems and the
number of heated rooms during the day and the evening. Logistic regression models were constructed
for the two secondary psychosocial outcomes of fuel poverty and social interactions. For the ordered
multinomial response and binomial models, a logit link function was used. Parameters in all models were
estimated using Markov chain Monte Carlo with 50,000 iterations. All analyses were conducted with and
without adjusting for the individual-level covariates of sex, age, housing benefits, household income and
smoking status. The five covariates were selected a priori.
TABLE 6 Sociodemographic and health characteristics of study respondents and those lost to follow-up (continued)
Characteristics
Respondents, % (n/N)
Study Lost to follow-up
Subjective well-being
Very low 12.2 (95/781) 13.1 (95/724)
Low 24.6 (192/781) 28.5 (206/724)
Medium 29.2 (228/781) 30.4 (220/724)
High 34.1 (226/781) 28.0 (203/724)
Respiratory symptoms
0 23.4 (183/781) 21.2 (154/725)
1 14.8 (116/781) 13.2 (96/725)
2 12.8 (100/781) 13.2 (96/725)
3 12.9 (101/781) 10.2 (74/725)
4 10.7 (84/781) 10.2 (74/725)
≥ 5 25.1 (197/781) 31.8 (231/725)
Asthma symptoms
0 31.6 (225/713) 30.8 (199/646)
1 23.0 (164/713) 20.3 (131/646)
2 11.1 (79/713) 12.5 (81/646)
3 6.5 (46/713) 7.3 (47/646)
4 7.2 (51/713) 7.6 (49/646)
≥ 5 20.9 (41/713) 21.5 (139/646)
CMD, common mental disorder.
Note
Denominators vary because of missing data.
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For the SF-12, missing data were dealt with using QualityMetric’s Missing Score Estimation algorithm
(QualityMetric, Lincoln, RI, USA), for which item response theory and regression methods were used to
estimate scores on the health domain scales and component summary measures (MCS and PCS) using
QualityMetric’s Health Outcomes Scoring Software (QualityMetric, Lincoln, RI, USA).113 All other missing
data were excluded from the statistical analyses, which were conducted without imputation, as the
percentage of missing values were in most cases low (< 3%). The missing values were higher for asthma
symptoms (8.8%). Little’s MCAR (missing completely at random) tests found that the data were missing
completely at random [primary and secondary health outcomes and sociodemographic characteristics:
χ2(26) = 28.745; p = 0.323; psychosocial outcomes: χ2(60) = 63.720; p = 0.347].
For the analysis of health-related quality of life and QALYs, the SF-6D index values were transformed into
utilities implementing the area under the curve approach, with these values baseline-adjusted. A linear
progression of SF-6D between baseline and follow-up was assumed in the absence of more data. For
the main analysis, a multilevel modelling, repeated measures approach was used, adjusting for the
individual-level covariates of sex, age, housing benefits, household income and smoking status.
Results
Participants
In total, 9137 questionnaires were distributed to eligible households across 47 intervention and control
areas at the start of year 2 and year 3 of the intervention programme (see Figure 6). Of these, 1508 were
completed and returned (656 from the intervention and 852 from the control areas), corresponding to an
overall response rate of 16.5%. Figure 7 illustrates the flow of participants through the study.
Out of the 1508 baseline participants in both the intervention and control groups, 220 did not consent to
be recontacted and a further 506 participants were lost to follow-up, reflecting an overall attrition rate of
48.1%. Eighty-one participants from the original intervention areas did not receive any upgrades to their
home as part of the intervention programme. These respondents were added to the control group. Some
of the properties in the matched control area for the delayed year 2 scheme in Gwynedd were included in
a year 3 scheme before follow-up data could be collected. The 22 respondents from these properties were
added to the intervention group.
Descriptive data
Table 7 summarises the final study sample in terms of sociodemographic and building characteristics.
The intervention and control populations were comparable in terms of sociodemographic and building
characteristics, with chi-squared tests showing no significant differences between the two groups for any
of the variables listed in the table. Because the intervention and control group are largely similar at
baseline, there is a low likelihood of confounding.
Of the 782 respondents who completed both the baseline and follow-up questionnaires, the highest
proportion was female, aged ≥ 65 years, did not live with children within their household, was either
married or cohabiting and was retired. The highest proportion of respondents had no formal educational
qualification, had a combined household income of £10,000–19,999. One-quarter of all respondents
received housing benefits, reflecting the overall levels of deprivation of the intervention and control areas.
The vast majority of respondents owned the properties they resided in and had lived in the same property
for > 9 years. The building type tended to be either semi-detached or terraced, built either before 1919 or
before 1945, with an average of three bedrooms.
External wall insulation was by far the most implemented measure (71.7%), followed by voltage
optimisers (44.4%) and full central heating systems (new condensing boilers and radiators and pipes
when needed; 39.0%). Respondents from three communities received a connection to the mains gas
network together with a new heating system (13.9%). Voltage optimisers were only implemented in
South Wales schemes.
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TABLE 7 Sociodemographic and building characteristics of the intervention and control groups of the study cohort
Characteristics
Study cohort, % (n/N)
Intervention Control
Sociodemographic
Sex
Male 41.2 (145/352) 40.3 (166/412)
Female 58.8 (207/352) 59.7 (246/412)
Age (years)
≤ 25 1.4 (5/362) 2.1 (9/414)
26–35 6.9 (25/362) 6.0 (25/414)
36–45 10.8 (39/362) 9.4 (39/414)
46–54 14.1 (51/362) 11.1 (47/414)
55–64 30.1 (109/362) 25.1 (104/414)
≥ 65 36.7 (133/362) 45.9 (190/414)
Household composition
Without children 79.1 (284/359) 83.1 (339/415)
With children 20.9 (75/359) 16.9 (76/415)
Marital status
Single 13.8 (50/363) 11.3 (47/412)
Married/cohabiting 55.1 (200/363) 51.6 (214/412)
Separated/divorced 16.0 (58/363) 21.7 (90/412)
Widowed 14.9 (54/363) 15.2 (63/412)
Household income
£0–4999 3.5 (12/339) 3.6 (14/392)
£5000–9999 23.5 (80/339) 25.8 (101/392)
£10,000–19,999 33.9 (115/339) 35.9 (141/392)
£20,000–29,999 18.0 (61/339) 15.3 (60/392)
≥ £30,000 20.6 (70/339) 19.4 (76/392)
Housing benefits
Yes 25.1 (89/354) 24.4 (98/402)
No 7.9 (265/354) 75.6 (304/402)
Tenure
Owner occupied 77.5 (276/356) 74.0 (307/415)
Private rental 3.9 (14/356) 6.7 (28/415)
LA rental 13.8 (49/356) 13.3 (55/415)
Housing association rental 3.4 (12/356) 5.3 (22/415)
Time lived at current address (years)
< 1 3.3 (12/360) 4.3 (18/416)
1–4 9.4 (34/360) 11.8 (49/416)
5–9 14.4 (52/360) 12.7 (53/416)
> 9 72.8 (262/360) 71.2 (296/416)
continued
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Main results
The impact of the intervention on the primary health outcomes
The primary health outcomes assessed were self-reported respiratory and asthma symptoms, and the
mental health composite score of the SF-12 (MCS). The study found no evidence that the intervention had
a significant impact on the primary health outcomes of the study. Table 8 shows that there was a small
reduction in the number of reported respiratory symptoms between baseline and follow-up for the
intervention group. However, the change does not statistically differ from the one observed for the control
group. Similarly, the reduction in the number of reported asthma symptoms for the intervention group did
not significantly differ from the change observed in the control group. There was a slight increase in the
MCS scores for the intervention group. However, the increase for the intervention group was similar to the
increase for the control group.
The impacts of the intervention on the secondary health outcomes
The secondary health outcomes were the PCS of the SF-12 and subjective well-being. The study found no
evidence that the intervention had an impact on physical quality of life, as measured by the PCS. Although
there was a slight reduction in PCS scores for the intervention group, the reduction was not significantly
different from the reduction observed for the control group.
Table 9 shows an increase in subjective well-being for the intervention group but a slight decrease for the
control group. This represents a significant measurement occasion × intervention group interaction effect
at the 1% level. The interaction effect remained significant after controlling for the covariates of sex,
TABLE 7 Sociodemographic and building characteristics of the intervention and control groups of the
study cohort (continued )
Characteristics
Study cohort, % (n/N)
Intervention Control
Building
Building type
Detached house 12.5 (45/360) 12.3 (51/416)
Semi-detached house 38.1 (137/360) 28.8 (120/416)
Terraced house 41.1 (148/360) 46.9 (195/416)
Bungalow 5.0 (18/360) 5.3 (22/416)
Flat 1.4 (5/360) 6.0 (25/416)
Year of construction
Before 1919 44.1 (152/345) 40.7 (166/405)
1919–1945 26.1 (90/345) 24.3 (99/405)
1945–1965 17.4 (60/345) 23.5 (96/405)
1965–1979 7.5 (26/345) 6.1 (25/405)
1980 or later 4.9 (17/345) 5.4 (22/405)
Number of bedrooms
1 1.7 (6/358) 5.4 (22/409)
2 19.8 (71/358) 20.8 (85/409)
3 68.2 (244/358) 65.3 (267/409)
≥ 4 10.4 (37/358) 8.5 (35/409)
Note
Denominators vary because of missing data.
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TABLE 8 Primary health outcomes at baseline and follow-up for the intervention and control group
Outcome Scale Model
Study cohort, M (SD)
Effect size Unadjusted AdjustedaIntervention Control
Baseline Follow-up Baseline Follow-up Cohen’s d B SE p B SE p
Respiratory symptoms 0–11 L 2.97 (2.74) 2.91 (2.74) 2.94 (2.67) 3.05 (2.77) 0.061 –0.155 0.192 0.419 –0.141 0.202 0.485
Asthma symptoms 0–9 L 2.34 (2.55) 2.20 (2.45) 2.23 (2.50) 2.24 (2.51) 0.051 –0.088 0.247 0.722 –0.133 0.253 0.600
MCS 0–100 L 44.81 (12.56) 45.62 (11.94) 46.02 (12.06) 46.85 (12.36) 0.005 –0.059 0.789 0.940 –0.003 0.812 1.000
L, linear; M, mean; SE, standard error.
a Adjusted for sex, age, housing benefit, income and smoking status.
TABLE 9 Secondary health outcomes at baseline and follow-up for the intervention and control group
Outcome Scale Model
Study cohort, M (SD)
Effect size Unadjusted AdjustedaIntervention Control
Baseline Follow-up Baseline Follow-up Cohen’s d B SE p B SE p
PCS 0–100 L 42.90 (13.94) 43.11 (13.80) 42.25 (14.47) 41.48 (14.24) 0.107 0.987 0.664 0.137 0.976 0.669 0.145
Subjective well-being 0–10 L 6.55 (2.50) 6.89 (2.25) 6.96 (2.42) 6.92 (2.42) 0.200 0.375 0.134 0.005 0.384 0.134 0.004
L, linear; M, mean; SE, standard error.
a Adjusted for sex, age, housing benefit, income and smoking status.
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age, household income, housing benefits and smoking status (B 0.38, 95% CI 0.11 to 0.64). This
suggests that the intervention had a small positive impact on people’s overall feelings of well-being
(Cohen’s d = 0.20).
The impacts of the intervention on the secondary psychosocial outcomes
Table 10 shows the results for the secondary psychosocial outcomes of the study. Analyses indicate that
the intervention had an impact on financial difficulties, thermal satisfaction, satisfaction of the state of
repair of the home, the number of housing problems and social interactions.
The number of respondents reporting putting up with feeling cold to save heating costs decreased for the
intervention group. A smaller decrease was observed for the control group. This represents a significant
interaction effect at the 5% level. The interaction effect remained significant after controlling for the
covariates [odds ratio (OR) 0.49, 95% CI 0.25 to 0.94]. The effect size of the interaction was small
(Cohen’s d = 0.15).
A significant interaction effect was observed for self-reported financial difficulties, even after controlling
for sex, age, household income, housing benefits and smoking status (B –0.15, 95% CI –0.25 to –0.05).
The size of the interaction effect was small (Cohen’s d = 0.20). Table 10 shows that self-reported financial
difficulties decreased to a greater extent in the intervention group than in the control group.
A significant interaction effect was observed for thermal satisfaction, which remained after controlling for
the covariates (B 1.34, 95% CI 0.91 to 1.77). This is a medium-sized effect (Cohen’s d = 0.46). Although
both the intervention and control groups saw an increase in thermal satisfaction, the increase was greater
in the intervention group.
Significant interaction effects were observed for the two housing conditions variables. The effects
remained significant after adjusting for the covariates for both people’s satisfaction with the current state
of repair of their home (B 1.35, 95% CI 0.92 to 1.79) and the number of reported housing problems
(B –1.10, 95% CI –1.54 to –0.66). The effects were small-to-medium sized (Cohen’s d = 0.44 and 0.39,
respectively). Table 10 shows that satisfaction with the state of repair of their home increased for the
intervention group but decreased for the control group. The number of reported housing problems
decreased for both the intervention and control groups but decreased to a greater extent in the
intervention group.
Finally, a significant interaction effect was found for social interactions, which remained after controlling
for the covariates (OR 0.32, 95% CI 0.13 to 0.77). The size of the interaction effect was small (Cohen’s
d = 0.19). The proportion of people feeling reluctant to invite friends or family to their home because of
difficulties with keeping it warm fell to a greater extent in the intervention group than in the control group.
The impact of the intervention on health-related quality of life and QALYs
Mean baseline SF-6D scores for the intervention and control groups of 0.685 (SD 0.167) and 0.683
(SD 0.164), respectively, were observed. Mean scores for follow-up were higher for both the intervention
0.692 (SD 0.168) and control group 0.695 (SD 0.170). The baseline-adjusted QALY gain for the intervention
group was 0.003, whereas the intervention group experienced an increase of 0.007 QALYs. SF-6D score at
both time points, the resulting change in SF-6D, and the QALYs difference were all insignificant between
groups {B –0.007 [standard error (SE) 0.016], 95% CI –0.04 to 0.02}. Accounting for covariates in a
regression analysis framework resulted in an insignificant and negative coefficient for the intervention.
These results suggest that the intervention did not have a significant impact on the quality of life or on
the utility score of respondents.
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TABLE 10 Secondary psychosocial outcomes at baseline and follow-up for the intervention and control group
Outcome Scale Model
Study cohort, M (SD)
Effect size Unadjusted AdjustedaIntervention Control
Baseline Follow-up Baseline Follow-up Cohen’s d B SE p B SE p
Fuel poverty
Putting up with feeling cold to
save heating costs
0–1 Bin 0.63 (0.48) 0.45 (0.50) 0.57 (0.50) 0.46 (0.50) 0.153 –0.720 0.324 0.026 –0.717 0.334 0.032
Financial stress 1–5 O 2.96 (1.40) 2.60 (1.35) 2.81 (1.38) 2.58 (1.36) 0.108 –0.381 0.213 0.074 –0.403 0.220 0.067
Financial difficulties 1–4 L 1.93 (0.90) 1.67 (0.73) 1.74 (0.75) 1.65 (0.73) 0.204 –0.148 0.047 0.002 –0.149 0.050 0.003
Food security 1–4 L 3.51 (0.77) 3.61 (0.73) 3.55 (0.77) 3.59 (0.73) 0.117 0.057 0.035 0.093 0.063 0.036 0.080
Thermal satisfaction 1–5 O 3.45 (1.15) 3.85 (1.10) 3.71 (1.16) 3.63 (1.22) 0.462 1.319 0.216 0.000 1.342 0.219 0.000
Housing conditions
Satisfaction with state of repair
of home
1–5 O 3.26 (1.28) 4.04 (1.06) 3.60 (1.26) 3.82 (1.20) 0.440 1.342 0.222 0.000 1.352 0.221 0.000
Number of housing problems 0–6 O 1.88 (1.53) 1.20 (1.32) 1.49 (1.53) 1.32 (1.45) 0.386 –1.065 0.221 0.000 –1.097 0.225 0.000
Number of heated rooms
Day 0–4 O 2.74 (1.29) 3.01 (1.21) 2.69 (1.32) 2.78 (1.28) 0.137 0.387 0.212 0.067 0.408 0.213 0.055
Evening 0–4 O 2.24 (1.01) 2.31 (1.04) 2.21 (1.01) 2.19 (1.02) 0.096 0.239 0.205 0.242 0.239 0.205 0.242
Social interactions 0–1 Bin 0.24 (0.43) 0.12 (0.33) 0.18 (0.39) 0.14 (0.34) 0.195 –1.052 0.429 0.014 –1.149 0.456 0.012
Bin, binomial; L, linear; M, mean; O, ordinal.
a Adjusted for sex, age, housing benefit, income and smoking status.
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Discussion
Key results
This was the first large quasi-experimental field study with a controlled pre-/post-test design to examine
both the short-term health and psychosocial impacts of energy efficiency investments in low-income areas.
This community-based study found no evidence that investments in energy efficiency improve respiratory
or mental health in the short-term. Furthermore, no evidence was found that they provide physical health
benefits in the short-term. However, those who received energy efficiency measures reported improved
subjective well-being as compared with the controls, as well as improvements in a number of the
secondary psychosocial outcomes that are conducive to better health. The study found that respondents
who received the intervention also reported fewer financial difficulties, higher thermal satisfaction and
higher satisfaction with the improvement of their homes. They also reported less reluctance to invite
friends or family to their homes. The results were similar with or without controlling for a number of
socioeconomic covariates.
Limitations
The field study in this chapter used self-completion questionnaires to be filled out by the study participants
themselves. It is therefore subject to a number of biases. The study had a low initial response rate and a
substantial loss to follow-up. However, the response and attrition patterns were similar for the intervention
and control areas, and an analysis showed that there were only a small number of differences between
study respondents and those lost to follow-up. The final samples appeared largely comparable in terms of
their composition. The low response and retention rates are perhaps not completely surprising given the
nature of the research. The study was conducted in low-income neighbourhoods, where response rates for
mail and door-to-door data collection methods tend to be low.114 Several strategies were used to increase
the response rates, including incentives and door knocking.
In order to make the control group as comparable as possible to the intervention group, the matched
control areas were selected using the same criteria as the intervention areas. This proved to be challenging,
given that many comparable areas had already received energy efficiency measures through the intervention
programme. A number of control areas were subsequently selected to receive energy efficiency investments
in the year after the study. The composition of the final samples suggest that the control participants may be
used as a robust ‘non-exposed’ comparator group.
A further limitation is the time frame of the study. Outcome measures were collected in the heating seasons
directly before and after the intervention. The short follow-up period means that claims can only be made
about the short-term effects of the intervention (see Interpretation). Studies with longer follow-up periods
are needed to establish the long-term impacts of energy efficiency investments.48 This has been done in the
data linkage study (see Chapter 2).
According to Thomson et al.48,115 interventions targeting at-risk populations provide clearer health benefits
than area-based housing improvement programmes. The benefits of area-based programmes may be less
pronounced because they do not target those who are most at need. Unlike other demand-led schemes
such as Warm Homes Nest, the Warm Homes Arbed intervention was not tailored according to individual
need. However, the intervention did target low-income areas with inadequate warmth owing to a large
number of hard-to-heat, hard-to-treat homes within the area. Still, no clear physical health improvements
were observed in this study, which may be explained by the limited follow-up period in the research. It
would be useful to directly compare area-based (e.g. Warm Homes Arbed) and demand-led, targeted
(e.g. Warm Homes Nest) schemes.
Researchers evaluating complex social interventions are faced with several challenges.116,117 The study
involved an evaluation of an external, in this case government-led, programme. That means that the
researchers did not have control over the content or delivery of the programme. Furthermore, the
intervention effects may be diluted by constant changes in the context. For example, it is possible that
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respondents may have independently chosen to undertake energy efficiency improvements to their home,
therefore diluting the effects of the intervention programme.117,118 However, there is no evidence that this
happened in the study.
Interpretation
The study suggests that, although there is no evidence that energy efficiency investments provide physical
health benefits in the short term, they improve social and economic conditions that are conducive to better
health. Furthermore, they were found to be beneficial for subjective well-being. Longer-term studies are
needed to establish the health impacts of energy efficiency investments. According to Thomson et al.,48,115
most studies investigating the health impacts of housing improvements have limited follow-up periods.
Studies have therefore been unable to detect longer-term health impacts. We would expect that the
changes in the psychosocial outcomes are conducive to better health in the longer term. The observed
changes in the social outcomes may be a valuable indicator of the potential for longer-term health benefits.
Generalisability
The results are likely to be generalisable to other low-income areas with inadequate warmth and other
vulnerable at-risk populations. The public health implications are typical for other deprived areas across
the UK with low-quality housing. The results may be less generalisable to other less-deprived areas.
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Chapter 4 The household monitoring study
This chapter contains material from Poortinga et al.119 © 2017 The Author(s). Published by Informa UKLimited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
This chapter follows the STROBE reporting guidelines for observational study designs.81
Background
It is widely acknowledged that living in cold conditions poses various health risks, in particular to
low-income, fuel-poor households.6 Improving the energy efficiency of the housing stock might bring
multiple positive health gains through improved hydrothermal conditions and lower financial stress
through reduced fuel consumption. More recently, there have been suggestions that increasing the energy
efficiency of a home could have detrimental effects on people’s health.64 Reduced ventilation through
insulation and draughtproofing may increase RH levels65 and, as a result, promote mould growth.66,67
Only a handful of studies to date have attempted to identify and measure the impact of affordable
warmth interventions on internal conditions and fuel consumption using a number of monitoring
methodologies and data analysis techniques. Most research in this area has been cross-sectional,71
reported means and/or temperature frequencies,49,120 monitored events for a short period only60 or did not
include control households.63,121 Furthermore, most studies did not make use of the granularity of the
measurements, consider the non-independent repeated nature of monitoring data or control systematically
for external conditions.
This household monitoring study addresses some of these issues through detailed long-term household
monitoring of intervention and control households at baseline and follow-up. Both the internal and the
external hydrothermal conditions are measured at a higher resolution than previous research and
combined into a comprehensive data set that was amenable to multilevel interrupted time series
analysis.122 This approach allows the impact of the energy efficiency interventions to be estimated
with a maximum level of statistical power, adjusting for external conditions at the same level as the
internal measurements.
Objectives
This chapter describes the methodology and findings of the household monitoring study. The study had the
overall aim to examine the impact of the second phase of the intervention programme on internal household
conditions and energy use. It set out to determine the impact of (1) the intervention on whole-house
indoor air temperature and RH; (2) individual measures on whole-house indoor air temperature and RH;
(3) the intervention on indoor temperatures at different times of the day; (4) the intervention on indoor
temperatures in different rooms within the home; (5) the intervention under different external hydrothermal
conditions; (6) the intervention on the average daily duration and cumulative substandard internal
hydrothermal conditions; and (7) the intervention on household energy use, in particular gas usage.
The research described in this chapter received ethics approval from the SREC of the Welsh School of
Architecture, Cardiff University (EC1308.160).
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Methods
Study design
The household monitoring study uses a quasi-experimental controlled before-and-after design consisting of
long-term hydrothermal condition monitoring in two subsequent heating seasons. The monitoring took
place in a number of households before and after they received energy efficiency improvements under the
intervention programme. The study further included a number of control households that did not receive
such improvements. The indoor measurements for the control households were taken at the same time
as for the intervention households. All households for the monitoring study were recruited from the
community sample described in Chapter 3.
Setting
The study was conducted in five low-income areas where energy performance investments were scheduled
and in five matched control areas where no such investments were planned (Figure 8). The baseline
measurements were taken in the 2013/14 heating season. The follow-up measurements were taken in the
2014/15 heating season.
The five intervention and control areas were selected from year 2 schemes included in the community-based
study (see Chapter 3). The intervention areas and their matched control areas were in Brynamman
(Carmarthenshire), Caerau (Cardiff), Llay (Wrexham), Hollybush (Caerphilly) and Pennydarren (Merthyr Tydfil).
The areas were selected based on the scheduling of the intervention work and the returns of the baseline
FIGURE 8 Locations of the intervention and control areas.
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questionnaires from the community-based study. This was to ensure that a sufficient number of households
could be recruited in time for the monitoring to take place in the 2013/14 heating season. The communities
varied in terms of their location, climatic conditions and dominant housing type. The Cardiff and Merthyr
Tydfil areas consisted predominantly of British steel-framed [British Iron and Steel Federation (BISF)] houses,
Caerphilly and Carmarthenshire were off-gas areas and Wrexham consisted predominantly of terraced
houses with solid walls. The control areas were selected to resemble the intervention areas as much as
possible in terms of housing type and level of deprivation (see Chapter 3).
Respondents from the selected areas who provided consent to be recontacted were invited by telephone
to have their house monitored. In total, 99 households agreed to take part in the study, of which 50 were
located in the intervention areas and 49 in the matched control areas. Households were visited between
11 January and 1 February 2014 to install indoor data loggers, and again between 25 March and 17 April
2014 to collect them. In the baseline period, houses were monitored for a minimum of 28 consecutive days
and a maximum of 71 days. On average, the houses were monitored for 46 days, with a SD of 9 days.
The households that took part in the first part of the study were recontacted by letter prior to the 2014/15
heating season for follow-up measurements. The reminder letter was followed up by a telephone call to
arrange an installation visit. Households were visited between 1 November and 18 November 2014 to install
indoor data loggers, and again between 12 April and 30 April 2015 to collect them. In the follow-up
period, houses were monitored for a minimum of 97 days and a maximum 181 days. On average, houses
were monitored for 127 days (SD 32 days). Loss to follow-up was low (11%), resulting in a final sample of
88 households (intervention, n = 48; control, n = 40). Local weather stations were installed in or close to the
five monitoring areas to record external meteorological conditions during the baseline and follow-up
periods. Gas and electricity meter readings were taken during the installation and collection visits.
Participants
Households for the monitoring study were recruited from the community sample described in Chapter 3.
The aim was to recruit 100 households for the monitoring study, with a subset of households undergoing
energy efficiency improvements (n = 50) and a control group that did not receive such improvements (n = 50).
Variables
The following exposure intervention and outcome variables were included in the analyses.
Intervention measures
The intervention measures included external wall insulation (with mechanical ventilation), new windows
and doors, boiler and heating system upgrades, connection to the gas mains network and installation
of voltage optimisers. The measures were recorded for each participating household. In this study,
35 households received external wall insulation, nine received new windows and doors, 48 received a
new boiler or heating system and 46 had a voltage optimiser installed. Furthermore, 20 properties from
two intervention areas were connected to the mains gas network. Figure 9 shows that, on average,
the measures increased the Standard Assessment Procedure ratings of the intervention households from
52 (SD 12) to 66 (SD 5). This is an average increase from Energy Performance Certificate rating band E to
band D. The Standard Assessment Procedure was developed by the Building Research Establishment and is
currently the methodology used by the UK Government to assess the energy performance of dwellings.123
It presents the energy performance of homes in a figure ranging from 1 to 100. This has been subdivided
into seven bands ranging from A to G.
Indoor air temperature and relative humidity
The main outcomes of the household monitoring study were indoor air temperature and RH at different
times of the day and in different rooms within the home. These were measured with three Tinytag Ultra 2
data loggers (Gemini Data Loggers, Chichester, West Sussex, UK) that were positioned in the living room,
kitchen and main bedroom, respectively. These rooms were selected as they represent the key living spaces
in domestic dwellings. The data loggers were positioned away from any direct heat source and external
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windows, in a location where they would cause the least disturbance to the occupants and were unlikely
to get covered, typically on top of a cupboard or shelf at a height of about 2 metres. Owing to practical
issues when placing loggers in households with diverse circumstances, furnishings and personal
preferences, the exact locations where they were positioned within rooms varied. Indoor air temperature
and RH were recorded every 15 minutes.
The data were used to calculate the average daily indoor air temperature and RH, as well as the average
indoor air temperature and RH in the morning (06.00–09.00), during the day (09.00–18.00), in the
evening (18.00–23.00) and at night (23.00–06.00). The data were used for the three rooms separately and
combined to calculate a whole-house average.
The Tinytag Ultra 2 data loggers have an air temperature reading range of –25 °C to 85 °C, with a
resolution of 0.01 °C and an error range of ± 0.35 °C, and a RH reading range of 0% to 95%, with a
resolution of 0.3% and an error range of ± 3.0% at 25 °C.
Duration and cumulative substandard internal conditions
The study further explored the impact of the intervention on the duration and cumulative substandard
internal conditions.
The duration of substandard internal conditions was determined by recording each day the time that the
indoor air temperature dropped to < 18 °C and dropped to < 16 °C and that the indoor RH was > 60%.
These thresholds were based on the literature, which shows that indoor air temperatures in winter of
≥ 18 °C pose minimal risk to the health of a sedentary person and to people aged > 65 years or with
pre-existing medical conditions.124 Indoor air temperatures of < 18 °C increase the risk of high blood
pressure and this risk is heightened in temperatures of < 16 °C. Indoor air temperatures of < 16 °C may
further diminish resistance to respiratory diseases.125 RH levels of > 60% have been linked to respiratory
and allergic conditions, as well as fungal growth and house dust mite infestations.66,67
The cumulative substandard internal conditions is the time intensity integral of substandard conditions
beyond the chosen thresholds, thus representing the daily dose of substandard internal conditions to
which householders are potentially exposed. The cumulative substandard indoor air temperature reflects
the amount of underheating over the period of 1 day. The cumulative substandard indoor RH reflects the
total amount of exposure to risky humidity levels.
Intervention group baseline
(mean = 52, n = 50)
Intervention group follow-up
(mean = 66, n = 50)
Intervention group baseline
normal curve
Intervention group follow-up
normal curve
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FIGURE 9 Standard Assessment Procedure ratings of intervention households before and after installation of the
energy efficiency measures.
THE HOUSEHOLD MONITORING STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
44
The cumulative substandard internal conditions are expressed as °C·hour and % RH·hour for indoor air
temperature and RH, respectively.
Outdoor air temperature and relative humidity
Outdoor air temperature and RH were measured by local weather stations that were installed in or close
to the five monitoring areas, typically in a participating household’s garden. Outdoor air temperature
and RH were recorded every 15 minutes by local Delta-T-GP1 weather stations (Delta-T Devices, Burwell,
Cambridgeshire, UK). Outdoor air temperature and RH were recorded for the full baseline and follow-up
periods for each of the five locations.
The measurements were combined to calculate the average whole-day outdoor air temperature and RH,
and to calculate the average outdoor air temperature and RH in the morning (06.00–09.00), during the
day (09.00–18.00), in the evening (18.00–23.00) and at night (23.00–06.00).
Delta-T-GP1 weather stations have an air temperature reading range of –20 °C to 70 °C, with a resolution
of 0.05 °C and an error range of ± 0.3 °C, and a RH reading range of 0–100%, with a resolution of 0.2%
and an error range of ± 2% between 5% and 95% and of ± 2.5% for < 5% and > 95% RH.
Heating demand: heating degree days
The outdoor air temperature measurements were subsequently converted into daily heating degree days
(HDDs).126 HDDs reflect the demand for energy needed to heat buildings over a specific period, in this
case 1 day. The heating demand is calculated by summing the differences between the outdoor air
temperature and a reference temperature. As such, the HDD measure is an exposure measure reflecting
the cumulative amount of degrees the temperature falls below the base temperature over 1 day. The
reference temperature, 15.5 °C in the UK, reflects the outdoor temperature at which, generally, no heating
is needed to maintain comfortable internal conditions.127,128 In this study, HDDs are calculated as the
mean temperature difference for the 96 daily readings, similar to the mean degree hour method, which
is considered the most detailed method of calculating degree days.126 The outside temperature is only
included in the calculations when it is lower than the reference temperature.
Heating degree days provide some advantages over other methods that use mean outdoor temperatures
to calculate energy demand: they take account of fluctuations in outdoor air temperature and exclude
periods when space heating is not needed, therefore capturing extreme conditions in a way that mean
temperature methods cannot. This makes them more reliable in predicting energy consumption,
particularly in milder conditions and in periods with fluctuating or extreme cold snaps, when they capture
both the magnitude and duration of an event. HDDs also have a number of shortcomings.129 They are
based on assumptions about when additional energy is needed to heat a building and ignore the fact that
some buildings are only heated during specific periods. Furthermore, they do not reflect variations in the
ability of different buildings to retain heat or to exploit solar gains.
Average daily gas usage
Average daily gas usage was calculated from meter readings taken during the installation and collection
visits for both the baseline and follow-up periods. The change in average daily gas usage provides an
indication of the effectiveness of the energy performance investments, as most of the metred gas will have
been used for space and water heating. It was not possible to take gas meter readings in off-gas areas.
Bias
The household monitoring study was undertaken in a subset of households that had already participated in
the community-based study. The biases described in Chapter 3 therefore also apply to this part of the project.
Another potential bias was that the local climate could lead households in different areas to be exposed to
different external hydrothermal conditions during the baseline and follow-up. To control for such biases,
the study compared internal conditions of the intervention households with the control households located
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within the same areas. Furthermore, internal hydrothermal conditions were adjusted for external
hydrothermal conditions as measured by weather stations installed in or near the different monitoring areas.
This design minimised differences between households resulting from external hydrothermal conditions.
Selection and attrition bias have the potential to overestimate and underestimate the effects of the
intervention. The household monitoring was undertaken in a subset of households that had already
participated in the community-based study (see Chapter 3).
There was a risk of selection bias in the households agreeing to their house being monitored, as well as
attrition bias between the baseline and follow-up monitoring. Households that had completed the
questionnaire and consented to be recontacted were invited to participate in the monitoring study.
The monitoring households and the overall sample from which they were selected were broadly similar in
terms of their building and sociodemographic characteristics. The monitoring sample contained a higher
percentage of terraced houses (47.9% vs. 29.0%) and private rentals (11.5% vs. 4.3%) than the overall
area sample. Figure 10 shows that the response rate for the intervention group (23.3%) was slightly lower
than that for the control group (30.2%). However, that was mainly owing to the size of the area sample
from which they were recruited. Attrition was higher for the control households (n = 9) than for the
intervention households (n = 2), but no monitored area lost more than four households. A loss to
follow-up analysis showed that attrition did not bias the samples in a systematic way. The final intervention
and control samples were comparable in terms of building age, building type, number of bedrooms,
tenure and household composition (i.e. with or without children) (see Table 11).
Study size
The study set out to monitor 100 properties over a 4-week period in two subsequent heating seasons. The
15-minute interval readings were combined to calculate whole-day averages, as well as averages for 4-day
segments (i.e. morning, day, evening and night). This would ensure that the statistical analyses were based
on ≥ 5600 data points clustered within the 100 households.
The eventual sample consisted of 99 households that were monitored for an average of 46 days (SD 9 days)
during the baseline period and 88 households that were monitored for an average of 127 days (SD 32 days)
for the follow-up period. This created a database with 15,771 data points for the different hydrothermal
outcome variables after the removal of missing day values. All measurements were included in the final data
set. This means that all 99 households contributed to the baseline estimates, but only the measurements of
the 88 households included in both the baseline and follow-up contributed to the estimates for changes
over time. This means that the parameters reported in this report were based only on the monitoring data
of 88 households for which we had both baseline and follow-up periods.
Statistical methods
The data were analysed by constructing a series of controlled multilevel interrupted time series regression
models, with daily internal conditions (level 1) nested within households (level 2) that either received an
intervention or did not. The nested multilevel design makes it possible to take account of the clustering of
the observations over time using random effects.130 The approach also enables the handling of unbalanced
data when the number of observations differ for the different households and time periods.130 This makes
the approach suitable for analysing monitoring data of multiple properties with different start and end dates.
Analyses were conducted with the MLwiN version 2.36 software package.109 The software package is
specifically designed for fitting multilevel models, in this case an interrupted time series regression analysis.
The analysis involved the use of the time series of the daily averaged hydrothermal conditions that were
measured during the baseline and follow-up periods in the intervention and control households. The
interruption occurred between baseline and follow-up sampling periods when intervention households had
improvement work done to their homes. Therefore, the interruption in the ‘interrupted time series’ refers
to the energy efficiency improvements undertaken in the intervention households. This was then compared
with control households that did not receive the energy efficiency investments during that period.
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Communities enrolled
(n = 10)
Intervention Control
Follow-up monitoring
(n = 48)
Baseline monitoring
(n = 50)
Excluded
[n = 3721 (85.0%)]
Baseline monitoring
(n = 49)
Follow-up monitoring
(n = 40)
• Not contacted, n = 68
• Refusal, n = 45
Lost to follow-up as 
a result of ill health
(n = 2)
Lost to follow-up as 
a result of ill health 
or relocation
(n = 9)
• Not contacted, n = 107
• Refusal, n = 57
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FIGURE 10 The flow diagram for the household monitoring study.
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The basic statistical models included three independent variables: (1) the intervention group, (2) the
measurement period and (3) an interaction between measurement period and intervention group.
The intervention group variable indicated whether the measurements were taken in an intervention or a
control household. The measurement period variable indicated whether the measurements were taken in
the baseline or the follow-up period. The interaction term of the measurement period and intervention
group variables indicated that the intervention has taken place in the follow-up period for the intervention
households. The regression coefficient related to this term shows the level of change in internal conditions
for the intervention group relative to the control group.
The statistical models were further controlled for external conditions. This was done by including the daily
averaged external measurements as independent variables. The models with indoor air temperature as the
outcome variable included daily HDD values as a covariate to control for external thermal conditions.
The models with indoor RH as the outcome variable additionally included a measure of the average daily
outdoor RH to control for external hydrological conditions.
Interrupted time series analyses typically include a time variable (indicating the time elapsed since the start
of the study, as measured in days) and a time after the interruption variable (indicating the time elapsed
since the intervention, as measured in days) in order to identify trends over time and changes in the trend
after the intervention, respectively.131 However, as no obvious trend over time was observed within the
baseline and follow-up periods, these terms were excluded from the regression models.
One problem with repeated measurement data is that the measurements are often not independent, which
violates one of the assumptions of ordinary least squares regression. Autocorrelation within time series, when
measurements close to one another are more similar than measurements that are further apart, may lead to
increased type 1 errors. The autocorrelation function and partial autocorrelation function in MLwiN indicated
autocorrelation with a diminishing lag. Autocorrelation reflects the internal correlation within a time series,
showing the degree to which the different measurements are interdependent.131 An autoregressive model
was constructed by adding a weight specifying that the error covariance decreases as the time distance
between measurements increases in order to control for the observed dependency.132
Results
Participants
The household monitoring study took place in five intervention areas and their matched control areas
nearby (see Figure 8). Respondents from these areas who provided consent to be recontacted were invited
to have their home monitored. In total, 202 households were invited by telephone to participate, of which
99 agreed to have their house monitored (intervention, n = 50; control, n = 49). This corresponds to a
response rate of 49%. The rest of the households were not contacted, either because they did not provide
a contact telephone number or because the maximum number of households for the area was reached.
Eleven households were lost to follow-up owing to ill health or relocation (intervention, n = 2; control,
n = 9). This means that 99 households were monitored at baseline and 88 households at follow-up.
Figure 10 shows the flow of households through the monitoring study.
Descriptive data
Table 11 summarises the characteristics of the intervention and control households at baseline and
follow-up. It shows that there were no statistically significant differences between the two groups in terms
of building age, building type, number of bedrooms, tenure and household composition.
Table 12 shows the average internal conditions for the intervention and control households at baseline and
follow-up, unadjusted for external conditions. The table suggests that indoor air temperatures increased
for the intervention group but decreased for the control group between baseline and follow-up. The
changes in indoor RH were less pronounced. Small reductions were observed for both the intervention
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and the control groups. The internal conditions presented in the table are not adjusted for external
hydrothermal conditions, which may differ across the monitoring periods and areas.
Table 13 shows the distribution of internal conditions for the intervention and control groups at baseline and
follow-up, again unadjusted for external conditions. The figures represent the proportion of measurements
falling into the different indoor air temperature and RH bands. The distribution of indoor air temperature
was similar for the two groups at baseline [χ2(3) = 1.761; p = 0.623] but differed at follow-up [χ2(3) = 18.231;
p = 0.000]. The proportion of substandard indoor air temperature measurements decreased for the
intervention group but increased for the control group. In contrast, the proportion of indoor air temperature
TABLE 11 Characteristics of the intervention and control households at baseline and follow-up
Characteristics
Study cohort, % (n/N)
Intervention Control
Baseline Follow-up Baseline Follow-up
Year of construction
Before 1919 22.5 (11/49) 28.9 (13/45) 39.1 (18/46) 35.9 (45/39)
1919–1945 28.6 (14/49) 20.0 (9/45) 32.6 (15/46) 33.3 (14/39)
1945–1965 32.65 (16/49) 37.8 (17/45) 0.0 (0/46) 0.0 (0/39)
1965–1979 8.2 (4/49) 8. 9 (4/45) 26.1 (12/46) 28.2 (11/39)
1980 or later 8.2 (4/49) 4.4 (4/45) 2.2 (1/46) 2.6 (1/39)
Building type
Detached house 4.0 (2/50) 4.4 (2/46) 4.1 (2/49) 4.8 (2/42)
Semi-detached house 42.0 (21/50) 47.8 (22/46) 49.0 (24/49) 40.5 (17/42)
Terraced house 52.0 (26/50) 45.7 (21/46) 40.82 (20/49) 47.6 (20/42)
Bungalow 0.0 (0/50) 0.0 (0/46) 2.0 (1/49) 2.4 (1/42)
Purpose-built flat 2.0 (1/50) 2.2 (1/46) 4.1 (2/49) 4.8 (2/42)
Construction type
British steel framed 30.0 (15/50) 32.6 (15/46) 38.8 (19/49) 42.9 (18/42)
Masonry solid wall 60.0 (30/50) 58.7 (27/46) 57.1 (28/49) 54.8 (23/42)
Masonry cavity wall 10.0 (5/50) 8.7 (4/46) 4.1 (2/49) 2.4 (1/42)
Number of bedrooms
1 2.0 (1/49) 2.2 (1/45) 4.1 (2/49) 4.8 (2/42)
2 8.2 (4/49) 8.9 (4/45) 10.2 (5/49) 9.5 (4/42)
≥ 3 89.8 (44/49) 89.0 (40/45) 85.7 (42/49) 85.7 (36/42)
Tenure
Owner occupied 61.2 (30/50) 57.8 (26/45) 61.2 (30/49) 61.9 (26/42)
Private rental 14.3 (7/50) 11.1 (5/45) 8.2 (4/49) 11.9 (5/42)
LA rental 24.5 (12/50) 24.4 (11/45) 28.6 (14/49) 26.2 (11/42)
Housing association rental 2.0 (1/50) 6.7 (3/45) 2.0 (1/49) 0.0 (0/42)
Household composition
Without children 68.8 (33/48) 67.4 (31/46) 81.3 (39/48) 80.5 (33/41)
With children 31.3 (15/48) 32.6 (15/46) 18.8 (9/48) 19.5 (8/41)
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TABLE 12 Average indoor conditions at baseline and follow-up for the intervention and control groups,
unadjusted for outdoor conditions
Outcome
Study cohort, M (SD)
Intervention Control
Baseline Follow-up Baseline Follow-up
Average indoor air temperature (°C)
Whole house
Overall 18.35 (2.99) 19.03 (2.58) 17.62 (2.59) 17.30 (2.87)
Morning 17.23 (3.32) 17.95 (2.91) 16.27 (2.67) 16.12 (2.97)
Day 18.45 (3.09) 19.10 (2.59) 17.64 (2.89) 17.42 (2.92)
Evening 19.09 (3.02) 19.89 (2.81) 18.62 (2.81) 18.12 (3.13)
Night 18.18 (3.09) 18.93 (2.70) 17.48 (2.46) 17.06 (2.93)
Living room daily 18.82 (3.11) 19.43 (2.85) 18.32 (2.51) 18.12 (3.00)
Bedroom daily 18.37 (3.38) 19.09 (3.11) 17.63 (3.14) 16.57 (3.39)
Kitchen daily 17.86 (3.54) 18.69 (3.12) 16.92 (3.65) 17.20 (3.63)
Average indoor RH (%)
Whole house
Overall 55.71 (11.48) 53.26 (11.35) 57.86 (11.17) 56.50 (11.70)
Morning 56.42 (12.41) 53.57 (12.01) 58.99 (11.18) 57.00 (11.97)
Day 55.22 (11.40) 53.00 (11.11) 57.54 (11.20) 55.89 (11.62)
Evening 55.91 (11.48) 53.52 (11.76) 57.67 (11.79) 56.88 (12.12)
Night 55.99 (11.95) 53.27 (11.74) 57.92 (11.33) 56.80 (12.03)
Living room daily 53.30 (12.44) 52.17 (11.90) 55.75 (11.60) 53.35 (12.54)
Bedroom daily 56.78 (12.95) 53.47 (12.40) 57.85 (11.55) 59.32 (12.69)
Kitchen daily 57.12 (12.37) 54.14 (12.72) 59.96 (14.75) 56.83 (13.84)
M, mean.
TABLE 13 Distribution of indoor conditions at baseline and follow-up for the intervention and control groups,
unadjusted for outdoor conditions
Outcome
Study cohort (%)
Intervention Control
Baseline Follow-up Baseline Follow-up
Indoor air temperature °C
< 16 23.5 11.0 27.0 30.4
16–18 20.3 18.5 26.3 26.6
18–24 55.1 68.5 45.5 42.9
> 24 1.2 2.0 1.1 0.1
Indoor RH (%)
< 40 5.2 9.8 3.5 6.1
40–50 30.3 34.3 26.5 25.3
50–60 30.7 29.3 25.1 34.8
> 60 35.4 25.0 45.0 33.8
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within the 18–24 °C band (the recommended comfort zone) increased for the intervention group but
decreased for the control group.
Furthermore, Table 13 shows that the proportion of substandard RH measurements (i.e. > 60% RH)
decreased for both the intervention and control groups. The distribution of indoor RH levels was similar at
baseline [χ2(3) = 2.659; p = 0.447] and at follow-up [χ2(3) = 3.001; p = 0.391].
Main results
Indoor air temperature
Figure 11 shows the estimates and 95% CIs of the measurement occasion × intervention group interactions
for the overall average whole-house temperature, and for the average whole-house temperatures in the
morning, day, evening and night, respectively. These interactions indicate the levels of change in indoor air
temperature observed in the intervention households in comparison to the control households. The figure
shows that, on average, the intervention increased the indoor air temperature by 0.84 °C (95% CI 0.64
to 1.04 °C). The largest changes were observed in the evening (1.17 °C, 95% CI 0.94 to 1.39 °C) and at
night (1.01 °C, 95% CI 0.79 to 1.24 °C). Slightly smaller changes were observed in the morning (0.51 °C,
95% CI 0.26 to 0.75 °C) and during the day (0.62 °C, 95% CI 0.40 to 0.85 °C).
Figure 12 shows that significant increases in indoor air temperatures were found for the living room and
bedroom. On average, the intervention increased the indoor air temperature of the living room by 1.01 °C
(95% CI 0.78 to 1.23 °C) in comparison to the control households. The largest change was observed in
the bedroom: bedroom temperature in intervention households increased by an average of 1.28 °C in
comparison to control households (95% CI 1.04 to 1.52 °C). The increases in the kitchen were the smallest
and non-significant (0.24 °C, 95% CI –0.01 to 0.48 °C).
Figure 13 shows that some intervention measures were more effective than others in raising indoor air
temperatures. External wall insulation produced the largest increase in indoor air temperature (1.12 °C,
95% CI 0.69 to 1.55 °C). Connecting a property to the gas mains network also increased the indoor air
temperature significantly by an average of 0.69 °C (95% CI 0.29 to 1.09 °C). A new boiler or heating
system (–0.19 °C, 95% CI –0.69 to 0.31 °C) and new windows and doors (–0.02 °C, 95% CI –0.39
to 0.35 °C) did not increase indoor air temperatures significantly.
Overall
Morning
Day
Ti
m
e 
o
f 
d
ay Evening
Night
– 1.5 – 1.0 – 0.5 0.0 
Relative change in daily average indoor 
air temperature (ºC) 
0.5 1.0 1.5 
FIGURE 11 Relative change in daily average indoor air temperature during different times of the day for the
intervention households.
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The effects of the intervention on indoor air temperatures were different for the different building
construction types. Figure 14 shows that the intervention increased indoor air temperatures in buildings
with solid walls (1.54 °C, 95% CI 1.26 to 1.83 °C) and in British steel-framed (BISF) buildings (0.74 °C,
95% CI 0.51 to 0.96 °C). The intervention did not increase indoor air temperature in buildings with cavity
walls (–0.17 °C, 95% CI –0.58 to 0.25 °C).
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FIGURE 13 Relative change in daily average indoor air temperature for different intervention measures.
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FIGURE 12 Relative change in daily average indoor air temperature for different rooms of the intervention households.
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FIGURE 14 Relative change in daily average indoor air temperature for different construction types.
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Figure 15 shows the change in indoor air temperatures as a result of the intervention under different
heating demand conditions. The increases in indoor air temperature ranged between 0.59 °C and
1.03 °C, and were the highest for the lower heating demand conditions (i.e. below 6 HDDs and between
6 and 8 HDDs).
Indoor relative humidity
Figure 16 shows that, on average, the intervention increased indoor humidity levels by 0.04% RH in
absolute terms. The increase in the intervention households was not significantly different from the one
observed for the control households (95% CI –0.74% to 0.83% RH). The figure further shows that
the changes were consistent for different levels of outdoor RH conditions. None of the changes differed
significantly from the changes observed for the control households under the same conditions.
Figure 17 shows that the different intervention measures had differential impacts on internal hydrological
conditions. Both a gas network connection (3.86% RH, 95% CI 2.31% to 5.41% RH) and the installation of
new windows and doors (5.15% RH, 95% CI 3.73% to 6.57% RH) increased indoor RH levels. However, the
increases were small in absolute terms. External wall insulation, which included the installation of mechanical
ventilation, did not increase levels of indoor RH (–0.60% RH, 95% CI –2.26% to 1.06% RH) nor did the
installation of boilers or heating systems (–1.59% RH, 95% CI –3.52% to –0.34% RH).
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FIGURE 15 Relative change in daily average indoor air temperature under different heating demand conditions for
the intervention households.
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FIGURE 16 Relative change in daily average indoor RH under different external RH conditions for the
intervention households.
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
53
The effects of the intervention on indoor RH levels were different for different building construction types
(Figure 18). The intervention increased indoor RH in buildings with cavity walls by 4.57% RH (95% CI
2.94% to 6.20% RH). The intervention decreased indoor RH levels in buildings with solid walls (–0.90% RH,
95% CI –1.76% to –0.03% RH). The intervention did not change indoor RH levels in British steel-framed
buildings (–0.35% RH, 95% CI –1.49% to 0.78% RH).
Duration and cumulative substandard internal conditions
The study further explored the impact of the intervention on the average daily duration and cumulative
substandard internal conditions. Figure 19 shows that there is no evidence that the intervention reduced
the daily duration of temperatures of < 18 °C (0.27 hours, 95% CI –0.49 to 0.96 hours) or <16 °C
(0.20 hours, 95% CI –0.48 to 0.88 hours). However, the intervention did reduce the duration of indoor
RH levels of > 60% RH by 1.14 hours (95% CI –2.00 to –0.28 hours).
Figure 20 shows that the intervention had a positive effect on the three cumulative substandard internal
conditions measures. The cumulative amount of indoor air temperature of < 18 °C was reduced by 3.62 °C·hour
(95% CI –6.95 to –0.30 °C·hour). The cumulative amount of the indoor air temperature of < 16 °C was reduced
by 4.20 °C·hour (95% CI –6.64 to –1.76 °C·hour). The cumulative amount of the indoor RH levels of > 60%
was reduced by 19.32% RH·hour (95% CI –29.68% to –8.96% RH·hour).
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FIGURE 17 Relative change in daily average indoor RH for different energy efficiency measures.
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FIGURE 18 Relative change in daily average indoor RH for different construction types.
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Average daily gas usage
Figure 21 shows the average daily gas usage for the intervention (n = 26) and control households (n = 37)
at baseline and follow-up periods. The calculation excluded the households from the off-gas areas for
which no gas meter readings could be taken. Average daily gas usage decreased from 3.88 m3 to 2.45 m3
in the intervention households, a decrease of 36.9%. In contrast, the average daily gas usage increased
from 4.60 m3 to 4.76 m3 in the control households. Having controlled by individual household heating
demand, a repeated measures ANOVA showed that the intervention group × measurement occasion
interaction was significant [F(1,60) = 35.985; p = 0.000; η2 = 0.379 (Cohen’s d = 1.41)].
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FIGURE 21 Daily average gas consumption for the intervention and the control households at baseline and follow-up.
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FIGURE 20 Relative change in daily average cumulative substandard internal conditions for the intervention households.
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FIGURE 19 Relative change in daily average duration of substandard internal conditions for the intervention
households.
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Discussion
Key results
This study provided new evidence on the impact of energy efficiency investments on internal conditions
and household energy use through detailed long-term household monitoring. Internal conditions were
monitored for a minimum of 28 consecutive days before and after the installation of energy efficiency
measures. These were compared with the internal conditions of households that did not receive such
measures. The study found that the intervention raised indoor air temperature by an average of 0.84 °C,
whereas average daily gas usage dropped by 37%. Similar increases were observed across different
heating demand conditions. Furthermore, the intervention reduced the cumulative amount of the indoor
air temperature that was substandard. Overall, the intervention did not increase indoor RH levels, although
small increases were found for some individual measures. The study found that the intervention reduced
the average daily duration and cumulative amount of indoor levels of > 60% RH.
The intervention measures were not equally effective. External wall insulation and connection to the gas
mains network significantly increased indoor air temperatures; new windows and doors or a new heating
system did not significantly increase indoor air temperatures. The increases in indoor air temperatures in
British steel-framed buildings and buildings with solid walls could largely be attributed to the external
wall insulation they received. Both new windows and doors and connection to the gas mains network
increased indoor RH, although these increases were small in absolute terms. External wall insulation
probably did not increase indoor RH because of mechanical ventilation. Increases in indoor RH levels were
observed only in buildings with cavity walls, and not in British steel-framed buildings or buildings with solid
walls. It shows the importance of using mechanical ventilation when making buildings more airtight.64
The observed changes in indoor conditions were similar to or somewhat smaller than those found in
previous research. The results of these studies are discussed in Chapter 1. However, in order to be able to
compare different studies, changes in indoor conditions need to be accompanied by data on energy use.
The extent to which the benefits of improved energy efficiency are taken as energy saving or as extra
warmth can then be assessed. The latter is also known as the rebound effect.133,134
Limitations
Although the study involved detailed long-term monitoring before and after the intervention, included a
control group and controlled for external hydrothermal conditions, it did not monitor occupancy, heating or
occupant behaviour. Occupancy and occupant behaviour have a large impact on the energy consumption
and internal conditions of buildings. Including these aspects would improve our understanding of adaptive
behaviours resulting from the energy efficiency investments. However, it was beyond the scope of the study
to incorporate internal household dynamics into the research. The research uses estimates from meter
readings made at the installation and collection of the monitors. This can only provide an indication of the
energy savings as a result of the energy efficiency investments. Higher-resolution energy monitoring would
allow the energy usage to be attributed to specific purposes and to provide information on occupancy and
occupant behaviour.
Limitations regarding the sample are similar to the community-based study, from which participating
households were recruited. These limitations are discussed in Chapter 3. The final sample of intervention
and control households, however, were largely comparable, and the study had relatively low attrition.
Although the study involved only a relatively small number of houses, they were observed for a minimum
of 4 weeks before and after the intervention, resulting in a detailed data set with > 15,000 data points.
The longitudinal study therefore allowed the model parameters to be estimated with far more precision,
using 28–231 observations per household as opposed to just one.
The intervention involved a number of different energy efficiency measures, depending on the type and
location of the properties. Although this means that the houses were non-identical and that the
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intervention differed across the different schemes, it allowed the study to estimate the effects of different
energy efficiency measures in different types of buildings.
Interpretation
The study suggests that the intervention successfully increased indoor air temperatures. Although the
overall increase was relatively small (in the order of 1.0–1.5 °C), it reflects long-term average increases,
reducing the potential exposure of substandard temperatures: it brought the majority of indoor
temperatures within the ‘healthy’ comfort zone of 18–24 °C.124,125 An above-average increase in bedroom
temperature suggests that the intervention helped to expand comfortable space within the home.61 There
is no evidence that insulation substantially increases indoor RH levels when accompanied by mechanical
ventilation. This suggests that energy efficiency investment programmes such as Arbed will be beneficial
primarily by providing improved living conditions that are conducive to good physical and mental health.54
The reduction in gas usage suggests that the intervention has been successful in reducing financial
pressure and improving living conditions in households in low-income areas, which were the main aims of
the intervention programme.
Generalisability
The study involved detailed long-term household monitoring of a number of different households receiving
a range of different energy efficiency measures through the intervention programme. There is little
evidence that selection and attrition have systematically biased the sample, suggesting that the results may
be generalised to similar energy performance investment programmes, as may the results regarding the
specific measures and construction types. However, the results may not be directly generalisable to
non-deprived communities or households with different financial circumstances, occupancy or heating
patterns.
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Chapter 5 The economic evaluation
Introduction
This chapter follows Consolidated Health Economic Evaluation Reporting Standards (CHEERS) reporting
standards (see Appendix 10).135
Background
Health economic studies are intended to inform policy-makers and health-care decision-makers about which
interventions, policies or services provide the best value for money. The challenge for such evaluations is to
find the right methodology to evaluate social policy interventions that is not overburdensome in terms of
data needs, yet appropriately informs decisions. The National Institute for Health and Care Excellence (NICE),
for health technology assessment, defines a reference case that specifies the most appropriate methods
consistent with the NHS objective of maximising health gain from limited resources. The reference case
involves the use of the QALY as a single index to measure and value the health effects of interventions.136
Social policy interventions, such as structural energy performance investments, have multiple social,
economic and environmental dimensions. This differentiates them from many other types of health
intervention.137 These investments do not always provide an immediate return in terms of health and other
social benefits.138 Therefore, they may not be considered cost-effective using accepted norms. There is
some evidence, summarised in a review paper by Fenwick et al.,74 that investments in the energy efficiency
of social housing stock provide wider benefits to the health and lives of residents, and that these
investments may furthermore have value in their benefits to the NHS and social services.
This chapter describes the analyses undertaken for the health economic evaluation of the intervention
programme. The analyses explore whether or not the structural energy performance investments under the
intervention programme have delivered health-related quality-of-life improvements and economic impact.
The value for money of a social policy intervention depends on several factors, including the timing and
setting of the intervention as well as the perspective of the evaluator. Considerations include the balance
between the estimated costs of the intervention and the expected outcomes for the beneficiaries, and the
time over which the costs fall and benefits are realised. Although energy efficiency programmes are
generally not provided or paid for by the health services – the intervention was funded through ERDF and
the Welsh Government – they may provide benefits to the health services in terms of cost avoided through
reduced health service usage. Furthermore, the intervention may not only benefit the NHS through
changing use of health services and a reduction in contact with health and social services, but it may also
result in improved quality of life of residents. To inform decisions about energy performance investments,
a comprehensive overview of the benefits of such investments and an understanding of how benefits are
realised beyond the perspective of the funder of the investments are required, for example benefits to the
health services.
Economic studies for public health
Health economic analyses take many forms but can be broadly classified into two categories: cost studies
and economic evaluations. A short description of the different types of cost studies and economic
evaluations is provided in Box 1. The difference between the two categories is that cost studies focus on
the identification of resources, impact and costs related to providing interventions and any cost offsets that
may arise, whereas economic evaluation studies are comparative analyses that take account of both costs
and benefits of the intervention and a comparator.
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Previous economic studies of the health impact of housing improvement
A number of cost studies and economic evaluations have been conducted to assess the health-related
quality of life and economic impacts of housing improvements. In a recent review of the literature, Fenwick
et al.74 identified 45 health economic studies relating to the health impacts of housing. It is clear from the
review that only a limited number of health economic evaluations had been conducted during the period
considered. Out of the 45 health economic studies, 29 reported cost and/or economic analysis and the
majority involved cost studies (n = 25). Only four studies involved an economic analysis, although,
in the opinion of the authors, 11 of the reported cost studies had sufficient data to conduct an economic
evaluation.74 Three studies stated that a CBA had been conducted but in fact it had not, and only one
study was found to have conducted a CEA. Barton et al.51 used the SF-36 to capture change in the
BOX 1 Description of different types of cost studies and economic evaluations.
Cost studies
l Cost–offset analysis establishes whether or not health-care utilisation decreases as a result of a health
intervention. A total offset occurs when general health-care savings exceed the cost of the health-care
intervention, effectively resulting in the treatment paying for itself.
l Cost minimisation analysis addresses assessment of costs if the health benefits of competing health-care
technologies have been demonstrated to have clinically equivalent outcomes.
l Cost–consequences analysis considers all the health and non-health benefits of an intervention across
different sectors and reports them in a disaggregated form. It accepts that different types of benefit cannot
be captured using the same units. All impacts and costs are considered when deciding which interventions
represent the best value, even if the impacts cannot be costed.
Economic evaluations
l Cost-effectiveness analysis typically involves measuring a specific, one-dimensional health or clinical
outcome for competing health technologies, for example ‘asthma attacks averted’.
l Cost–utility analysis is a special type of cost-effectiveness analysis in which multidimensional health
outcomes are reduced to a single dimension reflecting individuals’ preferences for the diverse health
outcomes. The most commonly used outcome in CUA is the QALY. For both cost-effectiveness and
cost–utility studies, value for money is identified using a measure of the additional cost per additional
outcome ratio (e.g. an incremental cost/QALY ratio) and comparing that with an external threshold or
with the ratio achieved by alternative policies.
l Cost–benefit analysis involves the measurement and valuation of all outcomes of interest in monetary
terms. Here the value for money is identified by positive net economic benefit associated with the
intervention compared with an alternative (i.e. the monetary value of the outcomes exceeds the net costs
of the intervention less any cost savings achieved elsewhere).
l Cost–utility analysis is a form of cost-effectiveness analysis (CEA) that uses the QALY as the measure of
benefit and is specified in the NICE reference case136 as a preferred method for conducting health economic
evaluations, although it is recognised that it has limitations as well. CUA does not consider wider
non-health benefits often associated with social policy interventions.139 When evaluating social policy
interventions, it is important to consider social and economic benefits beyond those for the health service,
which cannot easily be captured by the QALY metric. In reality, benefits are measured and valued
using different outcome metrics; therefore, an appropriate framework is needed that allows all relevant
benefits of an intervention to be taken into account in the analysis. Cost–consequence analysis (CCA)
and cost–benefit analysis (CBA) are considered suitable approaches by NICE, given that they allow all
relevant benefits to be considered. The difference between CCA and CBA is that the former reports
all health and non-health benefits in a disaggregated form, whereas the latter expresses all costs and
benefits in monetary terms.
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health-related quality of life of residents as the basis for the economic evaluation. They concluded that the
housing improvements did not produce substantial gains in terms of health-related quality of life, health or
more schooling. However, they also recognised that there may have been insufficient time for measurable
benefits to have materialised.
In addition to the studies reported by Fenwick et al.,74 a small number of more-recent health economic
studies have been conducted. The Gentoo social housing and sustainability group conducted a pilot study140
(n = 12) examining the health economic impact of energy efficiency improvements on people with COPD.
The study found that self-reported GP appointments were reduced by 60%, accident and emergency (A&E)
attendances by 30%, outpatient appointments by 22% and emergency admissions by 25%. The Warm
Homes for Health project141,142 involved similar improvements, mainly focused on heating and insulation.
The study suggests that installation of housing improvements produced cost savings to the NHS worth
> £50,000. This would equate to an annual saving of £1B if all 4.8 million substandard homes in the UK
receive the same energy efficiency measures. However, these two studies are at an early stage and at the
time of writing the full results of their final health economic analyses have not yet been published.
Lawson et al.143 conducted a CUA of a transfer of social and private tenants to new-build social housing
rather than regeneration of existing housing stock. The study did not find a significant change in outcomes
expressed as utility scores in the intervention group in comparison to a control group over a 2-year period.
As a result, they concluded that the intervention was not value for money in health terms, although this
was qualified by noting that not all benefits may have been captured and that they may not have been
fully realised over the period of the study.143
The research reported here builds on these prior studies but extends the body of evidence by using
routinely collected health data in addition to self-reported survey data. The use of routinely collected
health data allowed the intervention to be evaluated retrospectively using actual health-care utilisation
data from the SAIL databank.82–84,144 The study focuses on utilisation of secondary health-care services,
including emergency admissions and contacts with primary care within NHS Wales, by people living in
homes that received the intervention.
Objective
The objective of the economic analysis was to evaluate the costs and consequences of the intervention
from the perspective of NHS Wales. This was undertaken in the form of a CCA and a CUA.
Method
Study design
The health outcomes utilised in the economic analyses are based on the analyses undertaken using
routinely collected data held within the SAIL databank. The methods used for these analyses are described
in Chapter 2. Based on a literature review and the recommendations of NICE, CCA was considered to
be the most appropriate methodological approach for the evaluation as it allows for different types
of outcome to be considered. The CCA considers resource use and the related cost impacts of the
intervention and benefits of different kinds to be considered and to be reported in a disaggregated form.
Health service impacts and costs are thus considered as separate items to enable decision-makers to
determine if the intervention represents good value from their perspective.
In addition to the CCA, a CUA was considered as an approach to evaluate the intervention programme.
The CUA approach attaches utility values (the ‘Q’ value in QALYs) over time for study outcomes to provide
one single measure (i.e. QALYs). The CUA considers resource use and cost impacts of the intervention and
the benefits in terms of QALYs to be established for the intervention. In CUA, the intervention outcomes
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and the overall costs are compared with the relevant comparator. The intervention can ‘dominate’ the
control (greater effect/lower cost), in which case it will be unambiguously cost-effective, or, in the event
of a non-dominance (greater effect/higher cost), results are reported in the form of an incremental
cost-effectiveness ratio (ICER) showing the additional cost per QALY gained.
A simple CUA based on QALYs derived from SF-12 responses is reported in Chapter 3. However, the utility
values collected in the community-based study did not represent specific health states; rather, they were
valuations of health experienced before and after the intervention was completed.
The economic analyses utilise the outcomes from the SAIL databank analyses described in Chapter 2, and
follow a panel analysis approach utilising data available for the study population in the SAIL databank. The
data were extracted for the study populations in monthly increments and used to develop a retrospective
analysis (see Chapter 2). To fully utilise the SAIL databank outcomes, we looked to the literature and prior
research to identify utility values for the health states experienced by individuals experiencing COPD-related
emergency admissions.
The overall study period is 10 years, from 2005 to 2014. The intervention was delivered in 2010/11.
Information collected prior to the intervention was utilised as a baseline to observe any subsequent
changes in hospital admissions. The time horizon for the economic evaluation was 4 years post
intervention.
As described in Chapter 2, the intervention programme included external wall insulation, boiler upgrades
and replacements, microgeneration (photovoltaics/solar hot water/heat pumps) and general energy-saving
advice. The lifespans of the different elements range from 12 years for boiler upgrades and replacements
to 42 years for insulation (see Table 14).91 Considering that the shortest lifespan of an element was
12 years, residents remaining in the property after the improvements will have benefited from the
elements installed. Extrapolating beyond the study period seems inappropriate for the base case scenario,
given the uncertainty about the health benefits that remain with an individual if they move out of
properties over time. We believe that the 4-year time horizon of the study is appropriate and generalisable.
To explore this element of uncertainty further, we undertook a sensitivity analysis, using threshold analysis
to explore a range of durations of residency. We assumed that the impact was constant and the benefit
continued after the observed study period. As the follow-up period after the intervention was completed
was longer than 12 months, the costs and benefits beyond 1 year were discounted at a standard rate
for public health interventions, currently 3.5%, to bring them into 2013 prices and a sensitivity analysis
with 1.5%.139
Setting
The economic analysis focused on the first phase of the intervention programme that took place in 2010
and 2011, in which a total of £68M was invested, including leveraged funding. The programme improved
the energy efficiency of existing homes in low-income areas. LAs and RSLs submitted project plans to
improve thermal efficiency of homes in Wales. The majority of homes were social housing. This study
was undertaken using data for the intervention group providing their own historical controls. Individually
reported baseline and follow-up periods in the intervention cohort were used to calculate the duration
of the intervention for each resident and/or household.
Participants
The study participants within this study were individuals who lived within one of the intervention or
comparator homes during the period under consideration. Anonymised housing codes were used to link
the homes and individuals within the SAIL databank. All individuals who were a resident within a study
home for ≥ 60 days were included in the analysis. Baseline data were collected for several years prior to
the intervention.
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Variables
A range of explanatory variables was collected for each individual and/or household. The variables utilised
within this study were chosen for their theoretical power in explaining the levels of emergency admissions
experienced. Information was collected at the individual level for age (in 5-year bands), sex and
comorbidity (0, 1). Housing-level data were collected for area income deprivation (ordinal scale) and a
measure of rurality (urban or rural). Given the seasonal trend observed within the dependent variables, an
identifier for seasonality was also included. All outcome variables were grouped into the composite count
measure of cardiovascular and respiratory emergency hospital admissions. To account for the variability in
the duration over which individuals were observed, each of the count measures is transformed into a
yearly rate. Data for each of these emergency admission variables were collected from PEDW. The PEDW
data are structured into ICD-10 diagnosis chapters, described in Chapter 2.
Costs
The comparisons in health service resource use related to the study outcomes for the study population were
made between the baseline and follow-up intervention period. The resource changes for the health system
as a result of changes in health service use were calculated using the methods described in Chapter 2 and
standard NHS unit costs. The costs associated with the resources in secondary care health services used by
the recipients of the intervention include secondary care admissions for cardiovascular and respiratory
conditions. The total cost of the intervention was estimated from the cost of implementing the programme,
plus changes in health-care resource costs over the follow-up period. The comparison is made with the
pre-intervention period for the study population and no intervention costs and so the total costs are derived
solely from the changes in health-care resource use. The overall budget allocated to the intervention
programme was derived from records received from the Welsh Government and the 28 LAs and RSLs
involved in the scheme. The evaluation was undertaken from a NHS costing perspective; only costs and
benefits to NHS Wales were considered. We used 2015 as the base year for costs.
Outcomes
The health outcomes for the CCA were changes in emergency hospital admissions for cardiovascular and
respiratory conditions.
The intervention was expected to have an impact on the health-related quality of life of the residents
who received the intervention over the follow-up period. As reported in Chapter 3, the results of the
community-based study showed no difference in either health-related quality of life or utilities within
12 months of the delivery of the intervention. These results reflect those of similar studies evaluating
housing interventions and the subsequent impact on health-related quality of life, in which the authors
suggest that the relatively short time period of the follow-up did not allow the full impact of the
interventions to be reflected in health-related quality-of-life status.51,143
In order to undertake a meaningful CUA, we used an economic modelling approach, which instead used
literature-based utility values for the health states related to the primary and secondary health outcomes to
evaluate the probable impact of the intervention on QALYs. The CUA conducted here used only outcomes
relating to COPD. The reason for that is that there is a relative wealth of literature on utility values for
hospital admissions for exacerbations of COPD in comparison with the other reasons for hospital admissions.
A number of prior studies have examined the impacts of housing interventions on COPD, and COPD forms
an important part of the overall burden of disease.118,145,146 In order to identify utility values for COPD to
enable contextualisation of the results, a systematic approach was taken to reviewing the literature. The
literature review is provided in Appendix 12.
Economic analysis
Two types of economic analysis were conducted: CCA and CUA.
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Cost–consequences analysis
The primary outcome measure for the CCA was the change in cardiovascular or respiratory emergency
hospital admissions and utilised the financial costs of the intervention. The findings are reported as the
ratio of the cost per person per year and the changes in primary outcome. The statistical approach
undertaken to calculate the impact of the intervention on the primary outcome initially assessed the
presence of trends over the study period. The data were observed as a monthly count of emergency
admissions. In the absence of an evident trend, the data were conflated into a two-period comparison.
Our analysis compares the outcome rates before and after the intervention. To account for different
exposure durations and data containing incomplete years, the aggregated count data is transformed into
annualised rates when possible (see Chapter 2). The resulting annualised rates were compared using a
mixed multilevel linear model, which incorporates the covariates and explanatory variables.
The covariates included were age, sex, overall comorbidity score, a seasonality adjustment and area-based
deprivation. The age variable takes an average age for each of the two periods. In the event of clustering,
random effects modelling was used. Clustering was based on a person’s unbroken residence within a study
property. When an individual was observed inhabiting multiple properties within the study period, the
data are assumed to be independent owing to the influence of unobserved factors. The independence of
residential durations extends to individuals returning to an intervention property they previously inhabited.
A ‘bottom-up’ costing approach was undertaken as part of the economic analyses; details are provided in
Appendix 11. The rationale behind this costing approach was the desire to report figures that represent
the financial implications of replicating the intervention and enable both bottom-up and top-down
costing in the analysis, which may have inflated values owing to the inclusion of managerial, planning and
data collection components that may not be required in a replication intervention. The total bottom-up
cost of delivering the intervention was £32,484,900 for the 4968 households in the analysable data set
(i.e. with complete data on the property intervention and inhabitants). The Welsh Government intervention
top-down spend was reported to be between £60M and £68M (personal communication with Welsh
Government). However, these figures include additional properties and leveraged funding that were not
reported in the initial data set. The top-down costing approach was used for the sensitivity analysis.
Costs were initially estimated on a per-household basis and later adjusted to a per-person per-year level to
standardise the outcome measure. Given the range in effective duration for the different components of
the intervention, a time-dependent costing approach was adopted. Table 14 shows the frequency of each
intervention component alongside the effective duration and cost. Costs are reported at 2013 prices. The
resulting cost per household was calculated according to the average overall cost and then adjusted to
create a per-year figure. The intervention cost was spread across the effective lifetime using a straight-line
depreciation method given the assumption of zero residual value.
TABLE 14 Frequency, duration and cost of the intervention
Intervention measure
Number
delivered
Estimated
lifetime (years)147
Indicative cost (£)
(WG report)148
Average cost (£)
per year
External wall insulation 2709 36 7300 202.78
Photovoltaics 1458 25 5400 216.00
Solar water heating 928 25 2600 104.00
Air source heat pumps 401 15 6000 400.00
Loft/rafter insulation 172 42 100 2.38
WG, Welsh Government.
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The bottom-up costing approach provided a per-property per-year cost of £225.76. Given that all the
intervention elements have a life expectancy of > 4 years, the cost per household can be assumed to be
consistent across all the years included in the analysis. The data suggest an average occupancy of 2.7
individuals, resulting in an average per-person per-year cost of £83.61.
The CCA compared the cost of the intervention with the range of reported outcomes. The primary
outcome is the rate of combined cardiovascular and respiratory emergency hospital admission. The
secondary outcomes are the contributing subgroups of the primary outcome. The primary and secondary
outcomes are illustrated alongside their mean annualised change rates in Table 15.
The annualised prevalence rates reported here show that, without accounting for covariates, the primary
outcome rate increases by 0.0034 following the intervention. Changes in emergency admissions represent
an important component of the cost in CCA as a change in rate represents a change in cost. Using an
‘average duration’ approach and the reported emergency admissions, alongside NHS reference costs,149
results in a representative cost per event of £2734.29.
Cost–utility analysis
We developed the event profile for COPD-related emergency hospital admission based on a structured
literature review (see Appendix 12 and the search strategy reported in Appendix 13). The decline and
partial recovery profile that characterises a COPD exacerbation was modelled to include five distinct phases
as described by Seemungal et al.150
The baseline utility value was sourced from a systematic review151 that reported UK-based utility scores derived
from the EuroQol-5 Dimensions (EQ-5D) instrument for each of the four international severity levels for
COPD.152 The distribution of COPD in UK general practice using the Global Initiative for Chronic Obstructive
Lung Disease (GOLD) classification was described in a study by Haughney et al.,153 in which the combination of
the EQ-5D and weighting data provided the baseline COPD utility. The GOLD stages represent varying forced
expiratory volumes (FEVs). The baseline COPD utility score represents the value that individuals with COPD
experience before an exacerbation occurs, whether severe enough to cause a hospital admission or otherwise.
Table 16 reports the combination of the distribution of GOLD COPD stages and the utility scores representing
the valuation of the health state. The resulting weighted baseline value was a utility score of 0.750.
TABLE 15 Primary and secondary outcomes’ mean annualised rates before and after the intervention
Outcome Before, M (SD) [n] After, M (SD) [n] Change in rate
Cardiovascular or respiratory 0.0543 (0.4788) [22,209] 0.0577 (0.7079) [18,527] 0.0034
COPD 0.0062 (0.1468) [22,209] 0.0069 (0.1150) [18,527] 0.0007
Cardiovascular 0.0179 (0.2709) [22,209] 0.0171 (0.4377) [18,527] –0.0008
Respiratory 0.0324 (0.3720) [22,209] 0.0371 (0.5430) [18,527] 0.0043
M, mean.
TABLE 16 The utility scores for COPD GOLD stages
GOLD stage of COPD Distribution of COPD population (%) Utility score
1 17.1 0.806
2 52.2 0.767
3 25.5 0.704
4 5.2 0.616
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An emergency hospitalisation attributable to an exacerbation of COPD represents a detrimental impact
on an individual’s short-term and possibly long-term health-related quality of life, represented here by
health state utility scores. The literature search identified three papers that included utility valuations for
individuals on admission and on discharge from a hospital stay for a COPD admission.154–156 The utility
scores for use in this analysis were created using a weighted average of all those reported in these papers,
taking into account the number of individuals that the publication reported. Table 17 shows the number
of individuals, utility value and publication from which the value was derived. The average utility score,
derived from the literature for the COPD patients who experienced a hospital stay, is 0.504.
The COPD events that are serious enough to require hospital admission carry a risk of mortality. To account
for this within this model, an inflated relative mortality measure was calculated. The data on COPD hospital
admission mortality come from Esteban et al.157 Given the average hospital stay duration of 7 days, all-cause
mortality for this duration provides a baseline rate. The average age of patients in the literature was 72.6
years, whereas the data for COPD events utilised within this analysis show a mean age of 69.2 years. The
relative all-cause mortality for these two ages was used to deflate the mortality observed in the literature to
a rate representative of COPD hospitalisations for the data used in our analysis. The all-cause mortality was
calculated to be 0.031% for the 7-day period, whereas those experiencing a COPD-related hospitalisation
had a mortality rate calculated to be 2.507%. The net increase in mortality attributable to COPD
hospitalisation is 2.476%. Taking into account this increased mortality when estimating the utility value
for a COPD admission for an exacerbation, we estimated a utility value of 0.492.
The estimation of a discharge utility score follows the same approach as estimating the admission value.
Hospital discharge values were obtained from the same three papers as the admission figures.155–157
The data sourced from the literature report 1289 individuals with a mortality-adjusted average utility
score of 0.613. As previously mentioned, COPD events are characterised by an initially large reduction of
health-related quality of life followed by a recovery phase to prior health. However, some individuals may
ultimately never fully recover to the same health and FEV levels they had prior to the exacerbation.
The post-discharge recovery phase was estimated using the recovery statistics reported by Seemungal
et al.150 The duration of an event that began with a hospitalisation attributable to COPD was estimated
by Seemungal et al.150 to be a total of 91 days. Given a 7-day hospital stay, the remaining 84 days are
characterised by two phases: first, 28 days following discharge, during which 75.2% of individuals were
found to make a full recovery; and, second, the subsequent 56 days, during which 79.8% of those
remaining not fully recovered were reported as still experiencing a negative residual impact of their event.
The utility score of these two recovery points is calculated according to the percentage of individuals
recovering from the discharge utility value back to the initial baseline value. The utility score for individuals
28 days post discharge was calculated as 0.720, increasing to 0.726 at 84 days. The figure of 0.726 is
assumed to be the long-term utility score.
Figure 22 plots the five COPD health states and the related utility values, illustrating the sharp decline caused
by the hospitalised exacerbation event followed by the gradual recovery that ultimately never reaches the initial
baseline value. The area under the curve approach was used to estimate the short- and long-term reduction in
QALYs. The short-term calculation assumes that the hospitalisation occurs in the middle of the year with a
within-year QALY reduction of 0.022. The long-term impact of a COPD event is a reduction of 0.240 QALYs.
TABLE 17 Reported utility valuations for individuals on admission and on discharge from a hospital stay for a
COPD admission
Research paper Number of patients Utility value
Esteban et al.157 1421 0.600
Menn et al.155 117 0.446
O’Reilly et al.156 222 –0.077
Average 0.504
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Although commonly used for estimating health valuation over time, utility decrements may fail to account
for the full detrimental impact of a COPD event when used to estimate a structured event pathway for
a COPD patient. Rutten-van Mölken et al.158 sought to capture the broader holistic impact of a serious
COPD exacerbation using an isolated time trade-off valuation approach. This time trade-off study estimated
a single serious exacerbation to reduce health state utility by 0.042. This study viewed an event within the
context of 1 year as opposed to the modelling undertaken in this analysis. The extended time frame
obtained from the five-point calculation aligns well with the panel data analysis in that it accounts for the
longer-term impact of reductions in FEV.
To inform our CUA and economic model, each adverse health event resulting in a hospital admission had a
curve mapped from the utility values across the study period. This approach incorporates the initial impact
of the event and a time-variable component. The analysis utilised cost associated with the intervention and
the improved health following a reduction in COPD events to generate an ICER.159
Sensitivity analysis
To address uncertainty in our findings, a number of deterministic one-way sensitivity analyses were carried
out based on a number of variables that we were aware introduced uncertainty and/or had a substantive
impact on the health outcomes, resource use and costs. The CCA results offer a concise package of
findings on which a best-case and worst-case scenario evaluation is undertaken for the sensitivity analysis.
The uncertainty in the outputs of the CUA was explored using one-way sensitivity analysis, a threshold
analysis and a probabilistic sensitivity analysis (PSA).
The threshold analysis estimates the level of reduced COPD hospitalisations required to make the
intervention cost-effective at a £30,000 per incremental QALY gained level. Given the importance of the
time frame of the analysis, a range of different time horizons were taken. The PSA enabled a range of
variables with inherent uncertainty to be investigated to determine the impact on the results.
Uncertainty exists for two main components of the analysis:
1. costs
2. change in adverse health events resulting in hospital admissions.
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FIGURE 22 Time course and utility values for a COPD exacerbation event.
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Probabilistic sensitivity analysis was conducted to assess the uncertainty of each of these two areas. The
approach takes into account the uncertainty inherent in the Welsh Government top-down cost estimate
of approximately £60M–68M and models the uncertainty using a uniform distribution. The uniform
distribution was chosen in line with good practice because there is no centralised tendency and all figures
within the distribution are assumed to be as likely as any other. The change in hospitalisation event values
are estimated using normally distributed random samples. The normal distribution takes into account the
central point estimate used in the deterministic analysis and the SD from this position.
The PSA approach estimates 1000 resamples, which are calculated as individual ICERs (see Equation 1).
Findings from the PSA are reported in a cost-effectiveness plane (CEP). The 95% CIs calculated from
the PSA samples are reported alongside the main ICER finding. The ICER, CEP and cost-effectiveness
acceptability curve (CEAC) were evaluated relative to the NICE willingness-to-pay threshold values. NICE
generally considers that interventions costing the NHS < £20,000 per QALY gained are cost-effective.
Interventions costing between £20,000 and £30,000 can be deemed cost-effective, depending on the level
of uncertainty about the ICER, the impact on health-related quality of life of the intervention, the degree of
innovation and level of benefits that may arrive that are not easily quantifiable in terms of health gain:139
ICER =
Difference in costs between intervention and control
Difference in health effects between intervention and control
. (1)
Results
Cost–consequence analysis
The CCA outcomes are presented in Table 18. The outcomes for the primary objective are reported
separately from the costs. The average change in emergency admissions by year is weighted according to
the prevalence levels within each of the 4 post-intervention years. Table 18 reports the primary objective
alongside the intervention costs. The costs and outcomes are discounted to present-day values at 3.5%.
Table 18 reports four data columns and totals. The ‘weighting’ column offers the calculation needed to
transform the overall impact into a yearly value, which is based on the prevalence of the measure in each
year. The change in admissions (B) and SD are reported in the second data column; the fourth data
column reports the discounted effects and attached treatment costs. The third column includes the cost of
the intervention, which is combined with the changes in treatment costs to offer the final cost component.
The total effect value is a simple summation of the four yearly changes in admissions.
TABLE 18 Costs and consequences for the primary outcome (combined cardiovascular and respiratory
emergency admissions)
Year Weighting
Change in admissions
post intervention, B (SD)
Cost per person per year
for the intervention (£)
3.5% discounted event
(discounted event cost, £)
Overall 0.0010 (0.006)
1 1.078 0.0012 (0.006) 83.61 0.0012 (3.20)
2 0.919 0.0010 (0.005) 83.61 0.0010 (2.64)
3 1.011 0.0011 (0.006) 83.61 0.0010 (2.81)
4 0.992 0.0011 (0.006) 83.61 0.0010 (2.66)
Total 345.75 0.0041
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The results suggest a non-significant increase in hospital admissions for the primary outcome: over the
4 years, the cumulative impact is 0.0041 events per person. The per-person cost over the post-intervention
period amounts to £345.75, which is driven by an intervention cost of £334.44 and an increase in
treatment costs of £11.31. Given the increase in the primary outcome following the intervention and the
positive intervention costs, the intervention is not deemed as cost-effective.
The results using the secondary outcomes are reported in Tables 19–21. The approach is the same as with
the primary outcome but leaves out the intervention costs. The intervention costs are not included in the
tables to avoid double counting. Table 22 reports the combined outcomes and costs for the four measures.
Table 19 reports the impact on the COPD-related hospital admissions per person. The reduction in COPD
emergency admissions is not significant at a 95% confidence value; the summation of these event
reductions over the 4 years totals to –0.0006 per person. The scale of this reduction is very small and
suggests a reduction in NHS treatment costs of £1.64. The reduction of 0.0006 events should be
considered alongside each of the following impacts. The weighting levels in Table 20 show that COPD
events were increasing over the 4-year period.
Table 20 reports the impact on the cardiovascular-related emergency hospital admission events per person.
As with the COPD results, the cardiovascular event levels have reduced non-significantly. The scale of the
reduction is 0.0053 and the discounted amount saved is £14.56. The first year following the intervention
saw the lowest levels of cardiovascular emergency admissions.
TABLE 19 The COPD-related emergency admissions
Year Weighting Undiscounted change, B (SD)
3.5% discounted event
(discounted event cost, £)
Overall –0.0002 (0.001)
1 0.7724 –0.0001 (0.001) –0.0001 (–0.34)
2 0.8666 –0.0001 (0.001) –0.0001 (–0.36)
3 1.2057 –0.0002 (0.001) –0.0002 (–0.49)
4 1.1554 –0.0002 (0.001) –0.0002 (–0.45)
Total –0.0006 (–1.64)
Note
Discount rate= 3.5%.
TABLE 20 The cardiovascular-related emergency admissions
Year Weighting Undiscounted change, B (SD)
3.5% discounted event
(discounted event cost, £)
Overall –0.0014 (0.004)
1 1.1196 –0.0016 (0.004) –0.0016 (–4.28)
2 0.9067 –0.0013 (0.003) –0.0012 (–3.35)
3 0.8947 –0.0013 (0.003) –0.0012 (–3.20)
4 1.0790 –0.0015 (0.004) –0.0014 (–3.74)
Total –0.0053 (–14.56)
Note
Discount rate= 3.5%.
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Table 21 reports the impact on the respiratory-related emergency admission events per person.
The respiratory emergency admission event changes following the intervention are positive but do not
achieve statistical significance. However, the scale is much greater than that for either the COPD or the
cardiovascular results. Given that the overall respiratory and cardiovascular findings show an increase in
frequency, the two relatively small decreases and the finding that one component was positive and
dominating are not surprising.
The combinations of each of the secondary outcome measures alongside the intervention costs are
reported in Table 22. The intervention reduces COPD and cardiovascular emergency admissions but
increases the number of respiratory-related admissions. This is at a net cost of £248.48 per person over
a 4-year period.
Cost–utility analysis
The CUA utilises the data from the CCA and develops the analysis further into an economic evaluation
using the data identified in the literature review (reported in Appendix 12). Our analysis suggests that a
within-year QALY decrease for a single COPD exacerbation hospital admission is 0.022. The residual
decrement to utility scores in subsequent years after the initial year of the event results in a reduction in
QALYs of 0.024. The inclusion of these QALY valuations in the 4-year model is presented in Table 23.
The relatively small decrease in COPD events and the relatively large cost of the intervention programme
mean that the ICER is > £10M (£10,485,472.12) per QALY gained. When using a discount rate of 1.5%
instead of the base case 3.5%, the ICER reduced to £10,066,540.29. Both of these ICERs are deemed not
cost-effective.
Threshold analysis was undertaken to estimate the required reduction in COPD events and related utility
scores over the 4-year period to make the intervention cost-effective. The base-case analysis estimates
suggest that the intervention is not cost-effective, as it would require a constant yearly per-person
TABLE 21 The respiratory emergency admissions
Year Weighting Undiscounted change, B (SD)
3.5% discounted event
(discounted event cost, £)
Overall 0.0042 (0.005)
1 1.0083 0.0042 (0.005) 0.0042 (11.48)
2 0.9460 0.0040 (0.004) 0.0039 (10.57)
3 1.0918 0.0046 (0.005) 0.0043 (11.74)
4 0.9540 0.0040 (0.004) 0.0036 (9.84)
Total 0.0160 (43.66)
Note
Discount rate= 3.5%.
TABLE 22 Costs and consequences
Secondary outcomes
emergency admissions
Change in emergency
admission events
Net financial cost overall
per person (£)
COPD –0.0006 Effect –85.96
Cardiovascular –0.0053 Intervention 334.44
Respiratory 0.016 Net cost 248.48
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reduction in utilities associated with COPD events of 0.028 in order to make the intervention appealing
in terms of a cost per incremental QALY gained of £20,000–30,000. Given the long-term investment
associated with the intervention, a 10-year threshold analysis was estimated. The benefits of the
cumulative health-related quality-of-life benefits require a yearly decrease in utility scores of 0.013 for
the intervention to be considered cost-effective. The disparity between these two figures highlights the
influence of the duration of analysis. With a condition such as COPD, which has a long-term decrement to
health-related quality of life, interventions that deliver benefits consistently over an extended period may
be perceived more favourably with extended timelines. Given the relative scale of the required benefits
estimated by the threshold analysis in the shorter term compared with those reported in Table 23,
time horizons of > 10 years were not investigated.
The PSA varied the yearly reductions in COPD admissions alongside a uniformly distributed cost of intervention.
The 1000 replications are plotted on a CEP (Figure 23). Given the scale of reduction observed in the statistical
analysis and the costs involved, it is important to note the axis units. The QALY axis reports numbers in the
thousandths of a QALY whereas the net cost unit is in hundreds of pounds. The impact of the intervention
on COPD events has a 0% chance of the intervention being cost-effective at a £30,000 per incremental
QALY gained level. The CEAC is not illustrated owing to the lack of movement at plausible ICERs.
TABLE 23 The QALYs and costs related to COPD emergency admissions
Year
Undiscounted change,
B (SD)
3.5% discounted event
(discounted event cost, £)
Cost per year for
the intervention (£) QALY gains
1 –0.0001 (0.001) –0.0001 (–0.34) 83.61 –0.000003
2 –0.0001 (0.001) –0.0001 (–0.36) 83.61 –0.000006
3 –0.0002 (0.001) –0.0002 (–0.49) 83.61 –0.000010
4 –0.0002 (0.001) –0.0002 (–0.45) 83.61 –0.000013
Total 332.80 –0.000032
Notes
ICER = £10,485,472.12 per incremental QALY gained.
Discount rate= 3.5%.
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FIGURE 23 Probabilistic sensitivity analysis results on a CEP.
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The findings reinforce the uncertainty surrounding the statistical outcomes and highlight the relatively
small scale of the impact on COPD event rates in comparison with the intervention costs. The furthest
outlier in favour of the intervention saves 0.004 QALYs at a cost of £314.14.
The PSA estimations are also reported as a CEAC in Figure 24. The relatively small-scale impact on the
effectiveness of the intervention in terms of improvement of utility scores and relatively high costs of the
intervention resulted in a 0% chance of cost-effectiveness using a threshold of £30,000 per QALY gained.
The scale of the CEAC relates to the relative cost and effectiveness levels and provides an illustration of the
positions where the likelihood of cost-effectiveness changes. The upper left-hand quadrant of the CEP in
Figure 23 shows the occurrence of dominated observations (higher costs and worse health outcome),
which accounts for 36.1% of the estimations. The maximum percentage of estimations that could be
considered cost-effective (i.e. < £30,00 per QALY gained) is 65.9%; the CEAC illustrates up to 54%
of these.
Discussion
Key results
As with all economic evaluations, the outcomes of the analyses are driven by the effects of an intervention
as well as the costs. In the case of this analysis, the costs incurred by the intervention are large,
overwhelming the benefits. The disaggregated outcomes derived from the intervention were balanced
against the costs in the CCA. As shown in Chapter 2, the change in emergency admissions following the
intervention was non-significant. This could be interpreted to mean that the investments, whether the
lower bottom-up or the higher top-down reported cost, have not delivered identifiable health benefits in
terms of reduced costs to the health service. Similarly, in the CUA, which explored the impacts of the
intervention on QALYs relating to the change in rate of emergency admissions for people with COPD, the
small, non-significant reduction in emergency admissions is overpowered by the cost of the intervention.
Therefore, the intervention cannot be considered cost-effective using commonly accepted norms, with or
without discounting costs and benefits to present-day values in line with best practice. It is important to
consider that this does not mean that the intervention is without benefit, but rather it may be that the
benefits were not able to be identified and measured through the approaches we utilised.
Strengths and limitations
A strength of the current study was the use of routine data held within the SAIL databank. Unlike other
health economic studies that focused on affordable warmth interventions, this study was able to use
actual health-care utilisation data with near-complete data for the study population (see Chapter 2).
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However, the data set will have included people with a wide range of health problems of different stages
of severity and no information was available regarding the initial quality of housing and, therefore, the
relative improvement resulting from the intervention.
Another strength of the study was that data were used from both the data linkage and the community-based
field study. Although routine data allow calculations to be based on actual health-care utilisation, emergency
hospital admissions are only a proxy measure for health status. This type of contact with the health-care system
can provide a signal that health is changing but will only be one part of the overall story. The community-based
field study provided a more detailed understanding of the health, well-being and health-related quality-of-life
impact of the intervention, and was used as a basis for a CUA. The results of that analysis are reported in
Chapter 3.
It was not possible to undertake a CBA, an approach recommended by NICE as an option for evaluating
public health interventions, because the available data did not facilitate identification and valuation of all of
the impacts of the intervention to society and the full societal cost and consequences of the intervention.
It could be useful to conduct such analyses in the future, considering that a housing intervention is likely
to have a wide range of benefits beyond health improvements alone. The community-based study showed
that the intervention provided a wide range of psychosocial and economic benefits to residents. It is
recognised by NICE, however, that CBA poses challenges in terms of obtaining all necessary data to
undertake analysis. It was beyond the scope of the study to value these benefits.
We explored the impact of the intervention for up to 10 years (i.e. the probable lifespan of the shortest-lived
elements of the intervention), but the effects of the intervention are plausibly longer. A study using longer-term
data and a longer-term time horizon may deliver different results.
Interpretation
When trying to determine whether or not an intervention delivers good value for money, the intervention
does not necessarily have to be cost-sparing or cost-effective in terms of what would be acceptable for a
clinical intervention. Public health decision-makers and budget holders may feel that the goals of the
intervention – in this case the delivery of affordable warmth, alleviation of fuel poverty and reduction of
CO2 emissions – justify the costs of the intervention. The fact that our economic analysis suggests that the
intervention incurred major costs but did not lead to detectable cost reductions to the health service or
improvements in QALYs for people with COPD does not mean that the intervention is without benefit.
Indeed, the community-based study showed that the intervention provided a range of social benefits and
made it easier and cheaper for households in low-income areas to heat their homes. In addition, the
health benefits may emerge over a longer period than the 4-year horizon used in this study, especially as a
prevention intervention. A child growing up in a property may not have health impairments that he or she
may otherwise have had without the improvements.
The Gentoo140 and Warm Homes for Health studies,141 which found health improvements and cost savings
after housing improvements, were studies that targeted people with poor housing and the capacity to
benefit healthwise. The CUA undertaken with the COPD subpopulation may have been limited by a similar
problem. COPD that is sufficiently severe enough to present a risk of hospital admission is defined as moderate
to severe.160 People with moderate to severe COPD are prone to frequent exacerbations (three or more
exacerbations per year is part of the definition) and these are an important cause of hospital admission and
readmission and, therefore, have a considerable impact on health-related quality of life and daily activities.150
Reducing exacerbation frequency through improved housing for these people might be more valuable than for
others with less-severe COPD, and might spare more health-care resources. However, a hospital admission
may be precipitated by a lack of social support and comorbidities rather than severity, which our study data
were not able to reveal, but an exacerbation avoided by someone who might fall into this category may have
additional value. Focusing an analysis on all such patients may reveal a different picture to the one our present
analysis suggests.
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Generalisability
This economic study and our findings would be generalisable to a developed country in a temperate
region where a national health service exists founded on the principles of solidarity and tax-funded
health care.
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Chapter 6 Conclusion
Introduction
Improving the energy efficiency of existing housing stock not only has the potential to reduce fuel poverty
and carbon emission but it can also help to improve the health of residents.6 Research has shown that
housing quality is associated with a range of health and psychosocial outcomes, and that provision of
adequate, affordable warmth can lead to health improvements. However, a recent systematic review of
warmth and energy efficiency studies concluded that evidence of the effectiveness of housing improvement
is inconclusive, and that more robust research is needed to fill existing gaps in the literature.48 In particular,
limited follow-up periods have made it difficult to determine the long-term health impacts of housing
interventions, few studies have focused on psychosocial outcomes that may be part of pathways to better
health and only limited research has been conducted to determine whether or not affordable warmth
interventions produce better indoor hydrothermal conditions.
In this project, we took the opportunity afforded by a major energy performance investment programme in
Wales. The core objectives of the investment programme were to deliver affordable warmth, alleviate fuel
poverty and reduce CO2 emissions through area-based energy efficiency improvements. We examined
whether or not these investments provided additional health benefits to residents living in low-income
areas in Wales. This was done through a mixed-methods programme of work, including data linkage
(see Chapter 2), a community-based study (see Chapter 3), household monitoring (see Chapter 4) and a
health economic assessment (see Chapter 5). In addition, reconvened focus groups were conducted as part
of the wider resident engagement in the project (see Appendix 2).
In this final chapter, we will summarise the principal findings of the different studies, followed by a
discussion of the main contributions and implications of these findings, as well as the strengths and
limitations of the research. The chapter will be concluded with recommendations for further research.
Key findings
The research provided empirical evidence regarding the health and psychosocial impacts of energy
performance investments. The key findings of the different studies are reported in the following sections.
The community-based study and the reconvened focus groups
The community-based study found no evidence that the improvements in energy efficiency lead to better
mental and physical health in the short term. The intervention was associated with neither improvements
in key mental and physical health outcomes nor changes in self-reported respiratory and asthma-related
symptoms. However, quantitative evidence was found that the intervention led to improved subjective
well-being during the study period, as well as to improvements in a number of psychosocial outcomes
that may be part of pathways to better health. This included increased thermal satisfaction, fewer reported
financial difficulties, increased satisfaction among participants with the repair of their homes, fewer
reported housing-related problems and more social interactions.
These findings were reflected in the focus group discussions that were conducted as part of the resident
engagement. The longitudinal focus groups showed the importance of improving the energy efficiency of
houses in low-income neighbourhoods.161 According to residents, the intervention made a great difference
to the comfort and warmth of their homes, opened up spaces within the home and reduced their heating
bills substantially. This not only helped to relieve financial stress and fuel poverty but made them feel less
socially isolated. This confirms that the benefits of the improvements were, at least in the short term, more
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closely linked to better well-being owing to improved socioeconomic conditions than to physical health
outcomes. Experiences with the delivery of the intervention were mixed, which some residents found
disempowering and stressful.
The household monitoring study
The household monitoring study demonstrated that the improvements in energy efficiency raised indoor air
temperatures and helped households to reduce their energy use. The increase in air temperature was
consistent across different heating demand conditions. Although no evidence was found that the
intervention reduced the duration of substandard temperatures within the homes, there was a small
decrease in the cumulative amount of substandard temperatures (i.e. the time intensity integral of
substandard temperatures). However, this reduction was small in absolute terms.
The different energy efficiency measures were not equally effective in raising indoor air temperatures.
External wall insulation and connection to the gas mains network were the most effective, whereas new
windows and doors or a new heating system did not lead to significant changes in indoor air temperature.
The greatest increases in indoor air temperatures were found in British steel-framed (BISF) buildings and
buildings with solid walls, which had the lowest energy performance ratings before the intervention. That
indoor air temperatures increased most in the evening and at night, as well as in the living room and main
bedroom, suggests that the intervention makes the biggest difference when spaces are in use.
Overall, no evidence was found that the intervention increased indoor RH levels. However, some evidence
was found that the intervention decreased the duration and cumulative amount of substandard
temperatures. Although no evidence was found that the intervention increased indoor RH levels overall,
some evidence indicated that individual measures did. Both a connection to the gas mains network and
the installation of new windows and doors were associated with small increases in indoor RH levels.
However, the increases were small in absolute terms.
The data linkage study
The data linkage study found no evidence that the intervention reduced emergency admissions for either
the primary outcome (combined cardiorespiratory emergency hospital admissions) or most secondary
outcomes (emergency hospital admissions for cardiovascular, respiratory and COPD conditions, and excess
winter admissions) for people of all ages living in an intervention home. The study also did not find
evidence of a significant intervention effect on our primary outcome when focused only on residents aged
≥ 60 years at the mid-point of their residence in an intervention home. However, the study did find a
statistically significant intervention effect on cardiovascular-related emergency admissions: there was an
increase in emergency cardiovascular admissions post intervention for those aged ≥ 60 years. Although we
controlled for age in our analyses, it is possible our analyses have not taken all effects of ageing into
account. It may be that age does not have a linear response and the older people in this group are
increasingly frail, having had poor health conditions set in motion at an earlier age, working to outweigh
the potential for reduced admissions as a result of a single thermal efficiency intervention.
The economic evaluation
The CCA undertaken as part of the economic analysis did not find evidence that the intervention delivered
explicit reductions in cardiorespiratory-related emergency admissions. The costs of achieving this outcome
relate to the costs of delivering the intervention unmodified by savings in emergency admissions. However,
the purpose of undertaking CCA is to present costs and benefits separately, allowing the reader or
decision-maker to make their own decision about the relative value of the benefits compared with the
costs. As reported previously, there were social benefits from the intervention, albeit not demonstrably
seen in emergency admissions. The increased warmth and well-being derived from housing improvements
may well be considered worthwhile irrespective of the impact on health-care activity.
The CUA explored, through modelling methods, the impact on QALYs of the change in rate of emergency
admissions for people with COPD. However, the impact on COPD-related emergency admissions is
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overpowered by the cost of the intervention and, therefore, cannot be thought of as cost-effective using
commonly accepted norms.
Implications of the research
The research found no demonstrable effects of the intervention on health or health service utilisation in
the short and medium term. As a result, the health economic analysis concluded that the intervention
might not be considered cost-effective in a traditional sense. These findings appear to be in line with a
recent systematic review conducted by Thomson et al.48 in that area-based programmes are less likely to
produce improvements than interventions that specifically target at-risk populations. Emerging findings of
other research suggest that Nest – the more targeted part of the Welsh Government Warm Homes
programme – provides greater health benefits than the broader Arbed scheme that was evaluated in this
programme of work.162 It is nevertheless surprising that no apparent effects were found, given that the
intervention programme targeted low-income neighbourhoods with poor-quality housing and where, as a
result, residents were at a higher risk of living in fuel poverty.
However, that does not mean that the intervention was without substantial benefit. The main purpose of
the programme was to deliver affordable warmth, alleviate fuel poverty and reduce CO2 emissions. The
research found clear evidence that this was the case. The research showed that the investments in energy
efficiency provide a wide range of benefits to the lives and well-being of residents. It is not unlikely that
this may produce value in terms of benefits to the NHS and social services in the longer term. The time
horizon of 4 years may still be insufficient for the health benefits of the investments to have materialised.48
However, even without such demonstrable health improvements, it may be worth investing in the energy
efficiency of substandard homes if it provides better living conditions and quality of life for low-income
communities. Although it was not possible to undertake a full CBA, future research may consider the
wider social benefits of delivered affordable warmth to low-income households, reduced fuel poverty and
reduced CO2 emissions.
The project trialled a new approach to analyse household monitoring data, which can serve as a useful
model for further evaluations of housing improvement programmes. Variants of interrupted time series
analysis can be used to make robust assessments with relatively small sample sizes. It is often unclear
whether residents receiving energy efficiency improvements use them for extra warmth or benefit in a
different way.133,134 Researchers have observed greater temperature increases following energy efficiency
improvements among low-income groups, most likely because low-income groups may have a greater
unmet demand for space heating.163 The household monitoring study found evidence that the rebound
effects following the intervention were relatively small. The benefits of energy efficiency improvements
were taken as energy saving as well as extra warmth, suggesting that the potential long-term health
effects of energy efficiency improvements may work via the two main pathways of improved thermal living
conditions and more-affordable heating.54–56
The focus groups study highlighted the importance of involving residents in the decision-making regarding
affordable warmth interventions. Although residents were overwhelmingly positive about the intervention
programme, and felt that it had made a big difference to their lives, they were more critical about its
delivery. In line with previous research, some residents reported feelings of disempowerment and stress,
which may have partly offset any potential benefits.39,53,61 Extensive consultation and involvement
throughout a housing improvement programme may help to minimise disruption to residents.91
Strengths and weaknesses of the research
One of the strengths of the research is that it provided a comprehensive evaluation of a policy-led
affordable warmth programme through a longitudinal multimethod investigation comprising data linkage,
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a field study, household monitoring, qualitative focus groups with residents and a health economic
assessment. The different elements were combined to highlight areas in which results converge and
supplement each other. Although each method has its own strengths and weaknesses, as discussed in the
different empirical chapters, together they provide a more complete picture than could be obtained from a
single method alone.164
This research demonstrates the need for detailed assessment of policy-led interventions in order to fully
understand their impacts, and provides a toolkit for how this might be done in the future. Although data
linkage can be used to link the intervention to actual health service utilisation, the field study covers
more-subjective aspects resulting from the intervention. The household monitoring has helped to assess
the differential impacts depending on construction type and intervention measure. Furthermore, the
research has shown that more-qualitative research methods can help to improve our understanding of the
choices people make following affordable warmth interventions.
The research has a number of limitations. Most notably, it was not possible to randomise participation into
intervention and control groups and, as with any observational study, the potential for unmeasured
confounding remains. Both the community-based and household monitoring data relied on the responsiveness
of residents and were therefore subject to a number of biases. Response rates and retention rates were
particularly low for the field study. This was countered by the data linkage study, which minimised selection
and attrition biases with near-complete follow-up. However, data quality was also an issue. The effort required
to validate and clean intervention records received from data providers was considerable, and there were
missing data for many intervention homes. Furthermore, the data linkage study was only able to investigate
emergency hospital admissions. The lack of association with emergency hospital admissions may indicate that
the focus of the research was too narrow and the follow-up time too short. It is possible that the health
benefits will emerge over a longer period than the 4-year horizon used in this study, especially as a preventative
intervention. The finding that the intervention provides a wide range of psychosocial outcomes suggests that a
full CBA needs to be conducted to fully appreciate the benefits of affordable warmth improvements.
The research has highlighted the challenges of evaluating complex social interventions.116,117 Evaluators
generally do not have control over the content and delivery of the programme, nor the resources and costs
relating to the programme and data regarding the timing may not be in the format or of the quality that is
needed. There are added complexities of house moves and non-standard delivery of the intervention. Early
involvement may help to address these challenges by developing designs and data collection that would
provide the best quality of evidence. Equally, understanding of the resources deployed, their costs and how
they could be influenced or changed might improve the balance of costs and benefits of the programme.
Early consideration of evaluation methods may also help to increase response and retention rates.
Recommendations for further research
Evaluating housing interventions is challenging owing to a number of factors that affect their quality.
We make the following recommendations for future research.
l Our research suggests the importance of incorporating health and economic evaluations as part of
housing improvement programmes from the start. A stepped wedge randomisation in the delivery of a
programme, together with improved reporting standards regarding the timing, delivery and costs of the
intervention, would help to improve the quality of both prospective and retrospective evaluations.
l In the research, each component covered a different aspect of the evaluation. Data linkage in
combination with a field study, household monitoring and qualitative work can be used as a model for
the evaluation of future housing interventions to provide a comprehensive overview of their impact.
Process evaluation should become a core part of testing complex social interventions.116,165
l The lack of results in the research presented here may, as suggested by Thomson et al.,48 indicate that
area-based programmes are less likely to produce measurable health improvements than those that
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specifically target at-risk populations. A direct comparison between different types of programmes, for
example between the area-based Arbed and the demand-led Nest schemes, would help to determine
which approach leads to the greatest health improvements.
l The research found no evidence for changes in emergency admissions associated with the intervention.
One explanation is that the health benefits of housing interventions do not appear in hospital statistics.
Future research may therefore need to focus on lower-level health conditions as recorded in primary
health-care consultations.
l Future evaluations should ideally have longer follow-up periods and use CBA to fully capture the range of
benefits resulting from affordable warmth intervention, including both health and non-health outcomes.
l Long-term monitoring of internal and external hydrothermal conditions, in combination with detailed
monitoring of energy consumption and household behaviours, would help to improve our
understanding of adaptive responses following energy efficiency investments.166,167
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Appendix 1 Resident engagement: focus
group protocol
Introduction
Introduction (moderator): thank people for coming, introduce self, briefly outline goals for research,
reasons for recording the session given, ‘rules’: only one person to talk at a time, all data are treated
confidentially and will be anonymised, the session is open and everyone’s views are important, amount of
time that will be taken up. Aim for people to talk to each other, not moderator.
l Tell me a little bit about how long you have lived in this area, and what are the good and bad things
about living here.
l What are the good and bad things about living in your home?
l Tell me a little bit about your home – do you have any problems with it (e.g. condensation/mould)?
Before intervention (round 1, 2014)
1. THERMAL COMFORT: I’d like to talk to you about what conditions are like in your home (before any
Arbed measures were installed). Would you tell me what a typical winter’s day is like in your home?
Probe differences between household members (especially very young and very old): what was it like
getting up in the morning, washing/bathing, doing housework, going to bed, use of rooms/house
space, draughty/cold parts of the house, warmth and comfort. What would you like your home to be
like? What changes would you make if you had the resources?
2. KEEPING YOUR HOUSE WARM: How adequate is the heating system that you use to warm your
house (before Arbed)? How do you use it? What would you change about your home in order for you
to be comfortable in winter? What are the factors stopping you from doing this?
Probe: timing, warmth, cost/affordability, convenience, efficiency, ease of use. Have you put up with
feeling cold because of cost? Are there any rooms you do not heat?
3. USE OF LIVING SPACE: Does your ability to keep your house warm enough affect your use of different
rooms in your house? Does it ever stop you going out or inviting people home during the coldest days
in the winter?
4. FUEL POVERTY: Do you feel that paying for heating your home in winter is difficult? What would you
spend money on if fuel was less expensive? What is more important, eating well or warmth?
Probe (written on board): rent/mortgage; repairs to home; telephone bill; food and other necessities;
going out/treats; credit payments; occasional bills (e.g. insurance); stress; heat or eat.
5. HEALTH AND WELL-BEING: How do you think that living in a home that is not warm enough in
winter would affect a person’s feeling of health and well-being? (generally)
How do you think it affects different people: elderly, children, people with pre-existing health problems,
fit adults? Probe: effects on mood, state of mind, overall well-being, physical health? Respiratory health:
colds/flu?
Alternative: if you are cold in your home what effect has that on your life in general? AND do you think
being cold is connected to your health?
6. EXPECTATIONS AND EXPERIENCES OF ARBED UP TO DATE: What did you think the benefits of
Arbed might be? Do you think it will have a particularly big effect for any particular family member?
Probe: physical health and mental/well-being issues for self and other family members, use of home
(e.g. increase in living space), social interactions, effects of cold home as age, financial benefits
Imagine that this Arbed Scheme did not exist and the government would send you a cheque of the
same value for you to spend on absolutely anything you would like. How would you have spent it?
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
103
Just say the first thing that comes into your mind. Why that? Probe: the money or having the work
done: which do you think would benefit you more and why? If you had to spend it on improving your
home, what would you spend it on?
End (moderator): thank everyone for their participation, explain what will happen to the data they have
given, tell them about further session next year.
After intervention (round 2, 2015)
1. THERMAL COMFORT: I’d like to talk to you about what conditions are like in your home (after any
measures were installed). Would you tell me what a typical winter’s day is like in your home now?
Are you satisfied with the temperature of your home?
Probe: differences between household members (especially young and old): what was it like getting up
in the morning, washing/bathing, doing housework, going to bed, use of rooms/house space, draughty/
cold parts of the house, convenience, efficiency, warmth and comfort.
2. KEEPING YOUR HOUSE WARM: How adequate is the heating system that you use to warm your
house (after Arbed)? Do you use the heating/hot water any differently now? If yes, how and why?
Probe: timing, warmth, cost/affordability, convenience, efficiency, ease of use. Have you put up with
feeling cold because of cost?
3. USE OF LIVING SPACE: After Arbed, do you use/heat your home differently? Are there any rooms you
do not heat? Have you changed your habits of going out or inviting people into your home?
4. FUEL POVERTY: What difference has the Arbed work had on your energy bills? Do you find it easier
affording to heat your home? Have you changed the way you heat your home? What do you spend
any saved money on?
5. HEALTH AND WELL-BEING: After the Arbed work have there been any changes in the way you and
your family feel in terms of health or well-being?
In what ways do you think the new heating/hot water has affected your health/illness? Other
household member’s health/illness?
Has it affected your/their use of health services (GP visits and callouts; A&E, NHS Direct)? Probe: colds,
flu, asthma, other, feelings of well-being? Probe: effects on mood, state of mind, overall well-being,
physical health? Respiratory health – colds/flu?
6. EXPECTATIONS AND EXPERIENCES OF ARBED: Now you have had the Arbed work done, would you
say it has made a difference? To you? To other members of the household? In what ways?
Probe: the difference made by the most recent work, relative to the effects of any other previous work
(damp proofing, cavity wall insulation, loft insulation, double glazing etc.)? What made the biggest
difference?
Overall, would you say your experiences with Arbed were positive? Have you had any problems since
the work was carried out? If yes, what and how did you deal with it? If no, who would you contact if
you did have a problem? Probe: how contacted, choice, control, implementation, core components
everyone received.
Can you think of any other benefits from Arbed? Probe: what about in relation to the environment?
How important is it to you that your new heating is less harmful to the environment?
Imagine that this Arbed Scheme did not exist and the government would send you a cheque of the
same value for you to spend on absolutely anything you would like. How would you have spent it?
Just say the first thing that comes into your mind. Why that?
End (moderator): thank everyone for their participation, explain what will happen to the data they
have given.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
Appendix 2 Resident engagement: summary
results of the reconvened focus group study
This appendix contains material from Grey et al.161 This article is distributed under the terms of theCreative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which
permits any use, reproduction and distribution of the work without further permission provided the original
work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/
open-access-at-sage).
Introduction and aims
A reconvened focus group study was conducted as part of the wider residents’ engagement with the
research project. Three focus groups were held with residents before and again after they received energy
efficiency improvements under the second phase of the intervention programme. The aims of the focus
groups were to obtain a better understanding of the views and experiences of residents living in energy
inefficient (hard-to-heat, hard-to-treat) houses, and then to explore in what way the intervention may have
improved these experiences. The qualitative approach used in the study allows the residents to express
experiences in their own words and in greater detail than is possible in a quantitative survey. To date, only
a small number of qualitative studies have been conducted to examine psychosocial aspects of warmth
and energy efficiency improvement.39,53,61 This reconvened focus group study adds to the evidence of
residents’ experiences of living in cold homes, the stresses and consequences of living in fuel poverty, and
the ways that energy efficiency improvements may change those experiences.
Methods
The focus groups were conducted in three geographically distinct communities in South Wales that had
been selected to receive energy efficiency measures under the programme.
Box 2 provides details of the three communities, as well as specifics of the different schemes. The first
round of focus groups was held in March 2014 and lasted just under 1.5 hours. In total, 28 people took
part in the study (8 in Caerau, 9 in Brynamman and 11 in Hollybush). Participants were recruited from
30 households whose homes were being monitored as part of the project (see Chapter 4). They were
contacted by telephone to invite them to take part in the discussions. Therefore, one of the researchers (SJ)
had been in contact with the participants a number of times before the start of the focus groups. The
participants were made aware of the goals of the focus groups as well as the overall project. The focus
groups were held at a convenient location and took place either at lunchtime or in the early evening. In
one of the focus groups, three participants had already received energy efficiency improvements under the
intervention programme. Another three participants had recently received external wall insulation, but not
through the intervention programme.
The second round of focus groups was held in March and April 2015 after all improvement work was
complete in the three communities. The focus groups again lasted just under 1.5 hours. All participants
who took part in the first round were invited to attend. In total, 22 people took part in the reconvened
focus groups (5 in Caerau, 3 in Brynamman and 14 in Hollybush). This included three additional residents
from the Hollybush area who expressed interest in attending the discussions. A number of previous
participants were not available for the second round owing to other commitments or relocation.
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Out of the 31 residents who participated in the focus group discussions, 14 were male and 17 female;
24 owned their home and 7 rented; 4 were aged between 18 and 40 years, 9 were aged between 40 and
60 years and 18 were aged > 60 years. Eighteen residents occupied the home on their own, 19 occupied
the home as a couple and 4 could be considered a family (i.e. a couple plus children).
Topics for the focus group discussions were based on the themes from the household survey used for the
community-based study (see Chapter 3). The same themes were discussed in the before and after focus
groups. These included the topics of (1) health and well-being; (2) thermal comfort, staying warm and the
use of living space; (3) fuel poverty; and (4) experiences with the intervention programme (see Appendix 1
for the focus group protocol).
The discussions were led by two researchers (CG and SJ) and supported by Gabriela Zapata-Lancaster
and Martina Stefani (see Acknowledgements). All focus group discussions were recorded and fully
transcribed. The resulting discussions were analysed thematically, using the identified themes as organising
concepts. Ethics approval was received from the Welsh School of Architecture’s Research Ethics Committee
on 15 March 2014 (EC1403.184). Participants were given a £30 voucher as compensation for their time.
Analysis
A structured approach was applied for the analysis. The focus groups were recorded, transcribed and
coded using computer-assisted qualitative data analysis software. NVivo 11 (QSR International, Warrington,
UK) was used to code the transcripts using the key topics, described above, which were based on
identified themes within the context of the existing fuel poverty literature and policies. Transcripts were
coded separately by two researchers (CG and Tina Schmieder-Gaite) to ensure consistency. Figure 25
shows the coding tree that was used to analyse the focus group transcripts. After coding, each parent
and child node was analysed thematically and emerging patterns were refined and cross-compared.
The results are described according to these themes.
BOX 2 Focus group locations
Caerau (Cardiff) is a suburb located 3 miles to the west of Cardiff city centre. Housing is a mixture of housing
association flats, bricked terraced houses, traditionally built semi-detached houses and semi-detached BISF
houses. The work that took place was external wall insulation and boiler/heating system upgrades. Caerau has
a WIMD rank of 170 and is part of the Cardiff West Communities First regeneration cluster.
Brynamman (Carmarthenshire) is a village located on the south-facing side of the Black Mountain in an old
coal mining area within the Brecon Beacons National Park boundaries. Housing is predominantly small, stone
terraces. Before the first focus group was held, the area was not connected to the mains gas network. The
mains gas network was extended to homes in the village and boiler and central heating upgrades were
provided. The area has a WIMD rank of 651.
Hollybush (Caerphilly) is an old coal mining village situated between Blackwood and Tredegar, above the
Sirhowy Valley. Before the first focus group was held, the village was not connected to the mains gas network.
Housing is a combination of older small stone terraced houses (pre 1919) and post-1965 and 1980s detached
homes. The work extended the mains gas network to homes in the village and provided boiler and central
heating upgrades. The area has a WIMD rank of 565 and is located within the Mid Valleys East Communities
First regeneration cluster.
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Results
The main findings of the focus groups are presented here under the key themes investigated. The results
for the before and after focus groups are discussed separately. A more detailed description of the results
can be found in Grey et al.161
Round 1: before installation (2014)
Health and well-being
There was strong agreement among the focus group participants that living in a cold home is depressing
and detrimental to both mental and physical health. In line with the findings of Harrington et al.,39
participants thought that living in a cold home exacerbates ill health rather than causes it; in particular,
that a cold home may make it more difficult to live with or recover from pre-existing chronic conditions.
Many described how living in the cold affected their respiratory health and it was felt that the cold
environment exacerbated a range of conditions, including diabetes, arthritis and circulatory problems.
A cold home was thought to increase both the length and severity of illness. In addition, participants felt
that living in a cold home contributes to poor emotional well-being. The physical effects of exposure to
poor internal conditions and psychological stress resulting from fuel bills were felt to trigger feelings of
depression and anxiety. It was generally believed that a warmer home environment would contribute to
better mental and physical well-being.
FIGURE 25 Coding tree with coding parent nodes and child nodes.
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Thermal comfort, staying warm and use of living space
Participants commented on how unpleasantly cold their homes could be during the winter and expressed
concerns about the lack of thermal comfort and the negative consequences this may have for their
health. They described how difficult it is to stay warm in an energy inefficient house, in particular if it is
non-traditional housing (e.g. a steel frame construction). Respondents used a number of strategies to stay
warm and avoid turning on the heating. This included the use of heaters, hot water bottles and blankets, or
only heating a limited number of rooms. Similar strategies were reported in Harrington et al.,39 Gilbertson
et al.61 and Shortt and Rugkåsa.53 However, these strategies were seen as temporary stopgaps and were
considered unsustainable in the longer term. The lack of thermal comfort and living space was thought to
put a strain on social interactions within the households and, as a result, participants’ enjoyment of their
home. This also meant that some householders tried to avoid being at home for certain periods of time.
Fuel poverty
The focus group participants repeatedly mentioned how expensive it is to heat their homes and discussed
how easy it is for low-income households living in an energy inefficient house to fall into fuel poverty.
High fuel bills are not only stressful but also force householders to make difficult choices in their daily lives.
Participants frequently had to make compromises on how to spend their limited household budget. Just as
reported by Harrington et al.,39 households either economised on fuel or refrained from other activities or
expenditures in order to stay warm. Many considered the ‘heat-or-eat’ dilemma a reality in their own lives
as well as in their wider community. Some participants reported episodes in which they would not eat
because they had to heat their home. The findings support the conclusion of Harrington et al.39 that the
health impacts of fuel poverty involves more than the direct physical effects of exposure to poor internal
conditions. The cumulative stresses associated with fuel poverty were found to be particularly damaging.
Living in a cold, damp house is more depressing when you are not able to eat properly or go out. An
inadequate diet may not only lead to problems associated with food poverty but can also worsen feelings
of poor well-being in a cold home. Furthermore, the discussions showed how socially isolating fuel poverty
can be. Some of the participants described how friends and family were reluctant to come and visit them
in their homes because of the cold, even in summer.
Experiences with the intervention programme
All participants of the focus groups welcomed the energy efficiency measures they were expecting to
receive under the intervention programme. The participants who had already received some of the
measures felt grateful for them, not only because they were provided for free, but also because they
had made a noticeable difference to their comfort, finances and overall quality of life. These results are in
line with the findings of previous qualitative studies. Gilbertson et al.61 reported that recipients of Warm
Front energy efficiency work were generally positive about the upgrades and felt that the upgrades had
improved thermal comfort, use of living space and feelings of well-being. They also found that greater
warmth and comfort further enhanced emotional security and social relations within the home and eased
symptoms of chronic illness.
Although the participants of the first round of focus groups were generally positive about the intervention
programme and the provided energy efficiency upgrades, they felt that the communication with the
recipients could be improved and households themselves should have a greater say in the delivery of the
programme. The ‘one-size-fits-all’ approach was generally disliked and many questioned the motives for
taking this approach and the usefulness of some of the measures.
Round 2: after installation (2015)
Health and well-being
Improvements to health and well-being were discussed again in the second round of focus groups after
all improvement work was complete. The participants generally felt that the improvements had had
some effect on their health, in particular their respiratory health. However, participants did not discuss the
topic in as much detail as in the first round of focus groups. It appeared that health had become a lower
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priority, and it proved quite difficult to sustain discussion on the topic. Participants did feel that better
thermal comfort and aesthetic aspects of the improvements had had a positive effect on their general
well-being. The results of the focus groups suggest that the health benefits of the improvements were,
at least in the short term, more closely linked to psychological well-being – resulting from better thermal
comfort, having more control over of the heating in their homes and reduced stress from financial pressure
– than to the physical effects of exposure to improved internal conditions.
Thermal comfort, staying warm and use of living space
Participants of the second round of focus groups agreed that their homes were warmer and more
comfortable following the energy efficiency upgrades to their homes, which meant that they no longer
needed to find ways to economise on their fuel bills, for example by restricting their use of heating or
finding alternative ways of keeping warm. They discussed that they could now more easily afford to
maintain their whole house at a more comfortable temperature using their central heating. This negated
the need to use alternative ‘stay warm’ strategies such as the use of blankets. The energy efficiency work
not only improved the overall quality of the indoor environment but also opened up space that was
previously used less, effectively increasing the amount of usable living space within the home. Similar to
the findings of Harrington et al.,39 participants attached a great importance to their increased ability to
keep their homes warm. Most of the participants stated that their homes were now much warmer during
the winter and cheaper to heat. A few participants discussed how they now felt more comfortable inviting
family or friends into their homes, making them feel less socially isolated.
Fuel poverty
In contrast to Gilbertson et al.,61 who found that many participants had difficulties assessing whether or not
their fuel bills were lower, our study found that participants were generally aware of their reduced fuel bills.
Indeed, participants spent a large amount of time discussing their financial savings in detail and how much
easier it was to pay their fuel bills; particularly being able to pay a competitive dual-fuel energy tariff,
allowing for further discounts and savings. Gilbertson et al.61 stated that in the Warm Front programme it
was likely that householders were experiencing warmer homes but generally not also the dual benefit of
reduced bills. This is likely owing to differences in the two energy efficiency schemes: Arbed 2 invested more
financially into each home within the scheme, taking a whole-house approach, and the criteria for eligibility
to the programmes were different. Shortt and Rugkåsa53 further found that, although energy efficiency
measures helped to improve warmth, some households remained in fuel poverty after the measures were
installed, suggesting that, although homes might become easier to heat, this does not always translate to
lifting households out of fuel poverty and thereby potentially concealing possible health gains from such an
intervention. Post intervention, the ‘heat-or-eat’ dilemma was not discussed except by one participant who
mentioned that savings made on fuel costs meant they did have more money now to spend on a specialised
health diet, although this also meant that the savings did not make them feel better off.
Experiences with the intervention programme
Participants in the second round of focus groups appreciated that the energy efficiency improvements
were provided for free and were generally happy about the results. According to the participants, the
improvements made a big difference to the warmth of their homes. One occupant, who had received
energy efficiency measures through a different scheme, felt that the work had been much more effective
in making their home warmer. The work was not only seen to be beneficial in terms of providing
affordable warmth but it was also felt that the external wall insulation had improved the aesthetics of their
homes and the local environment. Participants discussed in detail how this improved their general sense of
well-being and pride. Participants in one focus group discussed the importance of energy efficiency
schemes for Wales and, in particular, for local communities such as theirs.
The participants were more critical of the delivery of the energy efficiency measures themselves. They
expressed some dissatisfaction about the quality of communication, work conducted by contractors and a
lack of involvement in the selection of energy efficiency measures that they felt would be the most
beneficial. Participants discussed that regular public meetings both before and during the improvement
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programme, as well as more personal contact between households and scheme managers, could have
improved communication. This would have helped to clarify the aims of the programme, reduced
misunderstandings about the measures households were to receive and enabled them to report issues with
contractors more easily. Finally, participants discussed that they felt that they had too little say over the
measures they would receive and expressed some frustration over the fact that they were expected to
simply accept the measures because they were free. In particular, participants who rented their home
privately or socially felt that they had little or no control over the whole process.
The results regarding the delivery of the programme resonate with previous research. Gilbertson et al.61
also found that recipients of a similar warm homes programme expressed frustration about the delivery of
the work. Some found the process of installation disempowering and stressful, which could undermine the
well-being of an already vulnerable population. Harrington et al.39 argued that people in fuel poverty
should not be viewed as passive targets for benevolence and that government-funded interventions will
confer far greater benefit if recipients are made to feel empowered. A greater emphasis on partnership
with the community could help address individual concerns, improve feelings of control and, as a result,
alleviate stress associated with the delivery of a housing improvement programme.168 Marmot et al.6
argued in their review that it is important for programmes to create opportunities for individuals and
communities to set the agenda for change and identify local solutions. Indeed, participants of the
reconvened focus groups felt that the benefits of the programme would have been greater if they had
been more closely involved in the decision-making process.
Discussion
The reconvened focus group study that was conducted as part of the residents’ engagement proved to be
a useful addition to the research project. The study provided a better understanding of the views and
experiences of residents undergoing energy efficiency improvements, which resonated with the results of
the research project. The study also gained from resident involvement in the research project itself. A
number of participants were recruited to a resident panel to provide feedback and contribute to the SSC
of the research project. This helped to ensure that the views of residents were represented in the research.
The reconvened focus groups showed the importance of structural energy performance investments of
hard-to-heat, hard-to-treat houses in low-income neighbourhoods. The study found that living in a cold
home was generally viewed as depressing, stressful and detrimental to both mental and physical health.
According to the participants, the energy efficiency work made great improvements to the comfort and
warmth of their homes, opened up spaces within the home and substantially reduced their heating bills.
This not only helped to relieve financial stress and fuel poverty but also made them feel less socially
isolated. Participants felt that physical health improvements following the work were secondary to
improvements in thermal comfort and their ability to invite friends and family into their homes. The lack
of discussions about physical health following the completion of the work suggests that adverse physical
conditions inside the home are no longer experienced as urgent.
Although the improvements were, for the most part, positively received by occupants and clearly fulfilled
the goal of the programme to make homes warmer and cheaper to heat, there were some complaints
about the delivery of the work itself. This adds weight to the need to consider community engagement
and communication to involve residents more closely in the decision-making and delivery of affordable
warmth programmes.
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Appendix 3 Consolidated criteria for reporting
qualitative research checklist
Item Guide questions/description Reported on page
Domain 1: research team and reflexivity
Personal characteristics
1. Interviewer/facilitator Which author/s conducted the interview or focus group? 104, Methods
2. Credentials What were the researcher’s credentials? (e.g. PhD, MD) NA
3. Occupation What was their occupation at the time of the study? NA
4. Gender Was the researcher male or female? NA
5. Experience and training What experience or training did the researcher have? NA
Relationship with participants
6. Relationship established Was a relationship established prior to study commencement? 104, Methods
7. Participant knowledge of the
interviewer
What did the participants know about the researcher?
(e.g. personal goals, reasons for doing the research)
104, Methods
8. Interviewer characteristics What characteristics were reported about the interviewer/
facilitator? (e.g. bias, assumptions, reasons and interests in
the research topic)
104, Methods
Domain 2: study design
Theoretical framework
9. Methodological orientation
and theory
What methodological orientation was stated to underpin the
study? (e.g. grounded theory, discourse analysis, ethnography,
phenomenology, content analysis)
104, Analysis
Participant selection
10. Sampling How were participants selected? (e.g. purposive, convenience,
consecutive, snowball)
103–4, Methods
11. Method of approach How were participants approached? (e.g. face-to-face,
telephone, mail, e-mail)
104, Methods
12. Sample size How many participants were in the study? 103, Methods
13. Non-participation How many people refused to participate or dropped out?
Reasons?
104, Methods
Setting
14. Setting of data collection Where were the data collected? (e.g. home, clinic, workplace) 103, Box 2
15. Presence of non-participants Was anyone else present besides the participants and
researchers?
NA
16. Description of sample What are the important characteristics of the sample?
(e.g. demographic data, date)
104, Methods
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Item Guide questions/description Reported on page
Data collection
17. Interview guide Were questions, prompts, guides provided by the authors?
Was it pilot tested?
Appendix 1, 101–2
18. Repeat interviews Were repeat interviews carried out? If yes, how many? 104, Methods
19. Audio/visual recording Did the research use audio or visual recording to collect the
data?
104, Methods
20. Field notes Were field notes made during and/or after the interview or
focus group?
NA
21. Duration What was the duration of the interviews or focus group? Pages 103 and 104,
Methods
22. Data saturation Was data saturation discussed? NA
23. Transcripts returned Were transcripts returned to participants for comment and/or
correction?
NA
Domain 3: analysis and findings
Data analysis
24. Number of data coders How many data coders coded the data? 104, Analysis
25. Description of the coding
tree
Did authors provide a description of the coding tree? 105, Figure 25
26. Derivation of themes Were themes identified in advance or derived from the data? 104, Methods
27. Software What software, if applicable, was used to manage the data? 104 (NVivo)
28. Participant checking Did participants provide feedback on the findings? NA
Reporting
29. Quotations presented Were participant quotations presented to illustrate
the themes/findings? Was each quotation identified?
(e.g. participant number)
NA, see page 104 for
a reference to Grey
et al.161
30. Data and findings consistent Was there consistency between the data presented and the
findings?
105–8, Results
31. Clarity of major themes Were major themes clearly presented in the findings? 105–8, Results
32. Clarity of minor themes Is there a description of diverse cases or discussion of minor
themes?
108, Discussion
NA, not applicable.
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Appendix 4 Resident engagement: key
findings brochure
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Appendix 5 Resident engagement: pull-up banner
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Appendix 6 Template for Intervention Description
and Replication checklist
Item
number Item
Page
number Further details
BRIEF NAME
1 Provide the name or a phrase that describes the
intervention
3
WHY
2 Describe any rationale, theory or goal of the elements
essential to the intervention
3
WHAT
3 Materials: describe any physical or informational materials
used in the intervention, including those provided to
participants or used in intervention delivery or in training
of intervention providers. Provide information on where
the materials can be accessed (e.g. online appendix, URL)
4 There was a large amount of
variation in materials in the two
phases of the intervention
programme; a list of materials
may be available from the
scheme managers of the
different schemes
4 Procedures: describe each of the procedures, activities
and/or processes used in the intervention, including any
enabling or support activities
4–5
WHO PROVIDED
5 For each category of intervention provider (e.g.
psychologist, nursing assistant), describe their expertise,
background and any specific training given
5
HOW
6 Describe the modes of delivery (e.g. face-to-face or by
some other mechanism, such as internet or telephone) of
the intervention and whether it was provided individually
or in a group
5
WHERE
7 Describe the type(s) of location(s) where the intervention
occurred, including any necessary infrastructure or
relevant features
4
WHEN and HOW MUCH
8 Describe the number of times the intervention was
delivered and over what period of time, including the
number of sessions, their schedule and their duration,
intensity or dose
4–5
TAILORING
9 If the intervention was planned to be personalised,
titrated or adapted, then describe what, why, when and
how
5
MODIFICATIONS
10 If the intervention was modified during the course of the
study, describe the changes (what, why, when and how)
NA
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
123
Item
number Item
Page
number Further details
HOW WELL
11 Planned: if intervention adherence or fidelity was
assessed, describe how and by whom, and if any
strategies were used to maintain or improve fidelity,
describe them
NA
12 Actual: if intervention adherence or fidelity was assessed,
describe the extent to which the intervention was
delivered as planned
NA
NA, not applicable.
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Appendix 7 Emergency-hospital-admission-based
outcome classification
The method of classifying hospital admissions in PEDW as primary outcomes, and as COPD outcomes fora subanalysis, is shown in Figure 26. Emergency admissions were identified using the admission method
of the first episode within a person spell (representing continuous periods of inpatient care for a single
patient), with primary diagnosis of cardiovascular or respiratory conditions contained within chapters ‘I’
(‘Diseases of the Circulatory System’) or ‘J’ (‘Diseases of the Respiratory System’) of the ICD-10.85 Episodes
representing symptoms and signs involving the circulatory and respiratory systems (R00–R09) in the first
diagnostic position with no subsequent secondary diagnosis codes were also classified as a primary
outcome.
The COPD outcomes using ICD-10 codes as a subgroup of the primary outcome emergency admissions
were selected, measured separately for people of all ages and those aged > 60 years. The codes and
age-based rules are shown below.
All admissions for any age for codes
l J40 (bronchitis, not specified as acute or chronic).
l J41 (simple and mucopurulent chronic bronchitis).
l J42 (unspecified chronic bronchitis).
l J43 (emphysema).
l J44 (other chronic obstructive pulmonary disease).
Admissions for which age at admission is > 40 years for codes
l J45 (asthma).
l J46 (status asthmaticus).
All admissions for any age for codes
l R06 primary code, with any ICD-10 code starting with J4.
Subgroups of the primary outcome were created for cardiovascular (codes J00–J99) and respiratory
(codes I00–I99) admissions.
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Apply exclusion criteria
Extract all health outcomes (PEDW)
FPD code = 'I%' or
FPD code = 'J%'?
• Emergency admissions only (admission method like '2%')
• First episode in person spell
FPD is NULL
(no non-RZ codes)
and
PD code between
'R00' and 'R09'?
Flag as non-outcome
(PD = 'J40', 'J41',
'J42', 'J43', 'J44')
or
(admission age > 40
and PD = 'J45',
'J46') or
(PD = 'R06' and
PD like 'J4%')
PD code = 'I00' to
'I99'?
PD code = 'J00' to
'J99'?
Flag as secondary
outcome:
cardiovascular
Flag as secondary
outcome: respiratory
Flag as secondary
outcome: COPD
Flag as primary
outcome:
cardiovascular
respiratory
Yes
Yes
Yes
Yes
Yes
NoNo
FIGURE 26 Flow chart to define emergency hospital admission outcomes. FPD, first non-RZ, missing diagnosis code;
PD, first diagnosis code (position 1); RZ, R or Z codes (from ICD-10 Chapters 18 or 21, respectively); SD, second to
fourteenth position diagnosis code.
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Appendix 8 Data for the two comparator groups
The data on the two comparator groups are potentially useful in assessing trends in the study window,following the usual assumption that trends are common across groups. Figures 27 and 28 show the
monthly emergency admission rates per person across the study window for the intervention groups, and
for the social housing and the top 10% deprivation groups, respectively. These time plots provide evidence
of little or no trend in these rates across the study window data; the corresponding correlations between
rates across the study window are 0.296 for intervention and social housing groups (conventionally
regarded as weak) and 0.506 for intervention and the top 10% deprivation groups (somewhat stronger
but conventionally only regarded as moderate).
The time plots and correlations offer only limited support for using data from either comparator group in
the analysis of the intervention group rates.
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FIGURE 27 Monthly emergency admission rates per person for intervention and social housing groups (study
month 1 is January 2005).
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FIGURE 28 Monthly emergency admission rates per person for intervention and top 10% deprivation groups (study
month 1 is January 2005).
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Appendix 9 Community-based study: the
health questionnaire
Questions 1–7 were from the SF-12 version 2 and have been redacted from this appendix.
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Appendix 10 Consolidated Health Economic
Evaluation Reporting Standards checklist
Section/item
Item
number Recommendation
Page
number
Title and abstract
Title 1 Identify the study as an economic evaluation or use more-specific
terms such as ‘cost-effectiveness analysis’, and describe the
interventions compared
XX
Abstract 2 Provide a structured summary of objectives, perspective, setting,
methods (including study design and inputs), results (including
base-case and uncertainty analyses) and conclusions
XX
Introduction
Background and
objectives
3 Provide an explicit statement of the broader context for the study XX
Present the study question and its relevance for health policy or
practice decisions
Methods
Target population and
subgroups
4 Describe characteristics of the base-case population and subgroups
analysed, including why they were chosen
XX
Setting and location 5 State relevant aspects of the system(s) in which the decision(s) need(s)
to be made
XX
Study perspective 6 Describe the perspective of the study and relate this to the costs
being evaluated
XX
Comparators 7 Describe the interventions or strategies being compared and state
why they were chosen
XX
Time horizon 8 State the time horizon(s) over which costs and consequences are
being evaluated and say why appropriate
XX
Discount rate 9 Report the choice of discount rate(s) used for costs and outcomes
and say why appropriate
XX
Choice of health
outcomes
10 Describe what outcomes were used as the measure(s) of benefit in
the evaluation and their relevance for the type of analysis performed
XX
Measurement of
effectiveness
11a Single study-based estimates: describe fully the design features of
the single effectiveness study and why the single study was a
sufficient source of clinical effectiveness data
XX
11b Synthesis-based estimates: describe fully the methods used for
identification of included studies and synthesis of clinical
effectiveness data
XX
Measurement and
valuation of
preference-based
outcomes
12 If applicable, describe the population and methods used to elicit
preferences for outcomes
NA
Estimating resources
and costs
13a Single study-based economic evaluation: describe approaches
used to estimate resource use associated with the alternative
interventions. Describe primary or secondary research methods for
valuing each resource item in terms of its unit cost. Describe any
adjustments made to approximate to opportunity costs
XX,
Appendix 12
13b Model-based economic evaluation: describe approaches and data
sources used to estimate resource use associated with model health
states. Describe primary or secondary research methods for valuing
each resource item in terms of its unit cost. Describe any
adjustments made to approximate to opportunity costs
XX
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Section/item
Item
number Recommendation
Page
number
Currency, price date,
and conversion
14 Report the dates of the estimated resource quantities and unit costs.
Describe methods for adjusting estimated unit costs to the year of
reported costs if necessary. Describe methods for converting costs
into a common currency base and the exchange rate
XX, Table
XX,
Appendix 11
Choice of model 15 Describe and give reasons for the specific type of decision-analytic
model used. Providing a figure to show model structure is strongly
recommended
XX
Assumptions 16 Describe all structural or other assumptions underpinning the
decision-analytic model
XX
Analytical methods 17 Describe all analytical methods supporting the evaluation. This could
include methods for dealing with skewed, missing or censored data;
extrapolation methods; methods for pooling data; approaches to
validate or make adjustments (such as half cycle corrections) to a
model; and methods for handling population heterogeneity and
uncertainty
XX
Results
Study parameters 18 Report the values, ranges, references and, if used, probability
distributions for all parameters. Report reasons or sources for
distributions used to represent uncertainty where appropriate.
Providing a table to show the input values is strongly recommended
XX
Incremental costs and
outcomes
19 For each intervention, report mean values for the main categories
of estimated costs and outcomes of interest, as well as mean
differences between the comparator groups. If applicable, report
incremental cost-effectiveness ratios
XX
Characterising
uncertainty
20a Single study-based economic evaluation: describe the effects of
sampling uncertainty for the estimated incremental cost and
incremental effectiveness parameters, together with the impact
of methodological assumptions (such as discount rate, study
perspective)
XX
20b Model-based economic evaluation: describe the effects on the
results of uncertainty for all input parameters, and uncertainty
related to the structure of the model and assumptions
XX
Characterising
heterogeneity
21 If applicable, report differences in costs, outcomes or cost-effectiveness
that can be explained by variations between subgroups of patients
with different baseline characteristics or other observed variability in
effects that are not reducible by more information
NA
Discussion
Study findings,
limitations,
generalisability and
current knowledge
22 Summarise key study findings and describe how they support the
conclusions reached. Discuss limitations and the generalisability of
the findings and how the findings fit with current knowledge
XX
Other
Source of funding 23 Describe how the study was funded and the role of the funder in
the identification, design, conduct and reporting of the analysis.
Describe other non-monetary sources of support
XX
Conflicts of interest 24 Describe any potential for conflict of interest of study contributors in
accordance with journal policy. In the absence of a journal policy,
we recommend authors comply with International Committee of
Medical Journal Editors recommendations
XX
NA, not applicable.
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Appendix 11 Costs of intervention measures and
their estimated lifetime
Intervention measure
Number
delivered
Estimated
lifetime-years
(DECC)147
Cost (£)
Indicative
(WG)148
Intervention
measure
Yearly per
measure
External wall insulation 2709 36 7300 19,775,700 549,325
Photovoltaics 1458 25 5400 7,873,200 314,928
Solar water heating 928 25 2600 2,412,800 96,512
Air source heat pumps 401 15 6000 2,406,000 160,400
Loft/rafter insulation 172 42 100 17,200 409.52
Total cost 32,484,900.00 1,121,574.52
DECC, Department of Energy and Climate Change; WG, Welsh Government.
The total yearly cost of £1,121,574.52 represents each of the individual measures’ totals divided by their
estimated lifetime. The per-house yearly cost is the total yearly cost divided by the number of properties
(n = 4968), which results in a figure of £225.76.
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Appendix 12 Chronic obstructive pulmonary
disease utilities literature review
Introduction
The review was designed as a structured narrative literature review. It sought to capture and draw
conclusions from the main body of literature reporting health state utility values (HSUVs) for patients
with COPD in order to build a profile of HSUVs before, during and after admission to hospital with an
exacerbation, including the longer-term residual effect.
The focus was on secondary health-care utilisation as the majority of patients with COPD are elderly and
thus are at risk of prolonged hospital stays.169 Hospital admission can have a considerable impact on
subsequent quality of life, often disempowering individuals and reducing functional independence.170,171
The evidence was compiled following systematic procedures and, when possible, adhered to PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses; see Appendix 15). PRISMA is an
evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA
focuses on the reporting of reviews evaluating randomised trials, but can also be used as a basis for
reporting systematic reviews of other types of research, particularly evaluations of interventions. The
protocol for the review was devised and included an initial scoping of the literature to identify existing
reviews, a comprehensive search strategy to identify relevant studies and a narrative data synthesis to
provide a summary of results in relation to each objective.
Aim and objectives
To review the literature in order to build a profile of HSUVs for patients with COPD before, during and
after admission to hospital with an exacerbation of COPD:
i. to quantify HSUVs for stable COPD patients
ii. to quantify the change in HSUV from hospital admission to discharge
iii. to quantify the residual effect of a hospital admission
iv. to identify other confounding variables that cause variation in HSUVs.
Methods
A scoping exercise identified several existing reviews that provided pooled HSUVs for patients with COPD,
including three open access reviews and one review of which only the abstract was available.151,172,173 The
scoping search revealed the availability of many recent systematic reviews/meta-analyses in relation to HSUVs
in patients with stable COPD (objective i). The focus of this review was to capture any additional reviews
relevant to stable COPD (objective i) and to identify studies reporting HSUVs at admission and discharge
(objective ii), the residual effect of a hospital admission (objective iii) and confounding variables (objective iv).
The review was designed using a two-stage process. First, a broad overview of HSUV studies for patients
with COPD was undertaken to identify the number and type of studies that are currently available in the
literature. The second selection process used additional inclusion and exclusion criteria to identify those
studies relevant to each objective. Primary inclusion and exclusion criteria were designed to incorporate all
studies reporting HSUVs for patients with COPD. The study used the inclusion and exclusion criteria
reported in Table 24.
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Secondary inclusion and exclusion criteria were developed to extract studies relevant to each objective
(Table 25). Based on the results of the first-stage search, it was established that the majority of studies
used EQ-5D-generated utility values; therefore, this was included in the secondary inclusion criteria in order
to ensure consistency and validity of the HSUV profile.
The review was restricted to articles published in academic journals. These were sourced from both
electronic databases and reference searching of relevant review papers. Searches were conducted on
27 July 2016. Advice was sought from subject librarians with regard to relevant electronic databases and
search terms for the review.
The following electronic databases were searched: (1) PubMed (via NCBI), (2) Web of Science (via
Thompson Reuters), (3) Scopus (via Elsevier), (4) The Cochrane Library (via Wiley Online Library), which
includes the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of
Effectiveness, the Cochrane Central Register of Controlled Trials and the Cochrane Methodology Register,
(5) ProQuest Health Management and (6) Cumulative Index to Nursing and Allied Health Literature
(CINAHL) (via EBSCOhost).
TABLE 24 Primary inclusion and exclusion criteria
Inclusion Exclusion
Population l Studies in which either:
¢ all or part of the population has a
respiratory disease defined by ICD-10
codes J00–J06, J09–J18, J20–J22, J30–J39,
J40–J47, J60–J70, J80–J84, J85–J86 or
J90–J94 (matching those used in the
Arbed study); or
¢ a descriptive definition (e.g. COPD) is used
if the condition is physician diagnosed
(including when reported by a third party
or self-reported)
l Studies in which the population includes
adults (aged ≥ 18 years) only
l Studies in which COPD was not the primary
disease state
l Studies that include patients with other
conditions and in which the data for patients
with COPD conditions are not distinguishable
l Studies including data on population in
correctional institutions only
l Studies in which the population has a genetic
disorder responsible for COPD
l Studies in which the study population is
< 18 years of age or in which data for adults is
not distinguishable
Study type l Studies published in the English language
l Analytical studies including randomised control
trials, cohort studies, cross-sectional studies,
case–control studies
l Studies using empirical data and
modelling studies
l Full text not available as an open access source
l Non-English-language studies (including those
with English abstracts only)
l Descriptive studies including case studies and
opinion-based literature (editorials/letters, etc.)
l Systematic reviews and meta-analyses (eligible for
referencing searching only)
Context l Studies based in primary, secondary or
tertiary care
NA
Outcomes l Studies including a HSUV measured by the
EQ-5D, SF-6D, HUI-2, AQoL, 15D or QWB
l Studies based on regression analysis that report
beta coefficients only
l Studies reporting HSUV graphically when values
cannot easily be identified
l Studies reporting experience-based HSUV
l Studies in which utility values were estimated
using mapping values from other instruments or
the questionnaire was completed by a third party
15D, 15-dimensional measure of health-related quality of life; AQoL, Assessment of Quality of Life; HUI, Health Utilities
Index; NA, not applicable; QWB, Quality of Well-Being.
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Search strategy
The search strategy was developed around the main themes of the review aim: ‘chronic obstructive
pulmonary disease’ and ‘HSUV’. Therefore, the search focused on all generic instruments for measuring
health-related quality of life that produce HSUVs [EQ-5D, SF-6D, Health Utilities Index (HUI)-2, HUI-3,
Quality of Well-Being (QWB), Assessment of Quality of Life (AQoL), AQoL2] and related terms (i.e. EuroQol
and Health Utilities Index), as well as all terms that could represent COPD.
The final search terms were:
COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung disease” OR
“chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease” OR emphysema
OR bronchitis
AND
“health state” OR “health states” OR “health preference” OR “health preferences” OR “health utility” OR
“health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility measure” OR “utility
measures” OR “utility value” OR “utility values” OR “utility score” OR “utility scores” OR “utility outcome”
OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility evaluation” OR “utility
evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol” OR “euro qols” OR “utility
analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR QALY OR “quality adjusted
life year” OR “quality adjusted life years” OR “time trade off” OR “time tradeoff” OR “timetrade off”
OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6 dimension” OR “short form 6
dimensions” OR “short form 6” OR AQoL OR “assessment of quality of life” OR HUI2 OR HUI3 OR QWB OR
QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional”
A combination of title, abstract or topic searches were adapted for use with each database depending
on the options available. Limitations included papers published in the English language and no date
restrictions were set. The full, unedited search strategies for each database can be found in Appendix 13.
All studies that were identified via electronic database searches were exported into EndNoteWeb [Clarivate
Analytics (formerly Thomson Reuters), Philadelphia, PA, USA] and duplicates removed. The remaining
references were then exported to Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA).
TABLE 25 Secondary inclusion and exclusion criteria
Objective Inclusion Exclusion
Change in HSUV
during hospital
admission
l Studies in which patients were admitted
to hospital with an exacerbation of COPD
l Studies based on the EQ-5D
l Studies in which exacerbations were
recorded in primary and community care
(including outpatient clinics)
Residual HSUV post
hospital admission
l Studies reporting change in HSUV from
hospital admission/discharge to a later
time point
l Studies reporting change in HSUV in
relation to the number of hospital
admissions for COPD
l Studies based on the EQ-5D
NA
Confounding variables l Studies reporting HSUVs for subgroups of
patients with COPD
l Studies based on the EQ-5D
l Studies reporting a single HSUV for
patients with COPD without subgroups
for comparison
l Studies reporting HSUVs when the
comparison group is patients
without COPD
NA, not applicable.
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Study selection
A multistage selection process was undertaken by the reviewer. First, all titles and abstracts were screened
against the inclusion criteria with a preference towards overinclusion in cases that were unclear. The
reviewer was not blinded to author and journal details. Next, full papers were obtained and, owing to time
constraints, those that were not available as open access sources were excluded from the review. Following
this, full studies were assessed against both the inclusion and exclusion criteria. Many of the studies include
duplicate data sets and these were therefore grouped together to ensure that information was not
reported twice.
Seventy-eight studies were accepted after the primary inclusion and exclusion criteria were applied (see
Table 24 and Figure 29). An overview of these studies was given, including country of origin, instruments
used to measure HSUVs, tariff values used and data sets used (Table 26). Subsequently, secondary
Studies identified via electronic databases
(n = 2302)
• PudMed, n = 495
• Web of Science, n = 458
• Scopus, n = 754
• The Cochrane Library, n = 264
• ProQuest Health Management, n = 197
• CINAHL, n = 134
Identified via reference searching
(n = 4)
Duplicate studies removed
(n = 838)
Titles and/or abstracts screened
with inclusion criteria
(n = 1468)
Studies excluded because of irrelevancy
(n = 1250)
Studies accepted for full-text review
and reference searching
(n = 218)
Studies excluded using primary
inclusion and exclusion criteria
(n = 136)
Accepted for final review
(n = 78)
Studies excluded using secondary
inclusion and exclusion criteria
(n = 55)
Objective ii
(n = 3)
Objective iii
(n = 5)
Objective iv
(n = 18)
Objective i
(n = 3)
FIGURE 29 Flow diagram: study selection process following PRISMA guidelines.
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TABLE 26 All studies accepted after primary inclusion and exclusion criteria were applied
Author Country Instrument Tariff values Data set
Boland et al.174 The Netherlands EQ-5D – RECODE trial175,176
Burns et al.177 UK EQ-5D UK Wilson et al.178
Cramm and Nieboer179 The Netherlands EQ-5D – Zichtbare visible link
programme180,181
Ding et al.182 China SF-36v2 (SF-6D),
SF-12v2 (SF-6D)
– CNHW survey183
Dritsaki et al.184 UK EQ-5D UK SPACE trial185,186
Eklund et al.187 Canada, Spain, Sweden,
UK
EQ-5D – SPARK188 and UPLIFT189 trial
Esteban et al.154 Spain EQ-5D – IRYSS-CAS190
Hoyle et al.191 UK EQ-5D UK ClinicalTrials.gov and
GlaxoSmithKline studies192
Jia et al.193,194 USA EQ-5D – NHANES 2005–2008195,196
Kwon and Kim194,197 South Korea EQ-5D South Korean KNHANES 2007–2012198,199
Lee et al.194,200 South Korea EQ-5D – KNHANES 2007–2012194
Lee et al.194,201 South Korea EQ-5D South Korean KNHANES 2007–2012194
Martinez Rivera et al.202 Spain EQ-5D – Original data203,204
Roncero et al.205 Spain EQ-5D – Original data206
Selya-Hammer et al.207 Italy EQ-5D – Rutten-van Mölken et al.208
Wacker et al.209 Germany EQ-5D German Rutten-van Mölken et al.210
Zanaboni et al.211 Norway EQ-5D – Original data211
Boland et al.212 The Netherlands EQ-5D Dutch RECODE trial175,176
Boland et al.213 The Netherlands EQ-5D – RECODE,175,176 GO-AHEAD,214
MARCH215 trials
Fishwick et al.216 UK EQ-5D UK Original data217
Hong et al.194,218 South Korea EQ-5D South Korean KNHANES 2007–2010199
Kim et al.194,219 South Korea EQ-5D South Korean KNHANES 2007–2010199
Miravitlles et al.220 Spain EQ-5D Spanish Original data – same data
as Miravitlles et al.221
Miravitlles et al.221 Spain EQ-5D Spanish Original data – same data
as Miravitlles et al.220
Stoddart et al.222 UK EQ-5D UK Original data223,224
Sundh et al.225 Sweden EQ-5D UK Original data225
Wilson et al.178 UK EQ-5D – Original data178
Wu et al.226 China EQ-5D – Original data226
Abdin et al.227 Singapore EQ-5D UK SMHS228
van Boven et al.229 UK, Sweden EQ-5D – PHARMACOP230
Chen et al.231 Hong Kong EQ-5D UK Original data231
García-Rio et al.232 Spain EQ-5D – EPI-SCAN study233,234
Karabis et al.235 USA EQ-5D – Rutten-van Mölken et al.210
continued
DOI: 10.3310/phr06050 PUBLIC HEALTH RESEARCH 2018 VOL. 6 NO. 5
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Poortinga et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trialsand Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
147
TABLE 26 All studies accepted after primary inclusion and exclusion criteria were applied (continued )
Author Country Instrument Tariff values Data set
Kim et al.236 South Korea EQ-5D South Korean Original data236
Lin et al.237 USA EQ-5D USA CONCERT study238
Miravitlles et al.239 Spain EQ-5D Spanish Original data239
Miravitlles et al.206 Spain EQ-5D Spanish Original data – DEPREPOC
study206
Miravitlles et al.240 Spain EQ-5D Spanish Original data – INSEPOC
study241,271
Mullen et al.242 Canada EQ-5D USA Combined data set243
Peters et al.244 UK EQ-5D – Original data – same data
as Peters et al.245
Peters et al.245 UK EQ-5D – Original data – same data
as Peters et al.244
Samyshkin et al.246 UK EQ-5D – Studies M2–124 and
M2–125, Rabe247 and
Rutten-van Mölken et al.158
Tsiachristas et al.248 The Netherlands EQ-5D Dutch Original data249
Gillespie et al.250 Ireland EQ-5D UK PRINCE trial251
Samyshkin et al.252 Switzerland EQ-5D – Rutten-van Mölken et al.158
and Takeda Pharma AG
(Pfäffikon, Switzerland)
Solem et al.253 USA EQ-5D USA Original data253
Asukai et al.254 UK EQ-5D UK INVOLVE,255 INHANCE256
and INLIGHT-2257 trials
DiBonaventura et al.258 USA SF-12v2 (SF-6D) – NHWS259
Goodacre et al.260 UK EQ-5D UK (using
pilot-study data)
Original data260
Taylor et al.261 UK EQ-5D UK Original data261
Fletcher et al.262 Brazil, China, Germany,
Turkey, USA, UK
EQ-5D Germany, UK
and USA
Original data262
Goosens et al.263 USA EQ-5D USA CASA-Q264
Janssen et al.265 The Netherlands EQ-5D – Original data266–268
Khdour et al.269 UK EQ-5D UK Khdour et al.270
Miravitlles et al.271 Spain EQ-5D Spanish Original data – INSEPOC
study241,271
Pickard et al.173 USA SF-36, EQ-5D UK and USA Joo et al.272
Starkie et al.273 Worldwide EQ-5D UK TORCH study274
Hoogensoorn et al.275 The Netherlands EQ-5D – Original data275
Menn et al.155 Germany EQ-5D, SF-12
(SF-6D)
UK Original data155
Rutten-van Mölken
et al.158
The Netherlands EQ-5D In-study
valuation
Original data158
Szende et al.276 Sweden EQ-5D UK Combined data – Szende
et al.277 and OLIN278
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TABLE 26 All studies accepted after primary inclusion and exclusion criteria were applied (continued )
Author Country Instrument Tariff values Data set
Punekar et al.279 USA, France, Germany,
Italy, Spain, UK
EQ-5D UK Original data – the
Respiratory Disease Specific
Programme III279
O’Reilly et al.156 Germany EQ-5D UK Original data156
Rutten-van Mölken
et al.208
Spain EQ-5D Spanish Six clinical trials and pooled
data280–283
Rutten-van Mölken
et al.210
13 countries
(% participants): USA
(34.5%), Czechia
(17.5%), Spain (11.9%),
Denmark (8.4%),
Germany (4.9%), Poland
(4.8%), the Netherlands
(4.4%), Italy (4.4%),
France (3.1%), Hungary
(2.5%), the Russian
Federation (1.5%),
Belgium (1.4%), Australia
(0.8%)
EQ-5D UK and USA UPLIFT trial284
Spencer et al.285 UK EQ-5D – Prescott-Clarke et al.,286
Brazier et al.,105
Spencer et al.287
Ståhl et al.288 Sweden EQ-5D, SF-36
(SF-6D)
– OLIN studies289–291
Sullivan et al.292 USA EQ-5D USA MEPS293
Borg et al.294 Sweden, UK EQ-5D UK OLIN studies289,295,296
Brazier et al.297 UK EQ-5D, SF-6D UK Thomas et al.298
Kaplan et al.299 USA SF-36 (SF-6D),
QWB-SA
– NETT300
Hazell et al.301 UK EQ-5D UK Original data301
Stavem et al.302 The Netherlands EQ-5D UK Original data – same data
as Stavem303
Paterson et al.304 UK EQ-5D UK Original data304
Stavem303 Norway EQ-5D, 15D,
SF-36 (SF-6D)
UK Original data – same data
as Stavem et al.302
Torrance et al.305 Canada HUI – Original data305
Harper et al.306 UK EQ-5D, SF-36
(SF-6D)
– Original data306
Jaeschke et al.307 Canada QWB – Original data307
–, unknown; 15D, 15-dimensional measure of health-related quality of life; CASA-Q, Cough and Sputum Assesment
Questionnaire; CONCERT, COPD Outcomes-based Network for Clinical Effectiveness and Research Translation;
CNHW, China National Health and Wellness Survey; DEPREPOC, Depression in Chronic Obstructive Pulmonary Disease;
GO-AHEAD, Assessment Of Going Home Under Early Assisted Discharge; INLIGHT-2, Indacaterol Efficacy Evaluation
Using 150-µg Doses with COPD Patients; INVOLVE, Indacaterol: Value in COPD: Longer Term Validation of Efficacy
and Safety; IRYSS-CAS, Investigacion en Resultados y Servicios de Salud COPD Appropriateness Study; KNHANES, Korean
National Health and Nutrition Examination Survey; MARCH, Health Status Guided COPD Care; MEPS, Medical Expenditure
Panel Survey; NHANES, National Health and Nutrition Examination Survey; NETT, National Emphysema Treatment Trial;
NHWS, National Health and Wellness Survey; OLIN, Obstructive Lung Disease in Northern Sweden; QWB-SA, QWB
self-administered; SF-36v2, SF-36 version 2; SF-12v2, SF-12 version 2; RECODE, Randomised Clinical Trial on Effectiveness
of Integrated COPD Management in Primary Care; SMHS, Singapore Mental Health Survey; SPACE, Self-management
Programme of Activity, Coping and Education; TORCH, Towards a Revolution in COPD Health.
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inclusion and exclusion criteria (see Table 25) were applied to filter these further, so that papers relevant to
each objective only were selected. The full review process was documented using the PRISMA flow
diagram (see Figure 29).
Data collection process
Data were extracted from the final selection of papers in a systematic manner in which each study was
scanned for the same fields. When multiple papers reported the same data set(s), only one paper was
included. Several criteria were used to prioritise the paper chosen in the following order: first, studies using
patient-reported data were prioritised (as opposed to secondary data used in modelling studies); second,
the papers with the most-recent data set were chosen (e.g. a study reporting 2014–16 data instead of
2013–15 data); and third, the study reporting the largest sample size and/or most information was selected.
Data items
The data items extracted included the following: author, year, country of origin (data), sample size, age,
sex, COPD GOLD stage/severity level, study type, time of measurement of EQ-5D, data source, EQ-5D tariff
value and HSUVs. Risk of bias was assessed at outcome level only. The primary outcome was HSUV.
Overview of all health state utility values studies for patients with chronic obstructive
pulmonary disease
After the initial search, 79 studies were identified to include HSUVs for patients with COPD. The studies
incorporated data from the UK, Spain, France, the Netherlands, Germany, Switzerland, Italy, Norway,
Sweden, Turkey, Brazil, China, the USA and Canada. In addition, several studies involved multicountry data
sets in which individual countries were not identified.210,273
The majority of studies reported HSUVs based on the EQ-5D (73 studies154–156,158,173,174,177–179,184,187,191,193,194,197,
200–202,205–213,216,218–222,225–227,229,231,232,235–237,239,240,242,244–246,248,250,252–254,260–262,265,269,271,273,275,276,279,285,288,292,294,297,301–304,306);
some studies also reported utility values based on the SF-36/SF-12/SF-6D (nine studies155,173,182,258,288,297,299,303,306).
In addition, one study used HUI,305 one study used QWB307 and one study used the 15-dimensional measure
of health-related quality of life.303
Eighteen studies177,178,184,191,216,222,244–246,254,260,261,269,286,297,301,304,306 were UK based (UK data set or, if secondary
data were used, UK lead authors), five studies included UK data in pooled analysis and 27 studies155,156,173,
177,184,191,210,216,222,225,227,231,250,254,260–262,269,273,276,279,294,297,301–304 used UK tariff values. Not all studies explicitly
stated the tariff values used so instead, when possible, this was deduced by the references used.
Although a large number of studies were identified, many used overlapping data sets that were not always
initially obvious. For instance, modelling studies often used secondary data from the same clinical trials;
for example, Eklund et al.187 and Karabis et al.235 used data from the UPLIFT trial.308 Other studies also
reported secondary data in other studies; for example, Wacker et al.209 report data from Burns et al.177
and Rutten-van Mölken et al.210 report data from Wilson et al.178 Many studies used pooled data from
several trials; for example, Boland et al.212 used pooled data from the Randomised Clinical Trial on
Effectiveness of Integrated COPD Management in Primary Care (RECODE),175,176 the Assessment Of Going
Home Under Early Assisted Discharge (GO-AHEAD) trial214 and the Health Status Guided COPD Care
(MARCH) trial.215 Other studies used data from the same national surveys for different and/or overlapping
years; for example, Kwon et al.,194,197 Lee et al.,194,201 Hong et al.194,218 and Kim et al.194,219 use data from the
Korean National Health and Nutrition Examination Survey (KNHANES).199
The initial scan found three review papers with full-text availability in relation to COPD patients with stable
COPD151,172,309 and the full search did not identify any additional reviews (Table 27).
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Pickard et al.309 estimated average HSUVs by disease severity based on pooled data from 1988 to 2007.
Petrillo et al.172 updated the search by Pickard et al.309 and provided HSUV ranges by disease severity and a
summary of the HSUV change during an exacerbation (community or hospital based). Moayeri et al.151
conducted a meta-analysis on COPD HSUV studies that were published prior to 2014 using UK tariff values
and produced average utilities by disease severity.
Change in health state utility values during a hospital admission for an exacerbation of
chronic obstructive pulmonary disease
Three studies considered change in EQ-5D-generated HSUVs from hospital admission to discharge,154–156
two of which used UK tariff values.155,156
There was large disparity in HSUVs between the studies using UK tariff values, particularly in relation to HSUVs
on admission. For instance, mean admission and discharge HSUVs for O’Reilly et al.156 were –0.077 and 0.576,
respectively; whereas, for Menn et al.,155 the reported weighted average admission and discharge HSUVs
were 0.61 and 0.78, respectively. However, differences can be explained by the timing of the measurement;
whereas patients in O’Reilly et al.156 completed the EQ-5D ‘on admission’ (i.e. at the most severe part of their
exacerbation), patients in Menn et al.155 completed the EQ-5D ‘within 3 days after admission’ (i.e. after
treatment had started, when it is likely symptoms had improved). Similarly, Esteban et al.154 reported similar
values (0.60 on admission and 0.64 on discharge) to those reported by Menn et al.,155 when data were
collected ‘on the first day after admission’, again after treatment had started (Table 28).
Residual effect on utility values after an admission to hospital with an exacerbation of
chronic obstructive pulmonary disease
Five studies (Table 29) report the residual effect of EQ-5D-generated HSUVs after an exacerbation requiring
hospital admission,156,158,246,252,253 three of which used the same data set.158,246,252 The residual effect was
tracked over three timescales: 3 months,156 12 months158 and a varied timescale related to previous
exacerbation.253 Only one study used UK tariff values.156
TABLE 27 Overview of reviews reporting HSUVs for stable COPD
Author Country Population Methods Instrument HSUV
Pickard
et al.309
All countries
considered
COPD and
asthma
Papers published
from January 1988
to January 2007
COPD
EQ-5D Mean EQ-5D-generated utilities using
UK tariff and GOLD stages (SD)
l 1 (mild) = 0.74 (0.62–0.87)
l 2 (moderate) = 0.74 (0.66–0.83)
l 3 (severe) = 0.69 (0.60–0.78)
l 4 (very severe) = 0.61 (0.44–0.77)
Petrillo
et al.172
All countries
considered
COPD Papers published
from 1997 to
August 2009
COPD
All instruments
considered
(generic and
specific)
Range EQ-5D-generated utilities based
on GOLD stages for UK studies
l 1 (mild) = 0.90–0.77
l 2 (moderate) = 0.79–0.68
l 3 (severe) = 0.81–0.62
l 4 (very severe) = 0.72–0.52
Moayeri
et al.151
All countries
considered
COPD Papers published
before 2014
COPD
English-language
studies
EQ-5D
(UK tariff)
Mean EQ-5D-generated utilities using
UK tariff and GOLD stages (95% CI)
l 1 (mild) = 0.806 (0.747 to 0.866)
l 2 (moderate) = 0.767 (0.740
to 0.795)
l 3 (severe) = 0.704 (0.670 to 0.739)
l 4 (very severe) = 0.616 (0.556
to 0.676)
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TABLE 28 Change in HSUV during a hospital admission for an exacerbation of COPD
Author Country Population Methods Instrument HSUV, mean (SD)
Esteban et al.154 Spain 1421 COPD (all stages) patients admitted to
hospital
l mean age, years (SD) = 72.6 (9.6)
l sex, male (%) = 90.3
950 COPD (all stages) patients discharged
l mean age, years (SD) = 73.0 (9.7)
l sex, male (%) = 91.8
Prospective cohort study;
patients recruited on
admission to hospital.
EQ-5D score measured in
an interview at admission
(24 hours after ED) and
discharge (next day or
week after)
EQ-5D Admission (n= 1421)= 0.60 (0.28)
Discharge (n= 950)= 0.64 (0.29)
Menn et al.155 Germany 117 patients
Mean age, years (SD)
l GOLD stage 3 (severe) (n= 34)= 67 (8)
l GOLD stage 4 (very severe) (n= 83)= 68 (8)
Sex, male (%)
l GOLD stage 3 (severe) (n= 34)= 59
l GOLD stage 4 (very severe) (n= 83) = 66
Prospective observational
study, data collected via
patient-completed
questionnaire during
hospital stay within
3 days of admission
and discharge
EQ-5D
SF-12 (SF-6D)
German and UK tariff
German tariff
l GOLD stage 3 (severe) (n= 34):
admission = 0.62 (0.26); discharge = 0.84 (0.20)
l GOLD stage 4 (very severe) (n= 83):
admission = 0.60 (0.26); discharge = 0.75 (0.22)
UK tariff
GOLD stage 3 (severe) (n= 34): admission = 0.46
(0.31); discharge = 0.72 (0.23)
GOLD stage 4 (very severe) (n = 83):
admission = 0.44 (0.31); discharge = 0.61 (0.28)
Sensitivity to change
l admission = 0.60 (0.26)
l discharge = 0.79 (0.21)
l absolute standardised difference= 0.69
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Author Country Population Methods Instrument HSUV, mean (SD)
O’Reilly et al.156 Germany All (n= 222)
GOLD
l stage 0 (at risk) or 1 (mild): 6
l stage 2 (moderate): 30
l stage 3 (severe): 52
l stage 4 (very severe): 45
Follow-up (n= 40)
l stage 0 (at risk) or 1 (mild): 2
l stage 2 (moderate): 5
l stage 3 (severe): 15
l stage 4 (very severe): 11
Prospective observation
study, data collected via
self-administered EQ-5D
and SF-12 during hospital
admission, at discharge
and at 3-month follow-up
EQ-5D (UK tariff)
SF-12
All (n = 222)
l admission = –0.077 (0.397)
l discharge (within 3 days) = 0.576 (0.317)
Patients with follow-up data (n = 40)
l admission = –0.120 (0.366)
l discharge (within 3 days) = 0.635 (0.243)
l follow-up = 0.389 (0.313)
Change in EQ-5D first admissions (n= 112)
l admission–discharge: 0.653 (0.434)
ED, emergency department.
D
O
I:10.3310/phr06050
PU
BLIC
H
EA
LTH
RESEA
RCH
2018
VO
L.6
N
O
.5
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2018.
This
w
ork
w
as
produced
by
Poortinga
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth
and
SocialC
are.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professional
journals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trialsand
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
153
TABLE 29 Residual effect on utility values after a hospital admission for an exacerbation of COPD
Author Country Population Methods Instrument HSUV
Solem et al.253 USA Overall (n= 314)
l mean age, years
(SD) = 68.0 (9.6)
l sex, male (%) = 51.3
GOLD stage 3 (severe) COPD
(n = 190)
l mean age, years
(SD) = 67.4 (9.8)
l sex, male (%) = 49.5
GOLD stage 4 (very severe) COPD
(n = 124)
l mean age, years
(SD) = 68.8 (9.2)
l sex, male (%) = 54
Cohort study, data collected
in a patient interview (including
EQ-5D), recruitment via primary
care physicians/pulmonologists
EQ-5D
(USA tariff)
Overall (n= 314), mean (SD)
l current health = 0.674 (0.204)
l last exacerbation = 0.552 (0.283)
l incremental disutility = 0.122 (0.213)
GOLD stage 3 (severe) COPD (n= 190), mean (SD)
l current health = 0.707 (0.174)
l last exacerbation = 0.590 (0.256)
l incremental disutility = 0.117 (0.205)
GOLD stage 4 (very severe) COPD (n= 124), mean (SD)
l current health = 0.623 (0.234)
l last exacerbation = 0.494 (0.312)
l incremental disutility = 0.128 (0.226)
Severity of last exacerbation (GP treated): moderate
(n= 205), mean (SD)
l current health: 0.698 (0.197)
l last exacerbation: 0.595 (0.257)
l incremental disutility: 0.103 (0.191)
Severity of last exacerbation (GP treated): severe
(requiring hospitalisation) (n= 109), mean (SD)
l current health = 0.627 (0.210)
l last exacerbation = 0.471 (0.313)
l incremental disutility = 0.157 (0.245)
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Author Country Population Methods Instrument HSUV
Rutten-van Mölken
et al.158 (same data as
in Samyshkin et al.246,252)
The
Netherlands
229 TTO data available
l mean age, years (SD) = 45 (16)
l male: 47%
Cohort study, recruited via
advertisement in local
newspaper; health states
valued during group session or
at home
EQ-5D
(Dutch tariff)
Estimated annual utility decrements, mean (SE)
l 1 non-serious exacerbation = 0.010 (0.007)
l 2 non-serious exacerbations = 0.021 (0.007)
l 1 serious exacerbation = 0.042 (0.009)
l 1 serious and 1 non-serious
exacerbation = 0.088 (0.009)
O’Reilly et al.156 Germany Follow-up (n= 40), GOLD stages
l 0 (at risk) or 1 (mild): 2
l 2 (moderate): 5
l 3 (severe): 15
l 4 (very severe): 11
Prospective observation
study, data collected from
self-administered EQ-5D
and SF-12 during hospital
admission, at discharge and
at 3-month follow-up
EQ-5D
(UK tariff)
SF-12
HSUV, mean (SD)
l discharge (within 3 days) (n= 40)= 0.635 (0.243)
l 3-month follow-up (n = 40)= 0.389 (0.313)
TTO, time trade-off.
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Confounding variables
The studies reported HSUV in a range of different subgroups, the most common being severity level,
phenotype, age, sex, number and severity of exacerbations, number and type of comorbidities, smoking
history, body mass index (BMI) and socioeconomic status. Tables for the confounding variables can be
found in Appendix 14.
Phenotype
Two studies reported utility values by phenotype, although each considered different subgroups. Mean
utility values in each group ranged from 0.63 to 0.69 in Ding et al.182 and from 0.52 to 0.69 in Miravittles
et al.220
Ding et al.182 found patients with asthma–COPD overlap syndrome (ACOS) and asthma only to have the
lowest HSUVs in comparison with COPD only (COPD, chronic bronchitis or emphysema) or controls (those
without asthma, COPD, chronic bronchitis or emphysema). In contrast, Miravitlles et al.220 studied a cohort
of COPD patients and found the ‘excerbators with chronic bronchitis’ group to have the lowest HSUV in
comparison with ‘excerbators without chronic bronchitis’, ACOS or ‘non-excerbators’.
Age
Four studies considered HSUV by age, with mean HSUV ranging from 0.42 to 0.94.194,219,262,279,301 All studies
showed a general trend towards a decrease in HSUV with age, with a slightly greater decrease seen in
females than in males.194,219,301 However, this sex difference is particularly pronounced in the South Korean
study, which, as mentioned previously, has a high percentage of males, meaning differences may be
exaggerated by a small female sample size.194,219
Sex
Six studies reported sex differences in HSUV, with overall mean utility values ranging from 0.60 to
0.93.191,194,219,225,236,262,279 Four out of six of the studies reported that females have a lower HSUV, with
differences ranging from 0.03 to 0.11.191,225 Two studies reported that males have a higher HSUV;
however, both studies have male-dominated cohorts [Kim et al.236 (91.5% male) and Kim et al.194,219
(74.0% male)] and are based on a specific population (i.e. South Korean).
Number and severity of exacerbations
Two studies looked at HSUV by number of exacerbations, reporting a reduction in HSUV with an
increasing number of exacerbations,221,279 and one study considered utility decrements by severity of
exacerbations, reporting greater decrements in HSUVs with increasing severity.158
Number and type of comorbidities
Three studies considered the effect of specific comorbidities on HSUV.202,206,221 The greatest differences
were found between those with and without depression. Both Martinez Rivera et al.202 and Miravitlles
et al.206 found that patients with COPD and depression had a lower mean HSUV than patients with
COPD only (0.40 and 0.55 vs. 0.76 and 0.83, respectively). Miravitlles et al.221 also found that those with
comorbid cardiovascular disease had a lower mean HSUV (0.78) than patients with COPD only (0.82);
however, no differences were found for patients with and without diabetes, and patients with comorbid
haematological malignancies had similar HSUVs.
One study measured HSUVs in relation to a number of comorbid diseases in patients with COPD and
found that HSUV decreased as the number of comorbidities increased.194,218 In addition, Miravitlles et al.221
also considered HSUV in relation to the Charlson index, with mixed results: those scoring 0, 1 and 3 had
similar utility scores (0.82, 0.82 and 0.81, respectively), whereas those scoring 2 had a lower HSUV
of 0.74.
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Smoking history
Three studies assessed smoking status in relation to HSUV in patients with COPD, with mixed results.
The studies report smokers with HSUVs higher than,194,201 lower than242 and the same as221 non-smokers.
Body mass index
Two studies report BMI in relation to HSUV in patients with COPD, with mixed results.221,232 The lowest
HSUV was reported in underweight patients (0.69)221 and the highest in overweight patients (0.90);232
however, the general relationship between HSUV and weight was not linear.
Socioeconomic status
Two studies considered HSUV by socioeconomic status for patients with COPD, both reporting that HSUVs
increase as socioeconomic status increases.194,219,271
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Appendix 13 Search strategy
PubMed: 495 (date of search: 27 July 2016).
Web of Science: 458 (date of search: 27 July 2016).
Scopus: 754 (date of search: 27 July 2016).
The Cochrane Library: 264 (date of search: 27 July 2016).
ProQuest Health Management: 197 (date of search: 27 July 2016).
CINAHL: 134 (date of search: 27 July 2016).
PubMed
Search terms #1 “Lung Diseases, Obstructive”[Mesh]
#2 COPD[tiab] OR COAD[tiab] OR “chronic obstructive pulmonary disease”[tiab] OR “chronic obstructive
lung disease”[tiab] OR “chronic lung disease”[tiab] OR “chronic respiratory”[tiab] OR “chronic obstructive
airway disease” [tiab] OR emphysema[tiab] OR bronchitis[tiab]
#3 “health state”[tiab] OR “health states”[tiab] OR “health preference”[tiab] OR “health
preferences”[tiab] OR “health utility”[tiab] OR “health utilities”[tiab] OR “utility index”[tiab] OR “utilities
index”[tiab] OR “utility indices”[tiab] OR “utility measure”[tiab] OR “utility measures”[tiab] OR “utility
value”[tiab] OR “utility values”[tiab] OR “utility score”[tiab] OR “utility scores”[tiab] OR “utility
outcome”[tiab] OR “utility outcomes”[tiab] OR “utility weight”[tiab] OR “utility weights”[tiab] OR “utility
evaluation”[tiab] OR “utility evaluations”[tiab] OR HUI[tiab] OR HSUV[tiab] OR eq5d[tiab] OR euroqol*
[tiab] OR “eq 5d”[tiab] OR “euro qol” [tiab] OR “euro qols” [tiab] OR “utility analysis”[tiab] OR “utility
analyses”[tiab] OR “cost utility”[tiab] OR “cost utilities”[tiab] OR CUA[tiab] OR QALY[tiab] OR “quality
adjusted life year”[tiab] OR “quality adjusted life years”[tiab] OR “time trade off”[tiab] OR “time tradeoff”
[tiab] OR “timetrade off”[tiab] OR TTO[tiab] OR “standard gamble”[tiab] OR sf6d[tiab] OR “sf 6d”[tiab] OR
“short form 6 dimension”[tiab] OR “short form 6 dimensions”[tiab] OR “short form 6”[tiab] OR AQoL
[tiab] OR “assessment of quality of life”[tiab] OR HUI2[tiab] OR HUI3[tiab] OR QWB[tiab] OR QWB-SA[tiab]
OR “quality of well-being”[tiab] OR 15D[tiab] OR “15 dimensional”[tiab]
#4 #1 OR #2
#5 #3 AND #4
Filters Species: Human
Language: English
SCOPUS
Search terms Title-Abstract-Key Words:
COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung disease” OR
“chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease” OR emphysema
OR bronchitis
AND
Title-Abstract-Key Words:
“health state” OR “health states” OR “health preference” OR “health preferences” OR “health utility”
OR “health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility measure” OR
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SCOPUS
“utility measures” OR “utility value” OR “utility values” OR “utility score” OR “utility scores” OR “utility
outcome” OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility evaluation” OR
“utility evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol” OR “euro qols”
OR “utility analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR QALY OR
“quality adjusted life year” OR “quality adjusted life years” OR “time trade off” OR “time tradeoff” OR
“timetrade off” OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6 dimension” OR
“short form 6 dimensions” OR “short form 6” OR AQoL OR “assessment of quality of life” OR HUI2 OR
HUI3 OR QWB OR QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional”
Filters Language: English
CINAHL
Search terms S1 (MH “Lung Diseases, Obstructive+”)
S2 AB COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung
disease” OR “chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease”
OR emphysema OR bronchitis
S3 AB “health state” OR “health states” OR “health preference” OR “health preferences” OR “health
utility” OR “health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility
measure” OR “utility measures” OR “utility value” OR “utility values” OR “utility score” OR “utility
scores” OR “utility outcome” OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility
evaluation” OR “utility evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol”
OR “euro qols” OR “utility analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR
QALY OR “quality adjusted life year” OR “quality adjusted life years” OR “time trade off” OR “time
tradeoff” OR “timetrade off” OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6
dimension” OR “short form 6 dimensions” OR “short form 6” OR AQoL OR “assessment of quality of
life” OR HUI2 OR HUI3 OR QWB OR QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional”
S4 S1 OR S2
S5 S3 AND S4
Note: AB= abstract, MH= Cinahl Heading
Filters Language: English
Species: Human
Web of Science
Search terms Topic:
COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung disease” OR
“chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease” OR emphysema
OR bronchitis
AND
Topic:
“health state” OR “health states” OR “health preference” OR “health preferences” OR “health utility”
OR “health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility measure” OR
“utility measures” OR “utility value” OR “utility values” OR “utility score” OR “utility scores” OR “utility
outcome” OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility evaluation” OR
“utility evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol” OR “euro qols”
OR “utility analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR QALY OR
“quality adjusted life year” OR “quality adjusted life years” OR “time trade off” OR “time tradeoff” OR
“timetrade off” OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6 dimension” OR
“short form 6 dimensions” OR “short form 6” OR AQoL OR “assessment of quality of life” OR HUI2 OR
HUI3 OR QWB OR QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional”
Filters Language: English
Databases: Web of ScienceTM Core Collection (SCI-EXPANDED, SSCI, CPCI-S, CPCI-SSH, ESCI)
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The Cochrane Library
Search terms #1 MeSH descriptor: [Lung Diseases, Obstructive] explode all trees
COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung disease” OR
“chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease” OR emphysema
OR bronchitis :ti,ab,kw
#3 “health state” OR “health states” OR “health preference” OR “health preferences” OR “health utility”
OR “health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility measure” OR
“utility measures” OR “utility value” OR “utility values” OR “utility score” OR “utility scores” OR “utility
outcome” OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility evaluation” OR
“utility evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol” OR “euro qols”
OR “utility analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR QALY OR
“quality adjusted life year” OR “quality adjusted life years” OR “time trade off” OR “time tradeoff” OR
“timetrade off” OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6 dimension” OR
“short form 6 dimensions” OR “short form 6” OR AQoL OR “assessment of quality of life” OR HUI2 OR
HUI3 OR QWB OR QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional” :ti,ab,kw
#4 #1 OR #2
#5 #4 AND #3
ProQuest Health Management
Search Terms Anywhere except full text:
COPD OR COAD OR “chronic obstructive pulmonary disease” OR “chronic obstructive lung disease” OR
“chronic lung disease” OR “chronic respiratory” OR “chronic obstructive airway disease” OR emphysema
OR bronchitis
AND
Anywhere except full text:
“health state” OR “health states” OR “health preference” OR “health preferences” OR “health utility”
OR “health utilities” OR “utility index” OR “utilities index” OR “utility indices” OR “utility measure” OR
“utility measures” OR “utility value” OR “utility values” OR “utility score” OR “utility scores” OR “utility
outcome” OR “utility outcomes” OR “utility weight” OR “utility weights” OR “utility evaluation” OR
“utility evaluations” OR HUI OR HSUV OR eq5d OR euroqol* OR “eq 5d” OR “euro qol” OR “euro qols”
OR “utility analysis” OR “utility analyses” OR “cost utility” OR “cost utilities” OR CUA OR QALY OR
“quality adjusted life year” OR “quality adjusted life years” OR “time trade off” OR “time tradeoff” OR
“timetrade off” OR TTO OR “standard gamble” OR sf6d OR “sf 6d” OR “short form 6 dimension” OR
“short form 6 dimensions” OR “short form 6” OR AQoL OR “assessment of quality of life” OR HUI2 OR
HUI3 OR QWB OR QWB-SA OR “quality of well-being” OR 15D OR “15 dimensional”
Filters Language: English
Databases: ProQuest Central, Health & Medical Collection, Nursing & Allied Health Database, Public
Health Database, Health Management Database, Family Health Database, Research Library, Research
Library: Health & Medicine
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Appendix 14 Additional tables for objective IV
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TABLE 30 Confounding variables: phenotypes
Author Country Population Methods Instrument HSUV
Ding et al.182 China ACOS = 350
Asthma only= 822
COPD only= 1598
Matched control = 2770
Mean age, years (SD)
l ACOS = 43.11 (14.42)
l asthma only= 43.47 (14.65)
l COPD only = 42.07 (14.69)
l matched control = 43.83
(15.11)
Sex, male (%)
l ACOS = 58.57
l asthma only= 57.54
l COPD only = 59.89
l matched control = 61.19
COPD (%) (n= 1602)
l mild = 75.59
l moderate = 22.85
l severe = 1.56
ACOS (%) (n= 366)
l mild = 74.86
l moderate = 22.95
l severe = 2.19
Cross-sectional cohort
study. China National
Health and Wellness Survey
data (self-administered
online survey). Data from
2010, 2012 and 2013.
Participants recruited using
online and offline methods
Control = no diagnosis of
asthma, COPD, chronic
bronchitis or emphysema
COPD only= COPD,
chronic bronchitis or
emphysema
SF-36v2, SF-12v2
(SF-6D algorithm
applied to get utility
values)
Adjusted mean (SE)
l ACOS (n= 350)= 0.63 (0.01)
l asthma only (n= 822)= 0.63 (0.00)
l COPD only (n= 1598)= 0.66 (0.00)
l matched control (n = 2770)= 0.69 (0.00)
ED visits in the past 6 months, adjusted mean (SE)
l ACOS (n= 350) = 1.09 (0.13)
l asthma only (n = 822)= 0.70 (0.04)
l COPD only (n= 1598)= 1.29 (0.10)
l matched control (n= 2770)= 0.46 (0.02)
Hospitalisations in the past 6 months, adjusted mean (SE)
l ACOS (n= 350) = 0.32 (0.05)
l asthma only (n = 822)= 0.48 (0.04)
l COPD only (n= 1598)= 0.17 (0.02)
l matched control (n= 2770)= 0.11 (0.01)
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Author Country Population Methods Instrument HSUV
Miravitlles et al.220 Spain 3125 patients
COPD (1974 primary care, 1151
pneumology departments)
ACOS (n= 496)
l mean age, years
(SD)= 64.6 (9.4)
l sex, male (%)= 69.8
Non-exacerbators (n = 1894)
l mean age, years
(SD)= 66.6 (9.7)
l sex, male (%)= 85.4
Exacerbators with chronic bronchitis
(n= 602)
l mean age, years
(SD)= 69.3 (9.2)
l sex, male (%)= 85.4
Excerbators without chronic
bronchitis (n= 133)
l mean age, years
(SD)= 68.8 (9.8)
l sex, male (%)= 73.7
Transversal observational
study; 875 primary care
physicians, 258
pneumologists recruited
3/4 patients each
EQ-5D (Spanish tariff) Unadjusted mean (95% CI)
l ACOS (n= 496)= 0.65 (0.31)
l non-exacerbations (n= 1894)= 0.69 (0.29)
l exacerbations with chronic bronchitis (n= 602) = 0.52
(0.35)
l exacerbations without chronic bronchitis
(n= 133) = 0.59 (0.32)
Mean adjusted for severity of airflow obstruction, sex and
age (95% CI)
l ACOS (n= 496)= 0.61 (0.58 to 0.64)
l non-exacerbations (n= 1894)= 0.68 (0.66 to 0.69)
l exacerbations with chronic bronchitis (n= 602) = 0.54
(0.52 to 0.57)
l exacerbations without chronic bronchitis
(n= 133) = 0.61 (0.56 to 0.66)
ED, emergency department; SF-36v2, SF-36 version 2; SF-12v2, SF-12 version 2.
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TABLE 31 Confounding variables: age
Author Country Population Methods Instrument HSUV
Kim and
Kim194,219
South Korea COPD patients
556 male
l aged 19–64 years = 49.3%
l aged ≥ 65 years = 50.7%
195 female
l aged 19–64 years = 37.5%
l aged ≥ 65 years = 62.5%
Data from KNHANES EQ-5D
(Korean tariff)
Male, mean (SE)
l aged 19–64 years = 0.94 (0.01)
l aged ≥ 65 years = 0.92 (0.01)
Female, mean (SE)
l aged 19–64 years = 0.92 (0.01)
l aged ≥ 65 years = 0.82 (0.03)
Fletcher et al.262 Brazil, China,
Germany, Turkey,
USA, UK
2426 participants
Age (years)
l 45–54 = 1029
l 55–64 = 971
l 65–67 = 426
MRC dyspnoea scale severity
l mild = 849
l moderate = 1012
l evere = 521
l missing data = 44
Cross-sectional study,
participants recruited
by a contract research
organisation and data
collected in interviews
that included the EQ-5D
EQ-5D
(German, UK
and USA tariff)
Age (years), mean (SD)
l 45–54 (n = 42)= 0.686 (0.85)
l 55–64 (n = 40)= 0.605 (0.80)
l 65–67 (n = 18)= 0.585 (0.79)
A
PPEN
D
IX
14
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
166
Author Country Population Methods Instrument HSUV
Punekar et al.279 USA, France,
Germany, Italy,
Spain, UK
2703 patients
l seen by PCP= 1381
l seen by RS= 1322
Mean age, years (SD)
l seen by PCP= 66 (0.29)
l seen by RS= 66 (0.31)
Sex, male (%)
l seen by PCP= 66
l seen by RS= 71
Forced spirometry, mean (95% CI)
l seen by PCP=mild: 0.77 (0.73 to 0.81);
moderate: 0.68 (0.62 to 0.74); severe: 0.62
(0.56 to 0.68)
l seen by RS=mild: 0.68 (0.64 to 0.72); moderate:
0.72 (0.69 to 0.75); severe: 0.64 (0.61 to 0.67)
Cross-sectional survey;
physicians recruited and
recorded information
for six patients during
consultations
EQ-5D
(UK tariff)
Patient seen by PCP (n= 1381) age,
mean (95% CI)
l < 65 years = 0.77 (0.75 to 0.79)
l ≥ 65 years = 0.65 (0.62 to 0.67)
Patient seen by RS (n= 1322) age,
mean (95% CI)
l < 65 years = 0.72 (0.70 to 0.75)
l ≥ 65 years = 0.64 (0.62 to 0.67)
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TABLE 31 Confounding variables: age (continued )
Author Country Population Methods Instrument HSUV
Hazell et al.301 UK 10,471 patients (aged ≥ 16 years)
l 16–24 years = 1205
l 25–34 years = 1189
l 35–44 years = 1029
l 45–54 years = 908
l 55–64 years = 872
l 65–74 years = 757
l 75–84 years = 721
Mean age, years (SD) = 48.5 (19.4)
Sex, male (%) = 45.1 (1054 with likely OAD)
Observational study; data
gained from postal
questionnaire that includes
EQ-5D. Recruitment via
two general practices
EQ-5D
(UK tariff)
Likely OAD, mean = 0.63
Female, mean (SD)
l aged 16–24 years = 0.87 (0.84–0.91)
l aged 25–34 years = 0.79 (0.74–0.85)
l aged 35–44 years = 0.72 (0.66–0.78)
l aged 45–54 years = 0.51 (044–0.59)
l aged 55–64 years = 0.48 (0.41–0.56)
l aged 65–74 years = 0.44 (0.33–0.55)
l aged 75–84 years = 0.42 (0.32–0.53)
Male, mean (SD)
l aged 16–24 years = 0.87 (0.82–0.92)
l aged 25–34 years = 0.84 (0.79–0.88)
l aged 35–44 years = 0.63 (0.56–0.71)
l aged 45–54 years = 0.55 (0.47–0.63)
l aged 55–64 years = 0.46 (0.36–0.55)
l aged 65–74 years = 0.57 (0.47–0.67)
l aged 75–84 years = 0.44 (0.28–0.59)
KNHANES, Korean National Health and Nutrition Examination Survey; MRC, Medical Research Council; OAD, obstructive airway disease; PCP, primary care physician; RS, respiratory specialist.
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TABLE 32 Confounding variables: sex
Author Country Population Methods Instrument HSUV
Hoyle et al.191 UK COPD patients
l baseline (n = 1658)
l visit 1 (n= 1447)
l visit 2 (n= 1341)
Sex, male (%)= 68.8
Data from two Phase III,
longitudinal, randomised controlled
trials. All patients randomised to
treatment. EQ-5D conducted at
baseline and two follow-up visits
EQ-5D
(UK tariff)
Baseline of trial, mean (SD)
l male = 0.752 (0.212)
l female = 0.721 (0.228)
GOLD stage
l 1 (mild) (n = 1138)
l 2 (moderate) (n= 2093)
l 3 (severe) (n= 1080)
l 4 (very severe) (n= 135)
Kim and Kim194,219 South Korea COPD patients Data from KNHANES EQ-5D
(Korean tariff)
Sex, mean (SE)
l male (n= 556) = 0.86 (0.02)
l female (n= 195)= 0.93 (0.01)
556 male
l aged 19–64 years = 49.3%
l aged ≥ 65 = 50.7%
195 female
l aged 19–64 years = 37.5%
l aged ≥ 65 = 62.5%
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TABLE 32 Confounding variables: sex (continued )
Author Country Population Methods Instrument HSUV
Sundh et al.225 Sweden 373 COPD patients
l GOLD stage 3 (severe) = 259
l GOLD stage 4 (very severe) = 114
Male (n= 165)
l mean age, years (SD) = 72.2 (8.11)
Female (n= 208)
l mean age, years (SD) = 70.5 (7.58)
27 hospital-based secondary care
respiratory units enrolled ≈10
patients each. EQ-5D completed by
patient during visit or later at home
EQ-5D
(UK tariff)
Sex, mean (SD)
l male (n= 165) = 0.71 (0.23)
l female (n= 208)= 0.60 (0.30)
Kim et al.236 South Korea 200 COPD patients (GOLD stages 1–4);
age, years
l < 60= 25
l 60–69 = 74
l 70–79 = 85
l ≥ 80= 16
Sex, male (%)= 91.5
Interview, including EQ-5D.
Recruitment by respiratory
specialists via outpatient
departments
EQ-5D
(Korean tariff)
Sex, mean (SE)
l male = 0.86 (0.02)
l female = 0.93 (0.01)
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Author Country Population Methods Instrument HSUV
Fletcher et al.262 Brazil, China,
Germany,
Turkey, USA,
UK
2426 patients
Age, years
l 45–54 = 1029
l 55–64 = 971
l 65–67 = 426
MRC dyspnoea scale severity
l mild = 849
l moderate = 1012
l severe = 521
l missing data = 44
Cross-sectional study. Data gained
from interviews with participants
(including EQ-5D). Recruited by a
contract research organisation.
Participants recruited to represent
wide range of demographics and
disease severity
EQ-5D
(Germany, UK
and USA tariff)
Sex, mean (SE)
l male (n= 1178) = 0.678 (0.009)
l females (n= 1243)= 0.596 (0.009)
Punekar et al.279 USA, France,
Germany, Italy,
Spain, UK
2703 patients
l seen by PCP= 1381
l seen by RS= 1322
Cross-sectional survey. Physicians
recruited and recorded information
for six patients during consultations
EQ-5D
(UK tariff)
Sex (seen by PCP), mean (95% CI)
l male = 0.70 (0.68 to 0.72)
l female = 0.69 (0.66 to 0.71)
Sex (seen by RS), mean (95% CI)
l male = 0.69 (0.67 to 0.71)
l female = 0.65 (0.62 to 0.68)
Mean age, years (SD)
l seen by PCP= 66 (0.29)
l seen by RS= 66 (0.31)
Sex, male (%)
l seen by PCP= 66
l seen by RS= 71
KNHANES, Korean National Health and Nutrition Examination Survey; MRC, Medical Research Council; PCP, primary care physician; RS, respiratory specialist.
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TABLE 33 Confounding variables: number and severity of exacerbations
Author Country Population Methods Instrument HSUV
Miravitlles et al.206 Spain 346 COPD patients
Mean age, years (SD) = 67.9 (9.7)
Sex, male (%)= 85.5
Multicentre observational
cross-sectional study;
15 hospitals. Patients
recruited at outpatient
clinic. All patients in stable
condition
EQ-5D (Spanish tariff) Exacerbations in previous year, median (IQR)
l no= 0.87 (0.25)
l yes = 0.78 (0.31)
l < 2= 0.84 (0.29)
l ≥ 2= 0.74 (0.54)
Punekar et al.279 USA, France, Germany,
Italy, Spain, UK
2703 patients
l seen by PCP= 1381
l seen by RS= 1322
Mean age, years (SD)
l seen by PCP= 66 (0.29)
l seen by RS= 66 (0.31)
Sex, male (%)
l seen by PCP= 66
l seen by RS= 71
Cross-sectional survey.
Physicians recruited and
recorded information for
six patients during
consultations
EQ-5D (UK tariff) Exacerbations (seen by PCP), mean (95% CI)
l 0= 0.78 (0.75 to 0.80)
l 1–2= 0.74 (0.72 to 0.77)
l ≥3 = 0.61 (0.59 to 0.64)
Exacerbations (seen by RS), mean (95% CI)
l 0= 0.75 (0.72 to 0.77)
l 1–2= 0.73 (0.71 to 0.76)
l ≥3 = 0.57 (0.54 to 0.60)
IQR, interquartile range; PCP, primary care physician; RS, respiratory specialist.
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TABLE 34 Confounding variables: number and type of comorbidities
Author Country Population Methods Instrument HSUV
Martinez Rivera
et al.202
Spain 115 COPD patients
l mean age, years (SD) = 66.9 (8.8)
l sex, male (%) = 93
Patients with depression
l mean age, years (SD) = 68.3 (8.1)
l sex, male (%) = 96.4
Patients without depression
l mean age, years (SD) = 66.5 (9)
l sex, male (%) = 92
Multicentre observational
cross-sectional study;
13 hospitals. Data also
used in Alcazar et al.204
and García-Polo et al.205
EQ-5D (Spanish
tariff)
Mean (SD)
l patients with depression (n = 28)= 0.40 (0.30)
l patients without depression (n = 87)= 0.76 (0.29)
Hong et al.194,218 South
Korea
1178 COPD patients
l mean age, years (SD) = 63.7 (9.5)
l sex, male (%) = 69
GOLD stage 1 (mild) COPD (n= 497)
l mean age, years (SD) = 65.1 (9.5)
l sex, male (%) = 71
GOLD stage 2 (moderate) COPD (n= 612)
l mean age, years (SD) = 62.4 (9.6)
l sex, male (%) = 68
GOLD stage 3 (severe) or 4 (very severe)
COPD (n= 69)
l mean age, years (SD) = 64.6 (8.0)
l sex, male (%) = 75
1178 control subjects
l mean age, years (SD) = 63.4 (9.3)
l sex, male (%) = 69
Data from KNHANES EQ-5D (Korean) Mean (SD)
l 0 comorbid diseases
¢ mild = 0.95 (0.12)
¢ moderate = 0.94 (0.12)
¢ severe = 0.91 (0.08)
l 1 comorbid disease
¢ mild = 0.91 (0.14),
¢ moderate = 0.93 (0.12)
¢ severe = 0.91 (0.08)
l 2 comorbid diseases
¢ mild = 0.86 (0.17)
¢ moderate = 0.88 (0.15)
¢ severe = 0.87 (0.14)
l ≥ 3 comorbid diseases
¢ mild = 0.84 (0.14)
¢ moderate = 0.82 (0.19)
¢ severe = 0.78 (0.18)
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TABLE 34 Confounding variables: number and type of comorbidities (continued )
Author Country Population Methods Instrument HSUV
Miravitlles et al.221 Spain 346 COPD patients
l mean age, years (SD) = 67.9 (9.7)
l sex, male (%) = 85.5
Multicentre observational
cross-sectional study; 15
hospitals. Patients recruited
at outpatient clinic. All
patients in stable condition
EQ-5D (Spanish
tariff)
Median (IQR)
l cardiovascular disease= 0.78 (0.30)
l no cardiovascular disease = 0.82 (0.25)
l diabetes= 0.81 (0.25)
l no diabetes = 0.81 (0.38)
l haematological malignancies = 0.80 (0.16)
l no haematological malignancies = 0.81 (0.27)
Miravitlles et al.206 Spain 713 COPD patients
l mean age, years (SD) = 68.3 (9.3)
l sex, male (%) = 83
Patients with depression (n= 527)
l mean age, years (SD) = 68.3 (9.1)
l sex, male (%) = 82.1
Patients without depression (n= 186)
l mean age, years (SD) = 68.3 (9.8)
l sex, male (%) = 85.7
DEPREPOC – a multicentre
observational cross-
sectional study
EQ-5D (Spanish
tariff)
Mean (SD)
l total patients (n = 713)= 0.62 (0.24)
l patients with depression (n = 527)= 0.55 (0.21)
l patients without depression
(n= 186) = 0.83 (0.16)
DEPREPOC, Depression in Chronic Obstructive Pulmonary Disease; IQR, interquartile range; KNHANES, Korean National Health and Nutrition Examination Survey.
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TABLE 35 Confounding variables: smoking history
Author Country Population Methods Instrument HSUV
Lee et al.194,201 South Korea Non-smoker (n= 399)
l aged < 65 years (%) = 52.4
l aged ≥ 65 years (%) = 46.6
l sex, male (%)= 25.1
Smoker (n = 823)
l aged < 65 years (%) = 50.1
l aged ≥ 65 years (%) = 50.4
l sex, male (%)= 93.6
Data from KNHANES EQ-5D (Korean tariff) Mean (SD)
l smoker (n= 823)= 0.91 (0.15)
l non-smoker (n = 399)= 0.87 (0.16)
Miravitlles et al.221 Spain 346 COPD patients
l mean age, years (SD)= 67.9 (9.7)
l sex, male (%)= 85.5
Multicentre, observational,
cross-sectional study,
15 hospitals. Patients
recruited at outpatient clinic.
All patients in stable condition
EQ-5D (Spanish tariff) Median (IQR)
l former smoker = 0.81 (0.25)
l current smoker = 0.81 (0.27)
Mullen et al.242 Canada 956 COPD
Smokers = smoked daily in the last 6 months
Mean age, years (SD)
l usual care= 62.3 (15.4)
l OMSC = 65.9 (10.6)
Smokers hospitalised for one
of four selected diagnoses.
Intervention: OMSC
intervention. Comparator:
usual care. Utility scores
calculated from Sullivan
et al.310 and Tillman
et al.311
EQ-5D (USA tariff) Former smoker = 0.52
Current smoker = 0.50
IQR, interquartile range; KNHANES, Korean National Health and Nutrition Examination Survey; OMSC, Ottawa Model for Smoking Cessation.
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TABLE 36 Confounding variables: BMI
Author Country Population Methods Instrument HSUV
Miravitlles et al.221 Spain 346 COPD patients
l sex, male (%) = 85.5
l mean age, years (SD) = 67.9 (9.7)
Multicentre observational cross-
sectional study; 15 hospitals.
Patients recruited at outpatient
clinic. All patients in stable
condition
EQ-5D (Spanish tariff) BMI, median (IQR)
l underweight = 0.69 (0.51)
l normal = 0.80 (0.31)
l overweight = 0.82 (0.25)
l obese = 0.81 (0.38)
García-Rio et al.232 Spain 3797 COPD patients, aged 40–80 years
Normal weight
l mean age, years (SD) = 61 (10)
l sex, male (%) = 63.9%
Overweight
l mean age, years (SD) = 64 (11)
l sex, male (%) = 75.6
Obese
l mean age, years (SD) = 66 (9)
l sex, male (%) = 68.1
EPI-SCAN study – multicentre
cross-sectional population-based
study
EQ-5D (Spanish tariff) BMI, mean (SD)
l normal weight (n = 97)= 0.83 (0.24)
l overweight (n= 172) = 0.90 (0.19)
l obese (n= 113) = 0.83 (0.21)
l total = 0.86 (0.21)
IQR, interquartile range.
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TABLE 37 Confounding variables: socioeconomic status
Author Country Population Methods Instrument HSUV
Kim and Kim194,219 South Korea COPD patients
556 male
l aged 19–64 years (%) = 49.3
l aged ≥ 65 years (%) = 50.7
195 female
l aged 19–64 years (%) = 37.5
l aged ≥ 65 years (%) = 62.5
Data from KNHANES EQ-5D (Korean tariff) Mean (SE)
l GOLD stage 1 (mild) = 0.90 (0.01)
l GOLD stage 2 (moderate) = 0.92 (0.01)
l GOLD stage 3 (severe) = 0.95 (0.01)
l GOLD stage 4 (very severe) = 0.96 (0.01)
Miravitlles et al.271 Spain 4574 COPD patients
l mean age, years (SD) = 67.06 (10.04)
l sex, male (%) = 83.7
Patients recruited from GPs
and respiratory specialists
EQ-5D (Spanish tariff) Socioeconomic status – unadjusted
l low= 0.63
l medium= 0.72
l high= 0.75
Socioeconomic status – adjusted for age
l low= 0.64
l medium= 0.71
l high= 0.73
Socioeconomic status – adjusted for age and severity
l low= 0.66
l medium= 0.70
l high= 0.71
KNHANES, Korean National Health and Nutrition Examination Survey.
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Appendix 15 Preferred Reporting Items for
Systematic Reviews and Meta-Analyses checklist
Section/topic Number Checklist item Reported on page number
Title
Title 1 Identify the report as a systematic review,
meta-analysis or both
The report was identified as a structured narrative
literature review, which followed systematic
procedures and, where possible, adhered to the
PRIMSA checklist (see Appendix 12, page 141)
Abstract
Structured
summary
2 Provide a structured summary including, as
applicable: background; objectives; data
sources; study eligibility criteria, participants
and interventions; study appraisal and
synthesis methods; results; limitations;
conclusions and implications of key
findings; systematic review registration
number
The literature review was conducted as
part of the economic evaluation section
(see Chapter 5) of the report and thus
inclusion of an abstract was not applicable
Introduction
Rationale 3 Describe the rationale for the review in the
context of what is already known
The rationale for the review was included as
part of the methodology of the report on
Chapter 5, page 61
Objectives 4 Provide an explicit statement of questions
being addressed with reference to
participants, interventions, comparisons,
outcomes, and study design (PICOS)
Four objectives for the review were stated
(see Appendix 12, page 141)
Methods
Protocol and
registration
5 Indicate if a review protocol exists, if and
where it can be accessed (e.g. web address)
and, if available, provide registration
information including registration number
The review protocol is described in
Appendix 12. No formal registration was
made
Eligibility
criteria
6 Specify study characteristics (e.g. PICOS,
length of follow-up) and report
characteristics (e.g. years considered,
language, publication status) used as
criteria for eligibility, giving rationale
The review was designed using a two-stage
process. Eligibility criteria were developed for
each stage based around the PICOS format
(when relevant) and included language and
year of publication (see Tables 24 and 25,
pages 142 and 143)
Information
sources
7 Describe all information sources (e.g.
databases with dates of coverage, contact
with study authors to identify additional
studies) in the search and date last searched
All information sources were described in
Appendix 12 (page 142) and databases, with
access dates were included in Appendix 13
Search 8 Present full electronic search strategy for at
least one database, including any limits
used, such that it could be repeated
Full electronic search strategies are presented
in Appendix 12 (page 143) and all individual
database searches are included in Appendix 13
Study
selection
9 State the process for selecting studies (i.e.
screening, eligibility, included in systematic
review, and, if applicable, included in the
meta-analysis)
The process of study selection, including use
of inclusion and exclusion criteria, was
described in Appendix 12, pages 144 and 148
Data
collection
process
10 Describe method of data extraction from
reports (e.g. piloted forms, independently,
in duplicate) and any processes for
obtaining and confirming data from
investigators
The process of data extraction, including how
duplicate information was dealt with, was
described in Appendix 12, page 148
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Section/topic Number Checklist item Reported on page number
Data items 11 List and define all variables for which data
were sought (e.g. PICOS, funding sources)
and any assumptions and simplifications
made
The data items extracted were listed in
Appendix 12, page 148
Risk of bias in
individual
studies
12 Describe methods used for assessing risk
of bias of individual studies (including
specification of whether this was done at
the study or outcome level) and how this
information is to be used in any data
synthesis
Not applicable (risk of bias was not formally
assessed, although potential bias was
considered when selecting studies for the
economic evaluation)
Summary
measures
13 State the principal summary measures
(e.g. risk ratio, difference in means)
The principal summary measures were
differences in HSUVs
Synthesis of
results
14 Describe the methods of handling data and
combining results of studies, if done,
including measures of consistency (e.g. I2)
for each meta-analysis
The studies were used individually for the
economic evaluation, except in one case in
which a weighted average of the results were
used (see Chapter 5, pages 63–5)
Risk of bias
across studies
15 Specify any assessment of risk of bias that
may affect the cumulative evidence (e.g.
publication bias, selective reporting within
studies)
Not applicable (risk of bias was not formally
assessed, although potential bias was
considered when selecting studies for the
economic evaluation)
Additional
analyses
16 Describe methods of additional analyses
(e.g. sensitivity or subgroup analyses,
meta-regression), if done, indicating which
were prespecified
Not applicable (no additional analysis was
undertaken for this review as it was deemed
outside the scope of the project)
Results
Study
selection
17 Give numbers of studies screened, assessed
for eligibility, and included in the review,
with reasons for exclusions at each stage,
ideally with a flow diagram
The study selection process was presented in
a PRIMSA flow diagram (see Appendix 12,
Figure 29, page 144)
Study
characteristics
18 For each study, present characteristics for
which data were extracted (e.g. study size,
PICOS, follow-up period) and provide the
citations
Study characteristics for all selected studies were
presented in Table 27–29 (see Appendix 12,
pages 149–53)
Risk of bias
within studies
19 Present data on risk of bias of each study
and, if available, any outcome level
assessment (see item 12)
Not applicable (risk of bias was not formally
assessed, although potential bias was
considered when selecting studies for the
economic evaluation)
Results of
individual
studies
20 For all outcomes considered (benefits or
harms), present, for each study: (a) simple
summary data for each intervention group
(b) effect estimates and confidence
intervals, ideally with a forest plot
For all selected studies, HSUVs (means and
SDs) were presented in Tables 27–29
(see Appendix 12, pages 149–53)
Synthesis of
results
21 Present results of each meta-analysis done,
including confidence intervals and measures
of consistency
Not applicable (meta-analysis was not
included as part of the data synthesis, instead
results were presented as a narrative
summary)
Risk of bias
across studies
22 Present results of any assessment of risk of
bias across studies (see item 15)
Not applicable (risk of bias was not formally
assessed, although potential bias was
considered when selecting studies for the
economic evaluation)
Additional
analysis
23 Give results of additional analyses, if done
[e.g. sensitivity or subgroup analyses,
meta-regression (see item 16)]
Not applicable (no additional analyses were
conducted)
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Section/topic Number Checklist item Reported on page number
Discussion
Summary of
evidence
24 Summarise the main findings including the
strength of evidence for each main
outcome; consider their relevance to key
groups (e.g. health-care providers, users,
and policy-makers)
Brief summaries of the results in relation to
each objective are provided in Appendix 12,
pages 148, 149, 154 and 155
Limitations 25 Discuss limitations at study and outcome
level (e.g. risk of bias), and at review-level
(e.g. incomplete retrieval of identified
research, reporting bias)
The purpose of the review was to identify
studies to inform the economic evaluation;
therefore, it was not written as a full review,
so a section on limitations was not applicable.
However, risk of bias and limitations of
individual studies were considered when
selecting studies for the economic evaluation
Conclusions 26 Provide a general interpretation of the
results in the context of other evidence, and
implications for future research
The review was designed specifically to
identify papers to support the economic
evaluation; therefore, this section was not
applicable
Funding
Funding 27 Describe sources of funding for the
systematic review and other support
(e.g. supply of data); role of funders for
the systematic review
The literature review was conducted as part of
the economic evaluation section (see Chapter 5)
of the report. Funding details can be found on
pages vi and xxvii
PICOS, participants, interventions, comparisons, outcomes and study design.
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